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ABSTRACT 
 
Samuel Lee Bartlett: New Complexity-Building Reactions of α-Keto Esters 
(Under the direction of Jeffrey S. Johnson) 
 
I. Introduction: Importance of Asymmetric Catalysis and the Reactivity 
Patterns of α-Keto Esters  
 
II. Synthesis of Complex Tertiary Glycolates by Enantioconvergent Arylation 
of Stereochemically Labile α-Keto Esters 
 
Enantioconvergent arylation reactions of boronic acids and racemic β-stereogenic 
α-keto esters have been developed. The reactions are catalyzed by a chiral (diene)Rh(I) 
complex and provide a wide array of β-stereogenic tertiary aryl glycolate derivatives with 
high levels of diastereo- and enantioselectivity. Racemization studies employing a series 
of sterically differentiated tertiary amines suggest that the steric nature of the amine base 
additive exerts a significant influence on the rate of substrate racemization. 
 
III. Palladium-Catalyzed β-Arylation of α-Keto Esters 
A catalyst system derived from commercially available Pd2(dba)3 and PtBu3 has 
been applied to the coupling of α-keto ester enolates and aryl bromides. The reaction 
provides access to an array of β-stereogenic α-keto ester derivatives. When the air stable 
 iv 
 
ligand precursor PtBu3·HBF4 is employed, the reaction can be carried out without use of 
a glovebox. The derived products are of broad interest given the prevalence of the α-keto 
acid substructure in biologically important molecules.  
 
IV. Catalytic Enantioselective [3+2] Cycloaddition of α-Keto Ester Enolates 
and Nitrile Oxides 
 
An enantioselective [3+2] cycloaddition reaction between nitrile oxides and 
transiently generated enolates of α-keto esters has been developed. The catalyst system 
was found to be compatible with in situ nitrile oxide generation conditions. A versatile 
array of nitrile oxides and α-keto esters could participate in the cycloaddition, providing 
novel 5-hydroxy-2-isoxazolines in high chemical yield with high levels of diastereo- and 
enantioselectivity. Notably, the optimal reaction conditions circumvented concurrent 
reaction via O-imidoylation and hetero-[3+2] pathways.  
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Chapter I Introduction 
 
1.1 Enantioselective Catalysis: Implications for Human Health 
 
The key role played by stereochemistry in biological molecular recognition events 
is now well understood. Related to the the development of small molecule 
pharmaceuticals, one enantiomer might possess desirable therapeutic properties, while 
the opposite antipode may be inherently detrimental. For instance (R)-levamisole is 
known to cause emesis.1 Alternatively, a member of an enantiomeric pair may simply be 
inactive. In such cases its presence may complicate the determination of precise dose-
response relationships and lessen the therapeutic window.2 These considerations 
underwrite the recent ascendancy of the single-enantiomer therapeutics, which now 
account for sales of over $100 billion.3 As a striking example, ledipasvir, an NS5A 
inhibitor of the hepatitis C virus, was the 2nd greatest selling pharmaceutical in 2016.4 
Considering the unremitting pressure on human health from factors including cancer and 
increasing microbial resistance to existing antibiotics, the development of novel organic 
transformations leading to diverse architecturally complex molecular frameworks with 
potential biological activity is an imperative scientific objective. Enantioselective catalysis 
of organic transformations is perhaps the most strategic and straightforward method to 
produce new organic scaffolds in enantioenriched form.5 A striking illustration of this can 
be found in the recent synthesis of idasanutlin 1, an MDM2 inhibitor currently in clinical 
trials, by Hoffman-La Roche.6 The process relies on a chiral Cu(I) complex-catalyzed 
azomethine ylide cycloaddition between readily accessed dipolarophile 2 and azomethine 
 2 
 
ylide precursor 3. This methodology enables assembly of the molecules formidably 
complex framework, including three of four stereocenters, in a single step (Scheme 1-1). 
 
Scheme 1-1 Catalytic Enantioselective Synthesis of Idasanutlin 
 
Within the realm of asymmetric catalysis, a handful of compound classes enjoy 
privileged status due to enabling reactivity features and the prevalence of derived 
products in biologically active organic structures.  Among these privileged compounds, α-
keto acid derivatives are particularly important due to the pervasiveness of the amino acid 
and glycolic acid substructure in pharmaceuticals and medicinally active natural products 
(5-10, Scheme 1-2).7  
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Scheme 1-2 Selected Examples of Medicinal Compounds Bearing the Amino Acid or 
Glycolic Acid Substructure 
 
 
 
1.2 Reactivity of α-Keto Esters 
With regards to their utility in synthesis, α-keto acid derivatives, including α-keto 
esters 11, are unique due to their dual electrophilic8  and nucleophilic9 modes of reactivity. 
The versatile reactivity of α-keto acid derivatives enables their transformation to diverse 
glycolates and amino acids (Scheme 1-3) The presence of an adjacent electron accepting 
ester functionality activates the keto functionality toward electrophilic reactivity, while 
simultaneously acidifying the β-proton, thereby promoting enolization and subsequent 
nucleophilic reactivity. As a point of comparison DFT calculations (B3LYP, 6-31+G(d,p)) 
 4 
 
show that the LUMO (lowest unoccupied molecular orbital) of ethyl pyruvate (11, R1 = H, 
R2 = ethyl) is considerably lower in energy than acetone (LUMOpyruvate = -2.35 eV, 
LUMOAcMe = -0.74 eV).10 As a result, ethyl pyruvate is approximately three orders of 
magnitude more acidic than acetone in aqueous solution and is expected to be more 
reactive in nucleophilic additions.11  
Scheme 1-3. Ambiphilic Reactivity of α-Keto Esters.  
 
The unique reactivity profile of α-keto acids is also of importance to numerous 
biological processes. For instance, α-keto acids give rise to amines via transaminase-
catalyzed amine transposition of the coenzyme pyridoxal phosphate Scheme 1-4, eq. 
1).12 In this process, the condensation of pyridoxalamine 16 to form imine intermediate 
18 is likely aided by the electrophilicity of the α-keto acid, while the key protoropic shift 
is driven by the presence of the adjacent electron withdrawing carboxylate functionality. 
The conversion of pyruvic acid 21 to the building block acetyl-CoA 22 during the Krebs 
cycle constitutes a second important biological process involving α-keto acids (Scheme 
1-4, eq. 2).12 Finally, the biological synthesis of N-acetylneuraminic acid 23, an important 
structural component of gangliosides, involves the aldolase-catalyzed condensation of 
pyruvic acid 21 and N-acetylmannosamine 24 (Scheme 1-4, eq. 3).13 This 
 5 
 
transformation is a notable example of the nucleophilic reactivity of α-keto acids in a 
biological process. 
The enantioconvergent arylation methodology14 to be described herein exploits the 
electrophilic activity of α-keto esters and the starting materials for this reaction can be 
synthesized using a newly developed palladium-catalyzed β-arylation that harnesses the 
nucleophilic activity of α-keto esters.15 Finally, we will discuss the development of an 
enantioselective [3+2] cycloaddition of α-keto ester enolates and nitrile oxides that 
simultaneously relies on both manifolds of reactivity.16  
Scheme 1-4 Reactivity of α-Keto Acids in Biological Processes 
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Chapter II Synthesis of Complex Tertiary 
Glycolates by Enantioconvergent Arylation of 
Stereochemically Labile α-Keto Esters 
 
 2.1 Synthesis of Alcohols by Enantioconvergent Addition Reactions 
Nucleophilic addition to α-stereogenic carbonyl derivatives is a robust strategy for 
the synthesis of complex alcohols.1 The requisite chiral electrophiles are readily prepared 
by the functionalization of enolate derivatives (i.e. the β-arylation methodology to be 
described herein). The addition of acyl anion equivalents to prochiral electrophiles 
constitutes an alternative approach that can be deployed in the synthesis of α-stereogenic 
carbonyls.2,3 Both strategies require basic reaction conditions and the inclination of 
optically active carbonyls bearing acidic protons to racemize via enolization can pose a 
significant challenge.4  
Scheme 2-1 Noyori’s Pioneering Dynamic Kinetic Hydrogenation 
 
Enantioconvergent catalysis represents a powerful solution to this problem.5 Disclosed by 
Noyori and co-workers in their foundational report of a dynamic kinetic hydrogenation, 
the ability to channel configurationally labile starting materials through stereoconvergent 
reaction pathways. (Scheme 2-1), represents a significant advancement in organic 
 9 
 
synthesis.6 Racemization, typically viewed as an undesired process, can be harnessed to 
achieve streamlined syntheses of complex molecular frameworks. 7 
Enantioconvergent additions are classified as either dynamic kinetic resolutions 
(DKRs) or Type I dynamic kinetic asymmetric transformations (DyKATs).5,8 In a DKR the 
racemization is independent of the chiral catalyst (Scheme 2-2) and the stereoselectivity 
is affected by the rate of racemization, which generally must be greater than the rate of 
reaction for the fast reacting enantiomer. In a Type I DyKAT, racemization is promoted 
by the chiral catalyst. The rates of formation and transformation of epimeric 
catalyst/substrate complexes and their concentrations influence stereoselectivity. 
Processes that fall within these mechanistic paradigs can be described according to 
Curtin–Hammett kinetics. (Scheme 2-2). 
Scheme 2-2 Mechanistic Considerations 
 
Numerous tranformations that operate under these mechanistic paradigms have 
been developed.5 The complexity found in the products ascends according to the number 
of stereocenters centers formed and the reagents coupled in the enantioselective step. 
Beginning with enantioconvergent reactions that furnish a single stereocenter,9,10 the next 
stratum of complexity includes Noyori-type hydrogenations that establish two chiral 
centers.6,11,12 As discussed above, facile substrate enantiomerization is a prerequisite for 
obtaining high stereoselectivity in certain enantioconvergent reactions;5,8 therefore, β-
 10 
 
oxo ester derivatives have emerged as the factotum substrate class for dynamic kinetic 
hydrogenations (Scheme 2-2, eq. 2). In contrast, by capitalizing on the inherent 
tunability of the basic Ru(II)-sulfonamide framework developed by Noyori, our lab 
identified a novel terphenylsulfonamide variant that made possible chemo- and 
enantioselective reduction of the α-keto ester moiety (Scheme 2-2, eq. 3). Non-
hydrogenative transformations that establish two chiral centers constitute the third 
echelon of complexity.13 In this realm our lab has developed organocatalytic dynamic 
kinetic aldolizations of β-halogenated α-keto esters and dynamic kinetic aminoallylations 
of β-formyl amides. The final echelon of complexity comprises a handful of reactions that 
involve the addition of prochiral nucleophiles and create three chiral centers, including 
an enantioconvergent homoenolate addition developed by our lab that furnishes 
stereochemically complex glycolate architectures (Scheme 2-3, eq. 5).14  
Scheme 2-3 Evolution of Complexity in Enantioconvergent Addition Reactions 
 
 
2.2 Enantioconvergent Arylation: Introduction 
The recognition that the basic additives or catalysts employed in the above 
transformations likely mediate substrate enantiomerization has been key to the de novo 
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design of enantioconvergent processes in our laboratory. Accordingly, the transition 
metal-catalyzed addition of nonstabilized carbon nucleophiles to ketones emerged as a 
compelling opportunity to generate complex tertiary alcohols not accessible  
 
 
 
Scheme 2-4 Proposed Enantioconvergent Hayashi–Miyaura-Type Reactions 
 
through other methods (Scheme 2-4). The Hayashi–Miyaura type reactions typically 
rely on the base-promoted transmetallation of an organoboron or organosilicon pro-
nucleophile to a chiral metal complex.15 As an example, the enantioselective addition of 
arylboronic acids to carbonyl derivatives, including α-keto esters, has been widely 
developed.16 Zhou and co-workers reported the asymmetric addition of arylboronic acids 
to arylglyoxylates such as 1 under the action of a complex comprising rhodium(I) and 
chiral phosphite 2, while Ready and co-workers developed a novel hybrid phosphine-
allene catalyst 5 for an analogous transformation (Scheme 2-5).  
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Scheme 2-5 Enantioselective α-Keto Ester Arylations 
 
Considering their chemical stability, ease of handling and broad commercial 
availability,17  we envisioned the deployment of arylboronic acids in an enantioconvergent 
addition to racemic α-keto ester electrophiles electrophiles would facilitate the 
production of diverse, stereochemically complex glycolate architectures.  
2.3 Optimization Studies 
Carbonyl electrophiles and their derivatives lacking electron withdrawing 
functionality (i.e. ketone, ester, or halogen) at the chiral α center are underutilized in 
dynamic kinetic resolutions (DKR). List and Zhao have reported a dynamic kinetic 
reductive aminations employing α-alkyl, aryl branched imines that presumably racemize 
via enamine intermediates.18 In addition, the cyclohexanecarboxaldehyde derivatives 
utilized by Ward and co-workers likely racemize via an analogous pathway.19 Finally, 
dynamic kinetic hydrogenations of nonactivated aldehydes and ketones have been shown 
to occur in the presence of tert-butoxide bases.20 Nevertheless, considering that facile 
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racemization is essential, the execution of DKRs employing compounds of lower acidity 
is inherently more challenging.8 However, in this context the use of less activated 
substrates would allow access to heretofore unknown glycolate architectures. 
In light of the considerations described above, the β-alkyl, aryl substituted α-keto 
ester derivative 7a was chosen as a model substrate for this transformation (Table 2-1).  
Our group has previously developed dynamic kinetic resolutions of α-keto esters that 
occur in the presence of tertiary amines;11b-e  therefore, we reasoned that an amine base 
would promote substrate racemization. Sterically hindered Hünig’s base (iPr2NEt) was 
initially selected to abate potential interference of the Rh(I)-catalyst through 
nonproductive binding. A substoichiometric quantity of potassium hydroxide was 
employed because analogous conditions promote the Hayashi–Miyaura arylation of  
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Table 2-1 Optimization of Enantioconvergent Arylation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a) All reactions were conducted on a 0.10 mmol scale. b) Determined by 1H NMR analysis of the 
crude reaction mixture. c) Determined by HPLC using a chiral stationary phase. d) Reaction time 
= 36 h. e) 3.0 equiv CsF. f) 6.0 equiv of Et3N. g) CHCl3 as solvent. h) Reaction time = 48 h. i) 
entrya cat. org. base inorg. base conv (%)b drb erc 
1 9 DIPEA KOH 59 >20:1 80:20 
2 10 DIPEA KOH 56 >20:1 90:10 
3 11 DIPEA KOH 40 >20:1 90:10 
4d 12 DIPEA KOH 61 2.7:1 43:57 
5e 11 DIPEA CsF >95 >20:1 70:30 
6e 11 Et3N CsF >95 20:1 89:11 
7e,f 11 Et3N CsF 85 >20:1 92:8 
8e,f,g,h 11 Et3N CsF >95 >20:1 94:6 
9e,f,g,h 10 Et3N CsF >95 >20:1 94:6 
10e,f,g,h,i 10 Et3N CsF >95 >20:1 94:6 
11j,k,e,f,g,h 11 Et3N CsF >95 >20:1 93:7 
12j,l,,e,f,g 11 Et3N CsF >95 14:1 91:9 
13e,g,h,j 13 Et3N CsF trace - - 
14e,g,h,j 14 Et3N CsF trace - - 
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Reaction was run at 60 °C. j) 3.0 equiv PhB(OH)2, k) Substrate ester = 
tBu. l) Substrate ester = 
CH2Ph 
isatins and 7 is sensitive to stoichiometric hydroxide base.21  An initial evaluation of 
ligands revealed that rhodium complex 9 bearing a Ph-substituted norbornadiene derived 
ligand, developed by Hayashi and co-workers, provided promising levels of 
enantioselectivity,22 although low conversion was observed under these conditions (entry 
1). Further screening showed the 4-CF3C6H4- and 3,5-(CF3)2C6H3-substituted analogues 
10 and 11 provided higher levels of enantioselection; however, conversion remained low 
(Table 2-1, entries 2 and 3). The supposed low acidity of these substrates caused us to 
wonder if a simple kinetic resolution was occurring under these conditions, but this 
possibility was ruled out by isolation of racemic unreacted 7a from entry 3. Interestingly, 
the benzyl substituted ligand 12 provided low enantioselectivity slightly in favor of 
opposite enantiomer, while also exhibiting drastically lower levels of diastereocontrol 
over the formation of 8a (entry 4). Switching the inorganic base promoter from 
potassium hydroxide to CsF while increasing the loading to 3.0 equiv promoted full 
conversion to the desired aryl glycolate, albeit with a striking decline in enantioselectivity 
(entry 5). Simply replacing Hünig’s base with triethylamine restored the previously 
observed levels of enantioselectivity (entry 6). Further increasing the amount of 
triethylamine to 6.0 equiv provided higher levels of enantioselectivity (entry 7), although 
a longer reaction time was necessary to achieve full conversion under these conditions. 
Satisfactory levels of enantioselectivity were achieved when chloroform was used as 
solvent in place of methylene chloride (entry 8). At this stage of optimization it was noted 
that both the 4-CF3C6H4- and 3,5-(CF3)2C6H3-substituted norbornadiene complexes 10 
and 11 provided identical levels of enantioselectivity (entries 8 and 9). Furthermore, 
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conducting the reaction at 60 °C does not influence the enantio- or diastereoselectivity of 
the process (entry 10). Substituting the ethyl ester of 7a with bulkier tBu or Bn groups 
(entries 11 and 12, respectively) did not result in improved enantioselectivity. Finally, 
although phosphine and phosphite based ligands have been utilized in Hayashi–Miyaura-
type arylation (Scheme 2-5) reactions of α-keto esters, a complex of triphenylphosphite 
(13, entry 13) as well as hydroxy[(S)-BINAP]rhodium(I) dimer (14, entry 14) failed to 
catalyze this transformation.  
 The superiority of the chiral(diene)Rh(I) catalysts merits further discussion. The 
original Miyaura arylation of aldehydes utilized an arylphosphine-Rh(I) catalyst 
system.15a In contrast, arylations of α-keto esters have relied on ligand systems 
characterized by higher π- accepting ability.16 For instance, although the ligand system 
reported by Ready and co-workers contains a bisphosphine motif (Scheme 2-5), X-ray 
crystallographic analysis revealed that the rhodium center interacts with the central π 
acidic allene.16b The systems reported by Zhou, Xu, and Yamamoto employ a phosphite, a 
sulfur-olefin hybrid, and a bisphosphoramidite ligand, respectively.Diene ligands are 
characterized by several features which likely manifest in their effectiveness for the title 
reaction.23 The aptitude of diene ligands to form ridged chelates underwrites the stability 
of the derived Rh(I) complexes; in contrast to arylphosphine-Rh(I) systems, the majority 
of chiral(diene)Rh(I) complexes, including those reported herein, are air tolerant and are 
stable to silica gel chromatography.22 Diene ligands exhibiting a greater degree of 
geometric strain are found to form more stable complexes due to binding induced 
pyramidalization (Scheme 2-6).24 The Dewar–Chatt–Duncanson accounts for the 
unique electronic properties of chiral(diene)Rh(I) catalysts; simultaneous σ donation and 
π back donation occurs between the ligand π system and the metal center.25 The large 
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change in chemical shift between the free and complexed ligand vinyl resonance upon 
formation of complex 10 provides evidence for these effects: the unbound ligand exhibits 
a vinyl resonance at δ 7.18 and this signal is shifted to 4.24 in complex 10. These unique 
electronic features may be important for activation of the bound α-keto ester electrophile 
which is more sterically hindered than the aldehydes originally reported by Miyaura. 
Finally, a feature inherent to Hayashi’s original design is the ability of the square planar 
chiral(diene)Rh(I) complexes to mimic the way analogous complexes of C2-symmetric 
bisphosphines relay chirality in asymmetric transformations (vide infra)  
Scheme 2-6 Binding Strength of Diene Ligands and the Dewar –Chatt–Duncanson 
Model 
 
2.4 Influence of Base Structure on Substrate Racemization 
At this juncture we sought to understand the large contribution to product 
enantioselectivity associated with the superficially similar structure of the amine base 
additive. We hypothesize that this difference arises from a faster rate of starting material 
racemization under the action of triethylamine. Using Hünig’s base in conjunction with 
low inorganic base concentration resulted in high levels of product enantioselectivity and 
the unreacted starting material recovered from the reaction was not enantioenriched 
(entry 3, Table 1), suggesting that an efficient dynamic kinetic resolution is occurring 
under these conditions. We postulate that under conditions of low inorganic base 
concentration the arylation reaction is slow relative to Hünig’s base promoted 
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racemization (krac > kfast)8  resulting in a dynamic kinetic resolution. However, in entry 5 
the higher loading of CsF results in a faster arylation reaction for both substrate 
enantiomers, presumably due to higher rates of transmetallation, while the rate of 
racemization by Hünig’s base occurs too slowly for efficient dynamic kinetic resolution. 
Rovis and co-workers noted a similar effect during the development of an enantioselective 
glyoxamidation reaction.26 To gain further insight into this phenomenon and to provide 
support for our hypothesis we studied the rate of racemization of 7 using an array of 
tertiary amine bases (Figure 2-1). At room temperature racemization with triethylamine 
was rapid; within eight minutes the extent of racemization had reached 87% and complete 
racemization occurred after 20 min. Tri-n-butylamine exhibited a noticeably slower 
racemization profile, but racemization was still nearly complete within 20 min. In 
contrast to triethylamine and tri-n-butylamine, the alkyl branched Hünig’s base displayed 
a slow racemization profile, and 7a was still  
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Figure 2-1 Influence of Base Structure on Racemization Rate 
 
 
a) Trial conducted at 40 °C. 6.0 equiv Hünig’s base. 
 
measurably enriched after 100 min at room temperature. When studied at 40 °C in the 
presence of 6 equiv of Hünig’s base, racemization of 7 was enhanced but complete 
racemization only occurred after 60 min. Thus, although Hünig’s base exhibits greater 
thermodynamic basicity than triethylamine it is less effective at promoting the 
racemization of 7a.27 Finally, N-methylpyrroldine, which possesses lower 
thermodynamic basicity than triethylamine,28 displayed the fastest racemization profile, 
promoting complete racemization of 7 in under two minutes. The observed trend suggests 
the kinetic basicity of the tertiary amine exerts a larger influence on the racemization of 
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7a than its thermodynamic basicity. This observation may prove to be generally 
important in the de novo design novel dynamic kinetic resolutions involving enolizable 
carbonyl substrates.29  
 
 
 
2.5 Scope of the Enantioconvergent Arylation Reaction 
With optimal reaction conditions in hand we began to study the scope of the process 
with respect to the arylboronic acid component (Scheme 2-7). It should be noted that 
while catalysts 10 and 11 provide identical levels of selectivity for product 8, in certain 
cases it was found that one catalyst was more selective for a particular substrate. 
Ultimately, electron-rich arylboronic acids were found to be suitable reaction partners as 
the p-tolyl adduct 8b was formed in high yield with high levels of diastereo- and 
enantiocontrol. Electron-poor arylboronic acids could also be used; however, in the case 
of p-fluoro- and p-chlorophenylboronic acid a larger excess was required to achieve good 
yields. Nevertheless, high levels of diastereo- and enantioselectivity were still observed 
for addition products 8c and 8d. Substitution of the arylboronic acid at the m-position 
was also tolerated. For instance, the m-methoxy and m-tolyl adducts 8e and 8f were 
obtained in good yield, with high levels of stereocontrol. Electron-withdrawing 
substituents were also tolerated at this position and the use of m-chlorophenylboronic 
acid afforded the desired arylation product 8g in good yield with high levels of 
stereocontrol. Polyaromatic boronic acids were also suitable substrates for this 
transformation, as the 2-naphthyl adduct 8h could be obtained in good yield with 
similarly high levels of diastereo- and enantiocontrol. The sterically demanding o-
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methoxy adduct 8i was formed in good yield with high levels of enantiocontrol, although 
in this instance a relatively large excess of the boronic acid substrate was required to 
achieve full conversion. Finally, we found that even unprotected 6-indoylboronic acid 
could be employed, furnishing adduct 8j, while maintaining reaction efficiency. It should 
be noted that at this stage of optimization certain electron poor arylboronic acid  
 
Scheme 2-7 Scope of Reaction: Boronic Acids 
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a) Reactions run on 0.1 mmol scale for 48 h or 60 h (see SI for individual reaction times 
and boronic acid equivalents), reported yields and er values are averages of two runs. 
Values in parentheses represent recrystallized yields and enantiomeric ratios. b) Catalyst 
10 employed. c) Catalyst 11 employed.  
 
substrates cannot be used, as the 4-pyridyl and 5-indazole adducts 8k and 8l were not 
formed. In addition, the reaction with 2-thienylboronic acid only reached 11% conversion 
after 36 h under the optimized reaction conditions (not shown). Efforts to address these 
limitations are currently underway in our laboratory.  
Next, we explored the scope of the reaction with respect to the α-keto ester reaction 
partner (Scheme 2-8). Substrates bearing electron donating substituents at the para-
position of the aryl ring were suitable reaction partners. For example, the p-tolyl 
substituted product 8m was obtained in good yield with high levels of stereocontrol. 
Higher levels of enantioselectivity were observed with this substrate when 2-
naphthylboronic acid was employed as a nucleophile furnishing the addition product 8n. 
Apparently, the electron-rich p-methoxy substituted substrate was subject to facile 
racemization under the reaction conditions, as product 8o could also be obtained in good 
yield with high levels of stereocontrol. An ortho-F substituted α-keto ester was subject to 
phenylboronic acid addition, producing 8p in acceptable yield and high 
diastereoselectivity and decent levels of enantiocontrol. The o-tolyl product 8q was 
afforded in 57% yield, and 94:6 er, while the m-tolyl product 8r was formed in 88% yield 
with 96:4 er, suggesting that the steric nature of the α-keto ester aryl component has a 
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slight impact on reaction efficiency and enantioselectivity. A 2-naphthyl substituted α-
keto ester could also be used, affording  
Scheme 2-8 Scope of Reaction: α-Keto Esters 
 
a) Reactions run on 0.1 mmol scale for 48 h or 60 h (see SI for individual reaction times 
and boronic acid equivalents), reported yields and er values are averages of two runs. 
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Values in parentheses represent recrystallized yields and enantiomeric ratios. b) Catalyst 
10 employed. c) Catalyst 11 employed.  
 
 
 
addition product 8s with high levels of enantio- and diastereoselectivity. Product 3s could 
be enriched to 97.5:2.5 er following a single crystallization. Notably, arylation of an 
unprotected 3-indole substituted α-keto ester with 6-indoleboronic acid afforded 
bis(indole) adduct 8t in good yield with high levels of selectivity. The use of 2-naphthyl 
and m-tolylboronic acid was also successful with this α-keto ester (see supporting 
information). Larger alkyl substituents at the β-position were tolerated and the β-ethyl 
substituted product 8u was obtained in good yield with acceptable levels of 
enantiocontrol. Product 8u could be obtained as a single enantiomer in acceptable yield 
following a single recrystallization. The arylation reaction exhibited functional group 
chemoselectivity in the presence of competing functionality as the bromoaryl and β-allyl 
substituted product 8v was obtained in acceptable yield with high levels of stereocontrol. 
Notably, less than 10% of Heck-type co-products were observed during formation of 8v.30 
The branched diester product was formed in excellent yield. Although lower levels of 
enantiocontrol were observed in this reaction, product 8w can be accessed as a single 
enantiomer in acceptable yield following a single crystallization. Finally, although 
pyridine containing boronic acids are not successful reaction partners at this stage of 
optimization, a 3-pyridyl substituted α-keto ester was tolerated under the reaction 
conditions and afforded arylation product 8x in good yields with high diastereo- and 
enantiocontrol. Product 8x could also be recovered as a single enantiomer, albeit in lower 
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yield, after a single crystallization. Substrates bearing only aliphactic substitution at the 
β-position have not been tested at this juncture; presumably these substrates are less 
acidic and would be challenging to implement under the present reaction conditions. 
2-6 1 Mmol Scale Reaction and Stereochemical Model 
Having investigated the scope of the DKR arylation process, we sought to examine 
the effect of increasing the scale of the reaction while simultaneously decreasing the 
catalyst loading (Scheme 2-9). The 4-bromo substituted α-keto ester 7y underwent 
arylation with 2-naphthylboronic acid on 1 mmol scale using 0.5 mol % of the catalyst (1 
mol % Rh)  to afford 8y in good yield with high levels of diastereo- and enantiocontrol. 
Product 8y could be recrystallized to 99:1 er allowing the absolute stereochemistry of 8y 
to be determined via X-ray crystallography. The configuration of the other arylation 
products 8a-8x were assigned by analogy.  
Scheme 2-9 Mmol Scale Arylation and Stereochemical Model 
 
aConditions: 0.5 mol % catalyst C, 4.0equiv CsF CHCl3, 40 °C, 72 h 
The observed stereochemistry can be attributed to the C2-symmetric nature of 
(R,R)-catalyst 11 which enforces high levels of enantiocontrol in this reaction by 
effectively blocking the shaded quadrants in the stereochemical model shown in 
Scheme 2-9; the bulky sp3 center is guided to the top left quadrant and the reaction of 
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the S configured starting material is favored.31 Aromatic interactions appear to be 
important for achieving high levels of enantio- and diastereoselectivity as evidenced by 
the inferior results using the benzyl substituted catalyst 12. 
2.7 Iodoetherification of β-Allyl Substituted Aryl Glycolate 
Finally, considering the sterically encumbered nature of the tertiary alcohol 
installed in the arylation reaction we wondered if this functionality could be leveraged in 
downstream transformations. Preliminary findings have been promising. For instance, 
unsaturated alcohol 8v undergoes iodoetherification to tetrahydrofuran 15v in 66% yield, 
albeit without diastereoselectivity. The diastereomers of 15v were easily separated by 
silica gel column chromatography.  
Scheme 2-10 Iodoetherification of 8v 
 
2.8 Conclusion 
In summary, we have developed an enantioconvergent arylation of racemic β-alkyl 
substituted α-keto esters catalyzed by a chiral rhodium-diene complex. A wide range of 
complex aryl glycolate derivatives could be obtained in good yields with high levels of 
stereocontrol. Notably, despite the longstanding use of transition metal catalysts in 
dynamic kinetic hydrogenations, this is the first use of analogous catalysts for the 
installation of C-C bonds in a dynamic kinetic addition to carbonyl electrophiles. 
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Considering the substantial number of commercially available arylboronic acid 
derivatives and the well-recognized biological activity of the glycolic acid substructure,32 
this chemistry opens the door to a diverse array of interesting building blocks. Although 
racemizationis central to efficient dynamic kinetic resolutions8 it is rarely discussed or 
studied in detail. Here we have shown that the racemization of less acidic β-alkyl/aryl 
substituted α-keto esters is strongly linked to the steric size of a tertiary amine additive. 
Preliminary results show that the products of this reaction can be utilized in additional 
downstream transformations including the synthesis of valuable tetrahydrofuran 
derivatives. Extension of this work to other classes of nonstabilized carbon centered 
nucleophiles is currently underway in our laboratory and will be reported in due course. 
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2.9 Experimental Details 
 
All air sensitive reactions were carried out under an atmosphere of nitrogen. Thin 
layer chromatography (TLC) was performed on Sorbtech plastic-backed 0.20 mm silica 
gel 60 plates. Visualization was accomplished with UV light and either an aqueous ceric 
ammonium molybdate (CAM) or potassium permanganate (KMnO4) solution, followed 
by heating. Flash chromatography was performed under positive nitrogen pressure using 
Siliaflash-P60 silica gel (40-63 μm) purchased from Silicycle. Semipreparative thin layer 
chromatography was employed for the generation of pure racemic samples for HPLC 
analysis and was conducted on 250 μm glass backed TLC plates. An Analtech 1000 
μm/silica gel GF glass backed preparative thin layer chromatography plate was used for 
the purification of 3o. Yields and enantiomeric ratios reported for the enantioconvergent 
arylation reactions represents the average of two trials.  
1H NMR, 13C NMR, and 19F NMR spectra were recorded on either a Bruker model 
DRX 500 or 600 (cryoprobe equipped) spectrometer.  The spectra were calibrated using 
residual solvent resonances: 1H NMR (CDCl3 at 7.26 ppm), 13C NMR (CDCl3 at 77.0 
ppm). 1H NMR data are reported as follows: chemical shift, multiplicity (abbreviations: s 
= singlet, br s = broad singlet, d = doublet, dd = doublet of doublets, ddd = doublet of 
doublet of doublets, dddd = doublet of doublet of doublet of doublets, dt = doublet of 
triplets, t = triplet, td = triplet of doublets, tt = triplet of triplets, qt = quintet, and m = 
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multiplet), coupling constant (Hz) and integration. High resolution mass spectrometry 
(HRMS) was performed using a Thermo Scientific LTQ FT Ultra mass spectrometer S2 
with direct infusion in either the positive or negative ion mode. Samples were prepared 
in HPLC grade methanol. High performance liquid chromatography (HPLC) was 
performed on a Perkin Elmer Flexar® HPLC system. Optical rotations were measured 
using a 2 mL cell with a 1 dm path length on a Jasco DIP 1000 digital polarimeter. Infrared 
(IR) spectra were obtained using a Jasco 260 Plus Fourier Transform Infrared 
Spectrometer. 
Chloroform was washed several times with water to remove the ethanol stabilizer, 
dried over MgSO4, then distilled from MgSO4 and stored in a Schlenk flask wrapped in 
aluminum foil in an N2 filled glovebox. All other solvents were purified by passage through 
a column packed with activated aluminum under N2 pressure. Phenylboronic acid was 
recrystallized from water. All other boronic acids were used as received. All boronic acids 
were stored in an N2 filled glovebox. All 1-(phenyl)ethanol derivatives used in the 
synthesis of racemic a-keto esters are known compounds and were prepared according to 
literature methods.   
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Procedure for Optimization Experiments: The α-keto ester was massed directly 
into a flame dried 1 dram vial equipped with a stir bar and red PTEF/silicone cap. This 
vial was taken into a glovebox, under an N2 atmosphere, where the organic base, 
arylboronic acid, and inorganic base were added successively to the vial containing the α-
keto ester substrate. Next, the catalyst was transferred from a separate 1 dram vial using 
1.0 mL of reaction solvent. The reaction vial was removed from the glovebox, sealed with 
electrical tape and heated at the indicated temperature for the specified duration, after 
which time the crude reaction mixture was passed through a silica gel plug (5.75 in, 4 mL 
capacity pipette filled ~ ½ full of silica gel) using ethyl acetate to rinse (10 mL) and 
concentrated. The diastereomeric ratio of the product and percent conversion 
[(prod./(prod. + starting material))*100] were determined by 1H NMR analysis of the 
entire crude reaction mixture. Around 150 μL of the 700 μL solution of crude material in 
CDCl3 was applied to the base of a 3.5 x 8 inch glass TLC plate (thickness of silica gel = 
250 μm) and purified by semi-preparative thin layer chromatography, using 5% ethyl 
acetate/hexanes to elute, so that pure material for chiral HPLC analysis could be obtained.  
Note: In all screening experiments listed in table Table 2-1, with exception of entry 13, 
the chloro(diene)rhodium (I) dimer isolated by silica gel column chromatography was 
employed. In entry 13 the catalyst was prepared in situ.  
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Procedure for Preparation of Racemic Standards: The α-keto ester substrate 
(0.042 mmol) was massed directly into a flame dried 1 dram vial equipped with a stir bar 
and a cap with a red PTFE/silicone septum. The vial was brought into a glovebox, under 
an N2 atmosphere, and chloro(1,5-cyclooctadiene)rhodium (I) dimer (2.5 mol %, 0.51 mg) 
was added, followed by the arylboronic acid (2.0 equiv) and potassium carbonate (3.0 
equiv, 17.2 mg). Finally, toluene (0.50 mL) was added and the vial was removed from the 
glovebox, sealed with electrical tape and heated to 40 °C for 24 h before being filtered 
through a silica gel plug using ethyl acetate to rinse. The crude sample was dissolved in 
1.0 mL of methylene chloride and approximately ¼ of the solution was applied to a 3.5 x 
8 inch glass TLC plate (thickness of silica gel = 250 μm) and purified by semi-preparative 
thin layer chromatography, using 5% ethyl acetate/hexanes to elute, so that pure material 
for chiral HPLC analysis could be obtained.  
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Preparation of α-Keto Ester Starting Materials  
 
 
Method A for the Preparation of β-Methyl and β-Ethyl Substituted Substrates 
7a,7m,7o,7p,7q and 7r, 7s, 7u, 7y: The listed substrates were prepared via a modified 
literature method.33,34 As noted by Ishii and co-workers , symmetrical dibenzyl ethers 
were sometimes observed as intermediates in the alkylation procedure detailed below; in 
some cases it was necessary to employ higher loadings of FeCl3 and longer reaction times 
to promote full conversion of these intermediates to the desired ethyl acetoacetate 
alkylation product. 
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Ethyl 3-(4-chlorophenyl)-2-oxobutanoate: Step 1: Ethyl 
acetoacetate (1.47 mL, 1.50 g, 11.50 mmol) and (±)-1-(4-
chlorophenyl)ethanol (2.01 g, 12.8 mmol) were combined with 
46.0 mL (0.25 M) of anhydrous methylene chloride in a 100 mL round-bottomed flask 
equipped with a reflux condenser . Next, iron(III) chloride (467 mg, 2.88 mmol, black 
anhydrous form) was added and the reaction was heated to reflux (external bath at 50 
°C). Analysis of a reaction aliquot by 1H NMR spectroscopy indicated completion after 20 
h; the reaction mixture was subsequently filtered through a pad of silica gel using 70/30 
hexanes/ethyl acetate and concentrated. In this case, purification by silica gel 
chromatography yielded ethyl 2-acetyl-3-(4-chlorophenyl)butanoate 7a’ as a yellow oil 
(10.3 mmol, 89% yield)1H NMR data for 7a’ (1:1 mixture of diastereomers): (600 MHz, 
CDCl3): δ 7.27–7.24 (m, 4H), 7.16–7.13 (m, 4H), 4.22 (q, J = 7.1 Hz, 2H), 3.92–3.89 (m, 
2H), 3.75–3.69 (m, 2H), 3.56–3.49 (m, 2H), 2.30 (s, 3H), 1.97 (s, 3H), 1.30–1.26 (m, 6H), 
1.21 (d 1.21, J = 6.9 Hz, 3H), 0.99 (t, 7.1 Hz, 3H). Step 2: Ethyl 2-acetyl-3-(4-
chlorophenyl)butanoate 7a’ (2.77 g, 10.3 mmol) was dissolved in MeCN (27.7 mL, 1 mL/ 
100 mg). Next, Cu(NO3)2·3H2O (498 mg, 2.06 mmol, 0.2 equiv) was added and the 
resulting green homogenous solution was sparged with O2 gas (O2 balloon attached to 
penetration needle) for 10 min. The reaction was stirred for 44 h at room temperature 
under an atmosphere of oxygen, at which point NMR analysis indicated full consumption 
of the starting β-keto ester. The reaction mixture was diluted with water and extracted 
three times with ethyl acetate (20 mL per extraction), the combined organic extracts were 
then washed with brine and dried over MgSO4 and concentrated. Purification of the 
resulting residue by silica gel column chromatography (1st column: 2.5% ethyl 
acetate/hexanes as eluent, 2nd column: methylene chloride as eluent) afforded 7a as a 
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clear oil (2.48 g, 5.1 mmol, 49% yield). Analytical Data for 7a: 1H NMR (600 MHz, 
CDCl3) δ 7.31–7.29 (m, 2H), 7.18–7.15 (m, 2H), 4.48 (q, J = 7.0 Hz, 1H), 4.24-4.16 (m, 
2H), 1.44 (d, J =  7.0 Hz, 3H), 1.24 (t, J = 7.1 Hz); 13C NMR (151 MHz, CDCl3): δ 193.5, 
161.0, 136.2, 133.6, 129.8, 129.2, 62.5, 47.7, 16.8, 13.9; IR (thin film): 3434, 2064, 1732, 
1697, 1647, 1636, 1522, 1507, 1374, 1268 cm-1; HRMS (ESI+): Calcd. for C12H13ClO3: 
([M+Na]): 263.0451, Found: 263.0450; TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): tR1 = 7.1 min, tR2 = 7.6 min. 
 
Ethyl 2-oxo-3-(p-tolyl)butanoate (7m): The title compound 
was prepared according to Method A with the following 
modifications:  Step 1: ethyl acetoacetate (4.82 g, 37.0 mmol, 1.0 
equiv), (±)-1-(4-methylphenyl)ethanol (5.04 g, 37.0 mmol, 1.0 equiv), and anhydrous 
FeCl3 (601 mg, 3.7 mmol, 0.10 equiv) were used. Methylene chloride (40.0 mL, 0.93 M) 
was used as solvent. The reaction time was 24 h. In this case the product from Step 1 was 
not purified by silica gel column chromatography and was taken on to step 2 in crude 
form. Step 2: Cu(NO3)2·3H2O (2.19 g, 9.1 mmol, 0.24 equiv with respect to ethyl 
acetoacetate) was used and the reaction was run in acetonitrile (40.0 mL, 0.93 M with 
respect to ethyl acetoacetate) for 60 h. The crude material from step 2 was purified by 
silica gel column chromatography (1st column: 2.5% ethyl acetate/hexanes acetate as 
eluent, 2nd column: methylene chloride as eluent) affording 7m as a clear oil (4.55 g, 
20.6 mmol, 56% yield over two steps). Analytical data for 7m: 1H NMR (600 MHz, 
CDCl3): 7.14–7.10 (m, 4H), 4.45 (q, J = 7.0 Hz, 1H), 4.22–4.13 (m, 2H), 2.32 (s, 3H), 1.44 
(d, J = 7.0 Hz, 3H), 1.22 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 194.1, 161.4, 
137.4, 134.6, 129.7, 128.3, 62.2, 48.0, 21.1, 16.8, 13.8; IR (thin film): 3445, 2982, 2937, 
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2360, 1731, 1646, 1636, 1540, 1508, 1457, 1269 cm-1; HRMS (ESI+): Calcd. for: C13H16O3 
([M+1]): 221.1178, Found: 221.1174. TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
 
Ethyl 3-(4-methoxyphenyl)-2-oxobutanoate (7o): The 
title compound was prepared according to Method A with the 
following modifications: Step 1: ethyl acetoacetate (4.27 g, 32.8 
mmol, 1.0 equiv) and (±)-1-(4-methoxyphenyl)ethanol (5.0 g, 32.8 mmol, 1.0 equiv), and 
FeCl3 (532 mg, 3.28 mmol, 0.10 equiv) were used. Methylene chloride (40.0 mL, 0.82 M) 
was used as solvent. The reaction time was 24 h. In this case the product from step 1 was 
not purified by silica gel column chromatography and was taken on to step 2 in crude 
form. Step 2: Cu(NO3)2·3H2O (1.94 g, 8.0 mmol, 0.24 equiv) was used and the reaction 
was run in acetonitrile (40.0 mL, 0.82 M) for 60 h. The crude material from Step 2 was 
purified by silica gel column chromatography (1st column: 2.5% ethyl acetate/hexanes 
as eluent, 2nd column: methylene chloride as eluent) affording 7o as a clear oil (2.76 g, 
11.7 mmol, 36% yield over two steps). Analytical data for 7o: 1H NMR (600 MHz, 
CDCl3): δ 7.15–7.13 (m, 2H), 6.86–6.85 (m, 2H), 4.44 (q, J = 7.0 Hz, 1H), 4.22–4.14 (m, 
2H), 3.78 (s, 3H), 1.43 (d, J = 7.0 Hz, 3H), 1.22 (t, J = 7.1 Hz); 13C NMR (151 MHz, CDCl3): 
δ 194.0, 162.0, 159.0, 129.6, 129.4, 114.4, 62.2, 55.2, 47.5, 16.7, 13.9; IR (thin film): 3431, 
2982, 2360, 2341, 1771, 1731, 1647, 1636, 1510, 1457, 1253, 1034 cm-1; HRMS (ESI+): 
Calcd. for C13H16O4: ([M+Na]): 259.0946, Found: 259.0943. TLC (90:10 hexanes: ethyl 
acetate): Rf = 0.3.  
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Ethyl 3-(2-fluorophenyl)-2-oxobutanoate (7p): The title 
compound was prepared according to Method A with the following 
modifications: Step 1: ethyl acetoacetate (4.76 g, 36.6 mmol, 1.0 
equiv), (±)-1-(2-fluorophenyl)ethanol (5.13 g, 36.6 mmol, 0.10 equiv), and FeCl3 (2.97 g, 
18.3 mmol. 0.5 equiv) were used. Methylene chloride (40.0 mL, 0.92 M) was used as 
solvent. The reaction time was 36 h. In this case the product from step 1 was not purified 
by silica gel column chromatography and the crude material was taken on to step 2. Step 
2: Cu(NO3)2·3H2O (2.16 g, 9.0 mmol, 0.24 equiv) was used and the reaction was run in 
acetonitrile (40.0 mL, 0.92 M) for 60 h. The crude material from step 2 was purified by 
silica gel column chromatography (1st column: 2.5% ethyl acetate/hexanes as eluent, 
2nd column: methylene chloride as eluent) affording 7p as a clear oil (3.88 g, 17.3 mmol, 
47% yield over two steps). Analytical data for 7p: 1H NMR (600 MHz, CDCl3): δ 7.28–
7.24 (m, 1H), 7.13–7.09 (m, 2H), 7.09–7.06 (m, 1H), 4.70 (q, J = 7.0 Hz, 1H), 4.23–4.16 
(m, 2H), 1.46 (d, J = 7.0 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 
193.6, 161.1, 160.4 (d, J19F-13C = 247.6 Hz), 129.3 (d, J19F-13C = 24.3 Hz), 129.2 (d, J19F-13C = 
19.8), 125.5 (d, J19F-13C = 15.4 Hz), 124.6 (d, J19F-13C = 3.4 Hz), 115.8 (d, J19F-13C = 22.5 Hz), 
62.3, 41.8 (d, J19F-13C = 1.9 Hz), 15.8, 13.8; 19F NMR (376 MHz, CDCl3): δ -117.5;  IR (thin 
film): 3446. 2985, 2940, 1732, 1698, 1653, 1636, 1507, 1492, 1456, 1233 cm-1; HRMS 
(ESI+): Calcd. for C12H13FO3: ([M+1]): 225.0927, Found: 225.0924. TLC (90:10 hexanes: 
ethyl acetate): Rf = 0.3.  
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Ethyl 2-oxo-3-(o-tolyl)butanoate (7q): The title compound was 
prepared according to Method A with the following modifications: 
Step 1: ethyl acetoacetate (1.93 g, 14.8 mmol, 1.0 equiv), (±)-1-(o-
tolyl)ethan-1-ol (2.02 g, 14.8 mmol, 1.0 equiv), and FeCl3 (1.20 g, 7.42 mmol, 0.50 equiv) 
were used. Methylene chloride (16.0 mL, 0.93 M) was used as solvent. The reaction time 
was 21.3 h. In this case the product from step 1 was not purified by silica gel column 
chromatography and the crude material was taken on to Step 2. Step 2: Cu(NO3)2·3H2O 
(877 mg, 2.97 mmol, 0.20 equiv) was used and the reaction was run in acetonitrile (16.0 
mL, 0.92 M) for 75 h. The crude material from step 2 was purified by silica gel column 
chromatography (1st column: 2.5% ethyl acetate/hexanes as eluent, 2nd column: 
methylene chloride as eluent) affording 7q as a light yellow oil (700 mg, 3.18 mmol, 21% 
yield over two steps). Analytical data for 7q: 1H NMR (600 MHz, CDCl3): δ 7.22–7.20 
(m, 2H), 7.18–7.12 (m, 2H), 6.93–6.90 (m, 1H), 4.64 (q, J = 6.8 Hz, 1H), 4.18–4.10 (m, 
1H), 2.44 (s, 3H), 1.39 (d, J = 6.8 Hz, 3H), 1.16 (t, J = 7.1 Hz, 3H); 13C NMR: (151 MHz, 
CDCl3): 194.5, 161.5, 136.5, 136.4, 131.1, 127.6, 127.1, 126.6, 62.2, 44.7, 19.5, 16.2, 13.8; IR 
(thin film): 3750, 3734, 3649, 3566, 2359, 2330, 1771, 1748, 1733, 1653, 1558, 1541, 1521, 
1507, 1457, 1270, 761 cm-1; HRMS (ESI+): Calcd. for C13H16O3: ([M+1]): 221.1178, Found: 
221.1176. TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
 
Ethyl 2-oxo-3-(m-tolyl)butanoate (7r): The title compound 
was prepared according to Method A with the following 
modifications: Step 1: ethyl acetoacetate (5.46 g, 41.9 mmol, 1.1 
equiv) and (±)-1-(m-tolyl)ethan-1-ol (5.19 g, 38.1 mmol, 1.0 equiv), and FeCl3 (3.09 g, 
0.50 equiv) were used. Methylene chloride (152 mL, 0.25 M) was used as solvent. The 
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reaction time was 21 h. In this case the crude material from step 1 was taken on without 
purification. Step 2: Cu(NO3)2·3H2O (1.84 g, 7.62 mmol, 0.20 equiv) was used and the 
reaction was run in acetonitrile (47.3 mL,   0.81 M) for 94.5 h. The crude material from 
step 2 was purified by silica gel column chromatography (1st column: 2.5% ethyl 
acetate/hexanes as eluent, 2nd column: methylene chloride as eluent) affording 7r as a 
light yellow oil (4.52 g, 54% yield over two steps). Analytical data for 7r: 1H NMR 
(500 MHz, CDCl3): δ 7.21 (app t, J = 8.0 Hz, 1H), 7.07 (d, J = 7.7 Hz, 1H), 7.03 –7.00 (m, 
2H), 4.45 (1, J = 7.0 Hz, 1H), 4.22–4.13 (m, 2H), 2.32 (s, 3H), 1.44 (d, J = 7.0 Hz, 3H), 
1.21 (t, J = 7.2 Hz, 3H); 13C NMR: (151 MHz, CDCl3): δ 194.1, 161.4, 138.7, 137.6, 129.1, 
128.9, 128.4, 125.5, 62.2, 48.3, 21.4, 16.8, 13.8; ; IR (thin film): 3767, 3750, 3734, 3649, 
3050, 2980, 2936, 2875, 2358, 2322, 1771, 1742, 1715, 1581, 1473, 1270, 1174, 1038, 787 
cm-1 ; HRMS (ESI+): Calcd. for C13H16O3: ([M+1]): 221.1178, Found: 221.1178. TLC 
(90:10 hexanes: ethyl acetate): Rf = 0.3. 
Ethyl 3-(naphthalen-2-yl)-2-oxobutanoate (7s): The title 
compound was prepared according to Method A with the 
following modifications: Step 1: ethyl acetoacetate (5.74 g, 44.1 
mmol, 1.50 equiv) and (±)-1-(naphthalen-2-yl)ethan-1-ol (5.00 g, 29.4 mmol, 1.0 equiv) 
and FeCl3 (2.38 g, 14.7 mmol, 0.5 equiv) were used. Methylene chloride (40.0 mL, 0.74 
M) was used as solvent. The reaction time was 48 h. In this case the crude material from 
step 1 was used without further purification. Step 2: Cu(NO3)2·3H2O (1.42 g, 5.88 mmol, 
0.2 equiv) was used and the reaction was run in acetonitrile (40.0 mL, 0.74 M) for 72 h. 
The crude material from step 2 was purified by silica gel column chromatography (1st 
column: 2.5% ethyl acetate/hexanes as eluent, 2nd column: methylene chloride as 
eluent) affording 7s as a light yellow oil (2.65 g, 10.3 mmol, 35% yield over two steps). 
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Analytical data for 7s: 1H NMR (600 MHz, CDCl3): δ 7.84 – 7.78 (m, 3H), 7.66 (s, 
1H), 7.50–7.45 (m, 2H), 7.36 (dd, J = 8.5, 1.8 Hz, 1H), 4.67 (q, J = 7.0 Hz, 1H), 4.19–4.10 
(m, 2H), 1.55 (d, J = 7.0 Hz, 3H), 1.18 (t, J = 7.1 Hz, 3H); 13C NMR: (151 MHz, CDCl3): δ 
193.8, 161.3, 135.1, 133.5, 132.7, 128.9, 127.8, 127.6, 127.5, 126.3, 126.3, 126.2, 62.3, 48.4, 
16.9, 13.8, IR (thin film): 3767, 3750, 3734, 3587, 3566, 3056, 2979, 2934, 2353, 2321, 
1771, 1748, 1732, 1717, 1558, 1541, 1521, 1507, 1269, 1037, 748 cm-1; HRMS (ESI+): Calcd. 
for C16H16O3: ([M+1]): 257.1178, Found: 257.1176. TLC (90:10 hexanes: ethyl acetate): Rf 
= 0.3. 
 
Ethyl 2-oxo-3-phenylpentanoate (7u): The title compound was 
prepared according to Method A with the following modifications: 
Step 1: ethyl acetoacetate (37.1 mmol, 4.83 g, 1.0 equiv), (±)-1-
phenyl-1-propanol (37.1 mmol, 5.05 g, 1.0 equiv), and FeCl3 (3.01 g, 18.5 mmol, 0.5 equiv) 
were used. Methylene chloride (40.0 mL, 0.93 M) was used as solvent. The reaction time 
was 36 h. In this case the product from Step 1 was not purified by silica gel column 
chromatography and the crude material was taken on to step 2. Step 2: Cu(NO3)2·3H2O 
was used (2.192 g, 9.1 mmol, 0.24 equiv) and the reaction was run in acetonitrile (40.0 
mL, 0.93 M). The crude material from Step 2 was purified by silica gel column 
chromatography (1st column: 2.5% ethyl acetate/hexanes as eluent, 2nd column: 
methylene chloride as eluent) affording 7u as a light yellow oil (3.05 g, 13.8 mmol, 37% 
yield over two steps). Analytical data for 7u: 1H NMR (600 MHz, CDCl3): δ 7.33–7.31 
(m, 2H), 7.27–7.25 (m, 1H), 7.22–7.20 (m, 2H), 4.29–2.27 (m, 1H), 4.22–4.14 (m, 2H), 
2.14–2.07 (m, 1H), 1.82–1.76 (m, 1H), 1.22 (t, J = 7.1 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H); 13C 
NMR (151 MHz, CDCl3): δ 193.6, 161.3, 136.1, 129.0, 128.9, 127.6, 62.3, 55.8, 24.7, 13.8, 
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11.8; IR (thin film): 3420, 2969, 2936, 2876, 2360, 2341, 1771, 1732, 1558, 1540, 1522, 
1507, 1457, 1248 cm-1; HRMS (ESI+): Calcd. for C13H16O3: ([M+1]): 221.1178, Found: 
221.1174. TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
 
ethyl 3-(4-bromophenyl)-2-oxobutanoate (7y): The title 
compound was prepared according to Method A with the following 
modifications: Step 1: ethyl acetoacetate (4.31 g, 33.2 mmol, 1.5 
equiv), (±)-1-(4-methylphenyl)ethanol (4.44g, 22.1 mmol, 1.0 equiv), and FeCl3 (10.5 
mmol, 1.70 g, 0.50 equiv) were used. Methylene chloride (24.0 mL, 0.92 M) was used as 
solvent. After 48 h the reaction was incomplete, an additional 1.70 g of FeCl3 and 2.16 g 
ethyl acetoacetate were added and the reaction was ran for an additional 96 h before being 
filtered through silica gel and concentrated. The resulting material was subjected to the 
next step without further purification. Step 2: Cu(NO3)2·3H2O was used (1.07 g, 4.42 
mmol, 0.20 equiv based on (±)-1-(4-methylphenyl)ethanol) and the reaction was run in 
acetonitrile (22.0 mL) for 60 h. The crude material from step 2 was purified by silica gel 
column chromatography (1st column: 2.5% ethyl acetate/hexanes as eluent, 2nd 
column: methylene chloride as eluent) affording 7y as a clear oil (3.19 g, 11.2 mmol, 51% 
yield over two steps). Analytical data for 7y: 1H NMR (600 MHz, CDCl3): δ 7.46 (d, J 
= 8.4 Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 4.47 (q, J = 7.0 Hz, 1H), 4.24–4.16 (m, 1H), 1.44 
(d, J = 7.0 Hz, 3H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 193.4, 161.0, 
136.8, 132.1, 130.1, 121.7, 62.5, 47.7, 16.7, 13.9; IR (thin film): 3446, 2981, 2937, 1792, 
1731, 1647, 1636, 1507, 1489, 1457, 1266 cm-1; HRMS (ESI+): Calcd. for C12H13BrO3: 
([M+Na]): 306.9946, Found: 306.9948. TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
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Method B for the Preparation of Ethyl 3-(1H-indol-3-yl)-2-oxobutanoate 
(7t):35 
The known compound, syn-(±)-ethyl 2-hydroxy-3-(1H-indol-3-yl)butanoate 7t’ (2.12 g, 
8.59 mmol, 1.0 equiv) was dissolved in ethyl acetate (43.0 mL, 0.2 M) in a round-
bottomed flask equipped with a reflux condenser. Next, o-iodoxybenzoic acid (IBX) was 
added and the mixture was heated at reflux for 16 h. Upon completion, the reaction was 
cooled to room temperature and the crude mixture was passed through a pad of silica gel 
using ethyl acetate to rinse. Upon concentration, the crude residue was subjected to silica 
gel column chromatography (15% ethyl acetate/hexanes followed by 20% ethyl acetate 
hexanes) affording 7t as a slightly brown oil (2.11 g, 8.59 mmol, >99% yield). Analytical 
data for 7t: 1H NMR (600 MHz, CDCl3): δ 8.18 (br s, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.37 
(d, J = 8.1 Hz, 1H), 7.22–7.20 (m, 1H), 7.17–7.14 (m, 1H), 7.06 (br s, 1H), 4.80 (q, J = 7.0 
Hz, 1H), 4.16–4.08 (m, 2H), 1.56 (d, J = 7.0 Hz, 3H), 1.13 (t, J = 7.1 Hz); 13C NMR (151 
MHz, CDCl3): δ 193.6, 162.0, 136.2, 126.3, 123.1, 122.5, 120.0, 119.0, 112.1, 111.3, 62.1, 
39.3, 16.2, 13.8; IR (thin film): 3502, 3408, 3058, 2980, 2936, 1792, 1770, 1726, 1684, 
1541, 1472, 1457, 1421, 1339, 1258, 1102, 1037, 744 cm -1 ; HRMS (ESI+): Calcd. for 
C14H15NO3: ([M+1]): 246.1130, Found: 246.1126. TLC (90:10 hexanes: ethyl acetate): 
Rf = 0.1. 
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Method C for the Preparation of β-allyl Substituted Substrate 1v: 
 
 
Ethyl 2-(allyloxy)-3-(3-bromophenyl)-3-hydroxypropanoate (7v’) Step 1:36 n-
BuLi (7.27 mL, 1.72 M, 12.5 mmol, 1.2 equiv) was added dropwise to a solution of 
diisopropylamine (1.37 g, 1.91 mL, 13.5 mmol, 1.3 equiv) in THF (21 mL) cooled to -78 °C. 
After the resulting solution had stirred for 10 minutes, ethyl 2-(allyloxy)acetate (1.5 g, 10.4 
mmol, 1.0 equiv) was added dropwise as a solution in THF (15.0 mL, 0.7 M) and the 
reaction was stirred for 15 minutes at -78 °C. Next, 3-bromobenzaldehyde (2.50 g, 13.5 
mmol, 1.3 equiv) was added dropwise in THF (10 mL). The reaction was stirred for an 
additional 45 minutes at -78  °C before being quenched with sat. NH4Cl (aq). The aqueous 
layer was extracted three times with methylene chloride (15 mL per extraction) and the 
combined organic layers were dried over MgSO4. Concentration and purification of the 
residue by silica gel column chromatography using gradient elution from 10% to 20% 
ethyl acetate/hexanes provided ethyl 2-(allyloxy)-3-(3-bromophenyl)-3-
hydroxypropanoate 7v’ as a clear oil (2.4:1 mixture of diastereomers, 2.13 g, 6.5 mmol, 
62% yield). Analytical data for 7v’ 1H NMR: (reported as 2.4:1 mixture of 
diastereomers normalized to the methine resonance corresponding to the minor 
diastereomer at δ 4.91 (500 MHz, CDCl3): δ 7.55 (s, 3.4H), 7.46–7.41 (m, 3.4H), 7.31–
7.30 (m, 3.4H), 7.24–7.19 (m, 3.4H), 5.82–5.76 (m, 3.4H), 5.24–5.19 (m, 6.8H), 4.99–
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4.97 (m, 2.4H), 4.91–4.91 (m, 1H), 4.18–4.06 (m, 10.6), 4.06 (d, J = 5.7 Hz, 2.4H), 3.98 
(d, J = 5.3 Hz, 1H),  3.96– 3.88 (m, 3.4H), 3.05–3.03 (m, 3.4H), 1.18 – 1.14 (m, 10.2H); 
13C NMR (151 MHz, C6D6): δ 170.7, 170.5, 143.7, 143.5, 134.6, 134.5, 131.7, 131.6, 131.0, 
130.8, 130.5, 130.3, 126.5, 126.2, 125.7, 123.2, 123.1, 118.3, 118.1, 83.3, 82.8, 74.9, 74.3, 
72.4, 72.4, 61.5, 61.4, 14.6, 14.6. 
 
Ethyl 2-(allyloxy)-3-(3-bromophenyl)acrylate (7v’’) Step 2:36 To a solution of 
ethyl 2-(allyloxy)-3-(3-bromophenyl)-3-hydroxypropanoate 7v’ (2.13 g, 6.5 mmol, 1.0 
equiv) and triethylamine (850 mg, 1.2 mL, 8.40 mmol, 1.3 equiv) in methylene chloride 
(20 mL, 0.3 M) cooled to 0 ° C was added methanesulfonyl chloride (889 mg, 0.60 mL, 
7.8 mmol, 1.2 equiv) dropwise. The resulting solution was allowed to warm to room 
temperature slowly and was then stirred for an additional 12h before being quenched with 
sat. NaHCO3 (aq). The aqueous layer was extracted three times with methylene chloride 
(15 mL per extraction) and the combined organic layers were dried over MgSO4 and 
concentrated. The crude mesylate was dissolved in tetrahydrofuran (12.9 mL, 0.5 M) and 
treated with 1,8-diazabicycloundec-7-ene (2.95 g, 2.89 mL, 19.4 mmol, 3.0 equiv) at room 
temperature. The reaction was stirred for 12 h before being diluted with water (2 mL/ 
mmol substrate, 13.0 mL). The aqueous layer was extracted three times with methylene 
chloride (15 mL per extraction) and the combined organic layers were dried over MgSO4. 
The crude residue was purified by silica gel column chromatography (5% then 10% ethyl 
acetate/hexanes) affording ethyl 2-(allyloxy)-3-(3-bromophenyl)acrylate  7v’’ as a pale 
yellow oil (1.47 g, 4.71 mmol, 73% yield over two steps). Analytical data for 7v’’:1H 
NMR (600 MHz, CDCl3) δ 7.98 (s, 1H), 7.66 (d, J = 7.9 Hz, 1H), 7.43 (d, J = 8.0 Hz, 1H), 
7.22 (t, J = 7.92 Hz, 1H), 6.90 (s, 1H), 6.04–5.98 (m, 1H), 5.36 (dd, J = 17.2, 1.3 Hz, 1H), 
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5.26 (d, J = 10.4 Hz, 1H), 4.51 (d, J = 6.1 Hz, 2H), 4.31 (q, J = 14.3, 7.1 Hz, 2H), 1.37 (t, J 
= 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 164.0, 145.2, 135.6, 133.2, 132.7, 131.6, 
129.9, 128.6, 122.5, 122.3, 118.8, 72.7, 61.4, 14.3.  
 
Ethyl 3-(3-bromophenyl)-2-oxohex-5-enoate (7v, Step 3):37 Ethyl 2-(allyloxy)-3-
(3-bromophenyl)acrylate  7v’’ (1.47 g, 4.71 mmol) was dissolved in toluene (11.8 mL, 0.4 
M) in a sealed reaction tube equipped with a stir bar and heated to 95 °C for 6 h, after 
which concentration provided ethyl 3-(3-bromophenyl)-2-oxohex-5-enoate 1o in 
quantitative yield (ca 94% pure, containing toluene). Analytical data for 7v: 1H NMR 
(600 MHz, CDCl3) δ 7.42–7.39 (m, 2H), 7.22–7.19 (m, 1H), 7.17–7.15 (m, 1H), 5.69–5.62 
(m, 1H), 5.06–5.03 (m, 1H), 5.01 (dd, J = 10.2, 1.3 Hz, 1H), 4.47 (t, J = 7.6 Hz, 1H), 4.26–
4.17 (m, 2H), 2.84–2.79 (m, 1H), 2.51–2.47 (m, 1H), 1.27–1.25 (m, 3H); 13C NMR (151 
MHz, CDCl3): δ 192.2, 160.6, 137.9, 134.2, 131.9, 131.0, 130.5, 127.5, 122.9, 117.8, 62.6, 
53.2, 35.7, 13.8; IR (thin film): 3446, 3080, 2982, 2938, 1793, 1731, 1646, 1569, 1559, 
1489, 1474, 1428, 1271, 1236; HRMS (ESI-): Calcd. for C14H15BrO3 ([M-1]): 309.0126, 
Found: 309.0133. TLC (90:10 hexanes: ethyl acetate): Rf = 0.3. 
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Method D for the preparation of (±)-4-ethyl 1,1-dimethyl 4-oxo-3-
phenylbutane-1,1,4-tricarboxylate 7w: Step 1:38 Magnesium turnings (333 mg, 13.7 
mmol, 2.0 equiv) were added to a flame dried round-bottomed flask equipped with a 
reflux condenser and stir bar under N2. The magnesium turnings were then activated by 
holding the flame of a Bunsen burner to the bottom of the flask for 1-2 min with stirring. 
Upon cooling to room temperature, tetrahydrofuran (13.7 mL) was added, followed by α-
bromostyrene (2.51 g, 13.7 mmol, 2.0 equiv). After approximately 10 min the reaction 
began to reflux after an additional 30 min the Grignard formation was complete as 
evidenced by consumption of the magnesium turnings and cessation of the reflux. Upon 
cooling to room temperature the resulting Grignard solution was added dropwise 
(manually) to a solution of diethyl oxalate (1.00 g, 6.84 mmol, 1.0 equiv) cooled to -70 °C 
using a dry ice/acetone bath. After complete addition of the Grignard reagent the 
resulting reaction was allowed to stir for 2.2 h at -70 °C before being quenched at this 
temperature with saturated aqueous ammonium chloride solution. The reaction was 
further diluted with water until the resulting salts had dissolved. The aqueous layer was 
extracted three times with ethyl acetate (50 mL per extraction) and the combined organic 
layers were dried over MgSO4 and concentrated. The resulting α,β-unsaturated α-keto 
ester 7w’ was found to be unstable to silica gel column chromatography as well as 
prolonged storage at low temperature and was therefore used directly without 
purification. Step 2: Crude 7w’ was dissolved in tetrahydrofuran (15.2 mL), 
dimethylmalonate (1.09 g, 8.21 mmol, 1.2 equiv) was added followed by 1,8-
diazobicyclo(5.4.0)undec-7-ene (DBU, 52.1 mg, 0.342 mmol, 0.05 equiv). The reaction 
was stirred for 13.5 h and concentrated. Silica gel column chromatography 10% ethyl 
acetate/hexanes delivered the desired product as a yellow oil (1.11 g, 3.32 mmol, 49% yield 
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over two steps, ~86% pure). Analytical data for 7w: 1H NMR (600 MHz, CDCl3): δ 
7.35–7.32 (m, 2H), 7.30–7.27 (m, 1H), 7.19–7.18 (m, 1H), 4.50 (dd, J = 8.6, 6.7 Hz, 1H), 
4.21–4.12 (m, 2H), 3.76 (s, 3H), 3.67 (s, 3H), 3.25 (dd, J = 8.8 Hz, 6.2 Hz, 1H), 2.64 (ddd, 
J = 14.3, 8.8, 6.6 Hz, 1H), 7.37 (ddd, J = 14.3, 8.6, 6.3 Hz, 1H), 1.20 (t, J = 7.1 Hz, 3H); 13C 
NMR (151 MHz, CDCl3): δ 192.0, 169.3, 169.2, 160.5, 134.5, 129.3, 129.1, 128.3, 62.5, 52.7, 
52.7, 51.4, 48.9, 30.1, 13.8; IR (thin film): 3750, 3734, 3566, 2955, 2359, 2341, 1792, 1748, 
1733, 1558, 1541, 1507, 1456, 1436, 1273, 1236, 1038, 701 cm-1 ; HRMS (ESI+): Calcd. for 
C17H20O7 :[(M+Na)]: 359.1107, Found: 359.1818. TLC (90:10 hexanes: ethyl acetate): Rf 
= 0.1. 
 
Method E for the preparation of tert-butyl 2-oxo-4-phenyl-3-(pyridin-3-
yl)butanoate 7x:38 
In an N2 filled glovebox a solution of the known9 α-keto ester 1x’ (70.3 mg, 0.30 mmol, 
1.0 equiv) and 3-bromopyridine (94.8 mg, 0.60 mmol, 2.0 equiv) was added in toluene 
(1.5 mL, 0.2 M) to a flame dried 1 dram vial containing Pd2dba3 (5.49 mg, 0.006 mmol, 
0.02 equiv), tri-tert-butylphosphine (0.024 mmol,24.0 µL, 1.0 M PhMe, 0.08 equiv), and 
K3PO4 (191 mg, 0.90 mmol, 3.0 equiv). The vial was capped (red silicone/PTFE septum 
cap), removed from the glovebox, and heated at 110 °C for 12 h. Upon cooling to room 
temperature, the reaction was quenched by the addition of 1 mL of saturated aqueous 
ammonium chloride and the mixture was allowed to stir for 20 minutes at room 
temperature until two separate homogenous phases were observed. The mixture was 
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further diluted with methylene chloride and water and the aqueous phase was etracted 
several times using methylene chloride. The combined organic layers were dried over 
MgSO4 and concentrated. Silica gel column chromatography (70:30 hexanes/ethyl 
acetate) afforded the desired compound as a yellowish solid (54.0 mg, 0.17 mmol, 58% 
yield). Analytical data for 7x: 1H NMR (600 MHz, CDCl3): δ 8.50 (d, J = 3.7 Hz, 1H), 
8.38 (s, 1H), 7.50–7.49 (m, 1H),  7.27–7.15 (m, 4H), 7.03 (d, J = 7.1 Hz, 2H), 4.63 (dd, J 
= 8.0 Hz, 7.1 Hz, 1H), 3.44 (dd, J = 13.9, 6.7 Hz, 1H), 2.97 (dd, J = 13.9 Hz, 8.4 Hz, 1H), 
1.36 (s, 9H); 13C NMR (151 MHz, CDCl3):  δ 193.3, 159.8, 150.5, 148.9, 137.8, 136.0, 132.0, 
129.0, 128.5, 126.6, 123.6, 84.6, 53.4, 37.7, 27.6; HRMS (ESI+): Calcd. for C19H21NO3: 
([M+1]): 312.1600, Found: 312.1597. TLC (70: 30 hexanes: ethyl acetate): Rf = 0.2. 
 
Catalyst Preparation 
 
Method F for the Preparation of Chiral Rhodium Catalysts: The 
(chiraldiene)rhodium(I) dimers 10 and 11 were prepared starting from known 
bis(triflate) (R,R)-16 according to the Kumada coupling method reported by Hayashi and 
co-workers for the synthesis of complex 9.22b As noted by Hayashi, the norbornadiene 
derived ligands reported here were sensitive and were directly complexed without 
purification. We have provided the crude 1H NMR spectra of the ligands L10 and L11 
corresponding to catalysts 10 and 11 below as a reference.  
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Preparation of Catalyst 10: To a suspension of magnesium turnings 
(187 mg, 7.7 mmol, 6.0 equiv) in THF (3.0 mL) in a flame dried round-
bottomed flask equipped with a reflux condenser  under N2 was added 
1-bromo-4-(trifluoromethyl)benzene (1.74 g, 7.7 mmol, 6.0 equiv) in 
THF (3.0 mL) once the ensuing reflux had subsided and complete consumption of the 
magnesium turnings was observed the resulting deep red solution was added slowly to a 
solution of bis(triflate) 16 (499 mg, 1.30 mmol), Fe(acac)3 (22.7 mg, 0.06 mmol, 0.05 
equiv) , and NMP (130 μL) in THF (6.0 mL) cooled to 0 °C (ice bath). The reaction was 
allowed to warm to room temperature and stirred for 20 h before being quenched with 
water (15 mL). The aqueous phase was extracted three times with ethyl acetate (15 mL per 
extraction) and dried over K2CO3. Upon concentration the residue was passed through a 
silica plug using 5/95 ethyl acetate/hexanes and concentrated. 1H NMR Data for L10 
(400 MHz, CDCl3) δ 7.58 (d, J = 8.3 Hz, 4H), 7.51 (d, J = 8.0 Hz, 4H), 7.18 (s, 2H), 4.11 
(s, 2H), 2.32 (s, 2H), see crude spectrum below. Complexation: In an N2 filled glovebox 
the crude diene ligand was dissolved in PhMe (2.0 mL) in a scintillation vial equipped 
with a stir bar. Next, di-μ-chlorotetraethylene dirhodium(I) (250 mg, 0.64 mmol, 0.5 
equiv) was added and the mixture was allowed to stir at room temperature for 2 h. The 
reaction was concentrated and the crude residue was purified by silica gel column 
chromatography (pressurized with N2, gradient elution, 25/75 DCM/hexanes then 50/50 
DCM/hexanes, followed by DCM), yielding catalyst 10 as a red solid (200 mg, 0.19 mmol, 
30% yield). Analytical data for catalyst 10:  1H NMR (600 MHz, CDCl3) δ 7.61 (d, J 
= 8.2 Hz, 8H), 7.54 (d, J = 8.2 Hz, 8H), 4.24 (m, 1H), 3.80 (s, 1H), 1.43 (s, 1H); 13C NMR 
(151 MHz, CDCl3): δ 142.1, 129.3 (q, J19F-13C = 32.6 Hz), 127.7, 125.2 (q, J19F-13C = 3.5 Hz), 
124.3 (q, J19F-13C = 272.0 Hz), 64.4 (d, JRh103-13C  =  10.3 Hz), 58.3 (d, JRh103-13C = 5.5 Hz), 
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53.1, 42.5 (d, JRh103-13C = 10.3 Hz);  19F NMR (565 MHz, CD2Cl2) δ -62.8. TLC (90:10 
hexanes: ethyl acetate): Rf = 0.2, red spot. Crystals suitable for X-ray analysis were 
obtained by adding catalyst 10 (15.0 mg) in hexanes (1 mL), heating the resulting 
suspension to reflux while adding chloroform dropwise until a homogenous red solution 
was observed and allowing the resulting solution to sit at room temperature for 48 h. 
 
Preparation of Catalyst 11: To a round-bottomed flask equipped 
with a reflux condenser containing a suspension of magnesium 
turnings under N2 atmosphere (226 mg. 9.3 mmol) in THF (5.0 mL) 
was added 1,3-Bis(trifluoromethyl)-5-bromobenzene (2.72 g, 9.3 
mmol). After the ensuing reflux had subsided and the magnesium turnings were 
completely consumed the resulting Grignard solution was added slowly to a solution of 
bis(triflate) 16 (400 mg, 1.03 mmol), Fe(acac)3 (18.2 mg, 0.05 mmol, .05 equiv), and NMP 
(291 μL) in THF (5.2 mL) cooled to 0 °C (ice bath). After 5 minutes TLC analysis showed 
complete consumption of bis(triflate) 16 and the reaction was quenched with water (12 
mL) and extracted three times with ethyl acetate (15 mL per extraction). The combined 
organic layers were dried over K2CO3 before being concentrated. The crude residue was 
passed through a plug of silica gel using 5/95 ethyl acetate/hexanes and concentrated. 1H 
NMR Data for Ligand 11: (500 MHz, CDCl3) δ 7.82 (s, 4H), 7.71 (s, 2H), 7.33 (s, 2H), 
4.19 (s, 2H), 2.39 (s, 2H), see crude spectrum below. In an N2 filled glovebox the crude 
diene ligand was dissolved in PhMe (3.0 mL) in a scintillation vial equipped with a stir 
bar. Next, di-μ-chlorotetraethylene dirhodium(I) was added and the mixture was allowed 
to stir at room temperature for 6 h. The reaction was concentrated and the residue was 
purified by silica gel column chromatography (N2 used to pressurize, 25/75 DCM/hexanes 
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as eluent) yielding catalyst C as a red solid (252 mg, 0.19 mmol, 37% yield). Analytical 
data for catalyst 11: 1H NMR (600 MHz, CDCl3) δ 7.90 (s, 4H), 7.84 (s, 8H), 4.30 (s, 
4H), 3.87 (s, 4H), 1.49 (s, 4H); 13C NMR (151 MHz, CDCl3) δ 140.5, 132.1 (q, J19F-13C = 
34.0 Hz), 127.0, 123.0 (q, J19F-13C = 273.1 Hz), 121.1, 64.0 (d, JRh103-C13 = 10.5 Hz), 58.7 (d, 
JRh103-13C = 5.2 Hz), 53.4, 42.9 (d, JRh103-13C = 10.2 Hz); 19F NMR (565 MHz, CDCl3): δ -
63.2. TLC (90:10 hexanes: ethyl acetate): Rf = 0.4, red spot.  Crystals suitable for X-ray 
analysis were obtained by adding catalyst 11 (10.0 mg) in hexanes (1 mL), heating the 
resulting suspension to reflux while adding ethyl acetate dropwise until a homogenous 
red solution was observed and allowing the resulting solution to sit at room temperature 
for 72 h. 
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Method G for Dynamic Kinetic Arylation Reaction: 
To a flame dried 1 dram vial equipped with a stir bar and red PTFE/silicone cap was added 
(in an N2 filled glovebox) triethylamine (0.6 mmol, 6.0 equiv), the arylboronic acid (3.0-
6.0 equiv, see below for individual loadings), and cesium fluoride (3.0-6.0 equiv, see 
below for individual loadings). Next, 0.50 mL of chloroform was added to a separate flame 
dried vial containing the chiral(diene)chlororhodium(I) dimer (.0025 mmol, 2.5 mol %) 
and the resulting solution was transferred to a third vial containing the α-keto ester 
substrate (0.1 mmol). The combined solution was transferred to the original stir bar, 
triethylamine, arylboronic acid, and cesium fluoride containing vial. The transfer process 
described above was repeated with an additional 0.50 mL of chloroform bringing the total 
reaction volume to 1.0 mL (.10 M). The reaction vial was capped tightly, removed from 
the glovebox, sealed with electrical tape and heated at 40 °C (external bath temperature, 
LabArmor® aluminum heating beads) with stirring (1100-1200 rpm) for the specified 
time. Upon completion, the reaction was allowed to cool to room temperature, 1.0 mL of 
sat. NH4Cl (aq) was added and the mixture was stirred until two homogenous layers were 
produced. The resulting mixture was transferred to a 30 mL separatory funnel using 5 mL 
of ethyl acetate. Next, 5-6 mL of water was added and the layers were separated. The 
aqueous phase was extracted three times (5 mL ethyl acetate per extraction) and the 
combined organic layers were washed with 6-8 mL of sat. NaCl (aq) and dried over 
MgSO4. The crude arylation products were purified by silica gel column chromatography, 
with the exception of product 8o which was purified using preparatory thin layer 
chromatography (see below for individual eluent systems).  
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Method H for the 1 Mmol Scale Arylation of 7y: 
Ethyl(2R,3S)-3-(4-bromophenyl)-2-hydroxy-2-
phenylbutanoate: Triethylamine (607 mg, 6.00 mmol, 6.0 
equiv), 2-naphthylboronic acid (688 mg, 4.0  mmol, 4.0 equiv), and cesium fluoride (608 
mg, 4.0 mmol, 4.0 equiv), and 5.0 mL of chloroform were combined in a flame dried 20.0 
mL reaction tube equipped with a stir bar in the glovebox. Next, 2.0 mL of chloroform 
was used to transfer catalyst C (6.55 mg, 0.005 mmol, .005 equiv) and α-keto ester 7y, 
which were contained in separate vials, to the reaction tube. Finally, the vials containing 
the catalyst and substrate were rinsed with an additional 3.0 mL of chloroform and the 
reaction tube was removed from the glovebox, sealed with electrical tape, and heated for 
72 h. The reaction was cooled to room temperature, 500 μL of ethanol was added and the 
mixture was allowed to stir for 5 min before being filtered through a pad of silica gel using 
ethyl acetate to rinse. The crude reaction mixture was purified by silica gel column 
chromatography using 2.5% ethyl acetate in hexanes as eluent affording 8y as an 
amorphous white solid (average yield of two runs = 77%). Recrystallization of 8y: The 
product could be recrystallized by titrating a hot suspension of 8y in hexanes with ethyl 
acetate and allowing the resulting solution to stand at room temperature which afforded 
8y enriched to 99:1 er in the form of needles suitable for x-ray crystal diffraction studies. 
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Method I for the Synthesis of Enantioenriched 7a: 
Step 1: DKR-ATH of (±)-7a11b 
Dichloro(p-cymene)ruthenium(II) dimer (25.4 mg, 0.0415 mmol, 0.02 equiv) and N-
[(1R,2R)-2-amino-1,2-diphenyl-ethyl]-2,6-diphenyl-benzenesulfonamide10 were massed 
into a flame dried 1 dram vial equipped with a stir bar in an N2 filled glovebox, DMF (2.0 
mL) was added and the mixture was heated to 70 °C for 30 minutes. Upon cooling to room 
temperature the solution of complexed catalyst was transferred to a solution of the α-keto 
ester (±)-7a in DMF (18.8 mL) in a 150 mL pressure vessel. The reaction was stirred for 
19 h at room temperature. Upon completion the reaction mixture was diluted with water 
and ethyl acetate. The organic layer was washed twice with brine and dried over 
magnesium sulfate and concentrated. The crude residue was purified by silica gel column 
chromatography affording α-hydroxyester 17 as a 5:1 mixture of diastereomers (406 mg, 
1.67 mmol, 81%). 1H NMR data for 17 (500 MHz, CDCl3, major diastereomer): δ 7.26 
(d, J = 8.5 Hz, 2H), 7.18 (d, J = 8.5 Hz, 2H), 4.31 (dd, J = 6.0, 3.7 Hz, 1H), 4.16 (q, J = 7.2 
Hz, 2H), 3.29–3.24 (m, 1H), 2.79 (d, J = 6.0 Hz, 1H), 1.44 (d, J = 7.3 Hz, 3H), 1.26 (t, J = 
7.2 Hz, 3H). HPLC (98:2 hexanes:iPrOH, Daicel CHIRALPAK IC): tR1 = min ; tR2 = min. 
 
Step 2: DMP oxidation of 17: 
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Ethyl 3-(4-chlorophenyl)-2-hydroxybutanoate 17 (mixture of diastereomers, 406 mg, 
1.67 mmol, 1.0 equiv) was dissolved in methylene chloride (11.1 mL, 0.15 M) and the 
resulting solution was cooled to 0 °C. Next, Dess–Martin Periodinane (2.13 g, 5.02 mmol, 
3.0 equiv) was added and the reaction was stirred for 3 h while warming to room 
temperature. Upon completion the reaction mixture was diluted with water and 
methylene chloride and filtered through a pad of celite, rinsing with methylene chloride. 
The aqueous phase was extracted with methylene chloride and the combined organic 
layers were dried over MgSO4. Silica gel column chromatography (2.5% ethyl acetate in 
hexanes) afforded optically active 7a (357 mg, 1.48 mmol, 89%, 88:12 er).  
 
Racemization Studies: 
A solution of optically active 7a (24.1 mg, 0.1 mmol) was transferred in chloroform (1.0 
mL 0.1 M) to a flame dried 1 dram vial containing the tertiary amine base, 2-
naphthylboronic acid, CsF, and a stir bar and the mixture was stirred at the indicated 
temperature. Aliquots were removed (100-200 µL) at the specified times and delivered to 
a scintillation vial containing a stir bar and methanol (1.0 mL). Sodium borohydride (~20 
mg) was immediately added and the resulting solution was diluted with water and 
extracted with ethyl acetate. The resulting α-hydroxy ester 7a’ was directly analyzed by 
chiral HPLC analysis.  
 Note: racemic 17 was prepared via an analogous procedure starting from (±)-7a.  
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Table 2-2 Racemization Studies. 
  
Time 
(min) 
nBu3N (% 
ee) 
Et3N (% 
ee) 
iPr2NEt, rt (% 
ee) 
iPr2Net, 40 ˚C (% 
ee) 
NMP(%ee) 
0 76 76 76 76 76 
2     0 
4 48 34    
8 24 10    
12 16 6    
15    73  
16 10 4    
20 4 2 76   
24 4 2    
30    54  
40   74   
45    19  
60   54 2  
75    0  
80   26   
100   14   
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Analytical Data for Arylation Products 
 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-
phenylbutanoate (8a): The title compound was prepared 
according to Method G using 3.0 equiv phenylboronic acid and 3.0 
equiv cesium fluoride. The reaction time was 48 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 2.5% ethyl acetate in hexanes 
affording 8a as a clear oil (27.3 mg, .086 mmol, 86% yield) Analytical data for 8a: 1H 
NMR (500 MHz, CDCl3) δ = 7.80 (d, J = 8.0 Hz, 2H), 7.41–7.38 (m, 4H), 7.34–7.31 (m, 
1H), 7.27 (d, J = 8.4 Hz, 2H), 4.04–3.98 (m, 2H), 3.77 (s, 1H), 3.68 (q, J = 7.1 Hz, 1H), 
1.17 (t, J = 7.2 Hz, 3H), 1.07 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CHCl3): δ 174.4, 
132.7, 130.4, 128.2, 128.1, 127.7, 126.1, 80.5, 62.5, 47.1, 15.2, 13.9; IR (thin film): 3501, 
2935, 1727, 1490, 1248, 1014 cm-1; HRMS (ESI+): Calcd. for C18H19ClO3 ([M+Na]): 
341.0920, Found: 341.0923; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 94:6 
er, tR (major) = 4.78 min, tR (minor) = 5.86 min; [α]D = -50.1 (c = 0.02, CHCl3). TLC (90:10 
hexanes: ethyl acetate): Rf = 0.4. 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-(p-
tolyl)butanoate (8b): The title compound was prepared 
according to Method G using 3.0 equiv of p-tolylboronic acid and 
3.0 equiv of cesium fluoride. The reaction time was 48 h. The diastereoselectivity was 
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determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 2.5% ethyl acetate in hexanes 
affording 8b as an amorphous white solid (30.9 mg, .093 mmol, 93% yield). Analytical 
data for 3b: 1H NMR (500 MHz, CDCl3) δ 7.66 (d, J = 8.2 Hz, 2H), 7.38 (d, J = 8.4 Hz, 
2H), 7.26 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 8.0 Hz), 4.04–3.95 (m, 2H), 3.74 (s, 1H), 3.65 
(q, J = 7.1 Hz, 1H), 2.37 (s, 3H), 1.65 (t, J = 7.2 Hz, 3H), 1.07 (d, J = 7.2 Hz, 3H); 13C NMR 
(151 MHz, CDCl3): δ 174.5, 140.5, 137.4, 137.4, 132.6, 130.4, 128.9, 128.0, 126.0, 80.4, 
62.4, 47.0, 21.0, 15.2, 13.9; IR (thin film): 3502, 3030, 2980, 2936, 2874, 1725, 1508, 
1492, 1248, 1138, 1041, 1016 cm-1; HRMS (ESI+): Calcd. for C19H21ClO3 ([M+Na]): 
355.1077, Found: 355.1080; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 
er, tR (major) = 5.28 min, tR (minor) = 7.45 min; [α]D = -57.7 (c = 0.01, CHCl3). TLC (90:10 
hexanes: ethyl acetate): Rf = 0.4. 
 
Ethyl (2R,3S)-2,3-bis(4-chlorophenyl)-2-
hydroxybutanoate (8c): The title compound was prepared 
according to Method G using 5.0 equiv p-chlorophenylboronic 
acid and 5.0 equiv cesium fluoride. The reaction time was 48 h. 
The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. The 
reaction was run in duplicate; the reported yields and enantioselectivities are averages of 
two runs. The crude product was purified by silica gel column chromatography using 2.5% 
ethyl acetate in hexanes affording 8c as an amorphous white solid (28.6 mg, 0.081 mmol, 
81% yield). Analytical data for 8c: 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.6 Hz, 
2H), 7.38–7.35 (m, 4H), 7.27 (d, J = 8.4 Hz, 2H), 4.06–3.97 (m, 2H), 3.76 (s, 1H), 3.61 (q, 
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J = 7.1 Hz), 1.17 (t, J = 7.1 Hz, 3H), 1.06 (d, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): 
δ 174.0, 140.0, 138.9, 133.7, 130.3, 128.3, 128.1, 127.7, 80.3, 62.7, 47.1, 15.06, 13.9; IR 
(thin film): 3494, 2980, 2937, 2359, 1730, 1490, 1473, 1249, 1138, 1093; HRMS (ESI+): 
Calcd. for C18H18Cl2O3 ([M+Na]): 375.0531, Found: 375.0538; HPLC ( 99:1 
hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 er, tR (major) = 4.70 min, tR (minor) = 5.58 min; 
[α]D = -58.0 (c = .01, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.4. 
 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-(4-fluorophenyl)-2-
hydroxybutanoate (8d): The title compound was prepared 
according to Method G using 5.0 equiv p-fluorophenylboronic acid 
and 5.0 equiv cesium fluoride. The procedure was modified for this 
product as follows: upon completion the reaction was allowed to cool to room 
temperature and 50 μL of ethanol were added, the resulting mixture was allowed to stir 
for 10 minutes before being filtered through a plug of silica gel using ethyl acetate to rinse 
and concentrated. When the work-up according to Method G was employed a large 
amount of inhomogenous material resulted, complicating extraction and crude 1H NMR 
analysis. The reaction time was 48 h. The diastereoselectivity was determined by analysis 
of the crude 1H NMR spectrum.  The reaction was run in duplicate; the reported yields 
and enantioselectivities are averages of two runs. The crude product was purified by silica 
gel column chromatography using 2.5% ethyl acetate in hexanes affording 8d as a clear 
oil (27.0 mg, .080 mmol, 80% yield). Analytical data for 8d: 1H NMR (500 MHz, 
CDCl3) δ 7.76 (dd, J = 8.8, 5.4 Hz, 2H), 7.36 (d, J = 8.5 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 
7.08 (t, J = 8.7 Hz, 2H), 4.06–3.97 (m, 2H), 3.76 (s, 1H), 3.62 (q, J = 7.1 Hz, 1H), 1.17 (t, 
J = 7.1 Hz, 3H), 1.06 (d, J = 7.1 Hz, 3H); 13C NMR (151MHz, CDCl3) δ 174.2, 162.2 (d, 
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J19F-13C = 247 Hz), 140.1, 136.1 (d, J19F-13C = 3.1 Hz), 130.4, 128.1, 128.0 (d, J19F-13C = 8.1 
Hz), 115.0 (d, J19F-13C = 71.6 Hz), 80.2, 62.7, 47.2, 15.1, 13.9; 19F NMR (376 MHz, CDCl3): 
δ 115.2; IR (thin film): 3495, 2981, 2937, 1726, 1603, 1506, 1493, 1250, 1136, 1041, 1015 
cm-1; HRMS (ESI+): Calcd. for C18H18ClFO3 ([M+Na]): 359.0826, Found: 359.0832; 
HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 95:5 er, tR (major) = 4.8, tR (minor) = 5.6 
min; [α]D = -54.8 (c = 0.01, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.5.  
 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-(3-
methoxyphenyl)butanoate (8e): The title compound was 
prepared according to Method G using 3.0 equiv of m-
methoxyphenylboronic acid and 3.0 equiv of cesium fluoride. The reaction time was 60 
h. The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. 
The reaction was run in duplicate; the reported yields and enantioselectivities are 
averages of two runs. The crude product was purified by silica gel column 
chromatography using 2.5% ethyl acetate in hexanes affording 8e as a clear oil (30.8 mg, 
.088 mmol, 88% yield). Analytical data for 8e: 1H NMR (500 MHz, CDCl3) δ 7.39–
7.37 (m, 4H), 7.33–7.30 (m, 1H), 7.27 –7.25 (m, 2H), 6.88–6.86 (m, 1H), 4.06–3.97 (m, 
2H), 3.85 (s, 3H), 3.77 (s, 1H), 3.65 (q, J = 7.1 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H), 1.08 (d, J 
= 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.3, 159.5, 142.2, 140.4, 132.7, 130.4, 
129.1, 128.0, 118.5, 112.9, 112.1; IR (thin film): 3502, 2979, 2936, 2835, 2360, 1725, 1600, 
1583, 1491, 1457, 1255, 1136, 1041, 1015; HRMS (ESI+): Calcd. for C19H21ClO4 ([M+Na]): 
371.1026, Found: 371.1031; HPLC (98:2 hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 
er, tR (major) = 6.0 min, tR (minor) = 12.6 min; [α]D = -35.6 (c = 0.01, CHCl3). TLC (90:10 
hexanes: ethyl acetate): Rf = 0.3. 
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Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-(m-
tolyl)butanoate (8f): The title compound was prepared 
according to Method G using 3.0 equiv of m-tolylboronic acid 
and 3.0 equiv of cesium fluoride. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 2.5% ethyl acetate in hexanes 
affording 8f as a clear oil (30.0 mg, .090 mmol, 90% yield). Analytical data for 8f:  1H 
NMR (600 MHz, CDCl3) δ 7.61–7.57 (m, 2H), 7.39 (d, J = 8.4 Hz, 2H), 7.30–7.26 (m, 
3H), 7.14 (d, J = 7.4 Hz, 1H), 4.04–3.96 (m, 2H), 3.76 (s, 1H), 3.68 (q, J = 7.1 Hz, 1H), 
2.41 (s, 3H), 1.17 (t, J = 7.1 Hz, 3H), 1.08 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): 
δ 174.4, 140.5, 140.3, 137.8, 132.6, 130.4, 128.4, 128.1, 128.0, 126.7, 123.2, 62.5, 46.9, 21.7, 
15.3, 13.9; IR (thin film): 3502, 2979, 2936, 2360, 2341, 1771, 1717, 1698, 1558, 1540, 
1490, 1457, 1254, 1231, 1134, 1093 cm-1; HRMS (ESI+): Calcd. for C19H21ClO3 ([M+Na]): 
355.1077, Found: 355.1079; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 96:4 
er, tR (major) = 4.48, tR (minor) = 5.53 min; [α]D = -44.5 (c = 0.01, CHCl3). TLC (90:10 
hexanes: ethyl acetate): Rf = 0.4.  
 
Ethyl (2R,3S)-2-(3-chlorophenyl)-3-(4-chlorophenyl)-
2-hydroxybutanoate (8g): The title compound was prepared 
according to Method G using 6.0 equiv of 3-
chlorophenylboronic acid and 6.0 equiv of cesium fluoride. The reaction was run for 60 
h. The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. 
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The reaction was run in duplicate; the reported yields and enantioselectivities are 
averages of two runs. The crude product was purified by silica gel column 
chromatography using 2.5% ethyl acetate in hexanes affording 8g as a clear oil (25.5 mg, 
0.072 mmol, 72% yield). Analytical data for 8g: 1HNMR (500 MHz, CDCl3): δ 7.82 
(s, 1H), 7.71 (d, J = 7.4 Hz, 1H), 7.39–7.28 (m, 6H), 4.09–4.02 (m, 2H), 3.81 (s, 1H), 3.63 
(q, J = 7.1 Hz, 1H), 1.20 (t, J = 7.2 Hz, 3H), 1.09 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, 
CDCl3): 173.8, 142.6, 139.9, 134.3, 132.9, 130.4, 129.4, 128.1, 127.9, 126.5, 124.4, 80.3, 
62.8, 47.2, 15.1, 13.9; IR (thin film): 3524, 3502, 3481, 2979, 2936, 2359, 2340, 1748, 
1732, 1717, 1698, 1569, 1558, 1541, 1507, 1418, 1248, 1139, 1015 cm-1; HRMS (ESI+): 
Calcd. for C18H18Cl2O3: ([M+Na]): 375.0531, Found: 375.0542; HPLC (99:1 hexanes: 
iPrOH, Daicel CHIRALPAK IC): 94: 6 er, tR (major) = 4.55 min, tR (minor) = 5.90 min; [α]D = 
-90.5 (c = 0.01, CHCl3); TLC (90:10 hexanes: ethyl acetate): Rf = 0.4. 
 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-
(naphthalen-2-yl)butanoate (8h): The title compound was 
prepared according to Method G using 3.0 equiv 2-
naphthylboronic acid and 3.0 equiv of CsF. The reaction was 
run for 48 h. The diastereoselectivity was determined by analysis of the crude 1H NMR 
spectrum. The reaction was run in duplicate; the reported yields and enantioselectivities 
are averages of two runs. The crude product was purified by silica gel column 
chromatography using 2.5% ethyl acetate in hexanes affording 8h as a white amorphous 
solid (30.3 mg, .082 mmol, 82% yield). Analytical data for 8h: 1H NMR (500 MHz, 
CDCl3) δ 8.30 (s, 1H), 7.92–7.86 (m, 4H), 7.52–7.51 (m, 2H), 7.44 (d, J = 8.3 Hz, 2H), 
7.30 (d, J = 8.4 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 3.91 (s, 1H), 3.83 (q, J = 7.1 Hz, 1H), 1.19 
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(t, J = 7.1 HZ, 3H), 1.10 (d, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.3, 140.3, 
137.7, 133.0, 132.8, 132.7, 130.5, 128.4, 128.1, 127.9, 127.4, 126.3, 126.2, 125.6, 124.0; IR 
(thin film): 3502, 3058, 2980, 2935, 2359, 1725, 1491, 1256, 1240, 1132 cm-1; HRMS 
(ESI+): Calcd. for C22H21ClO3 ([M+Na]): 391.1077, Found: 391.1084; HPLC (99:1 
hexanes:iPrOH, Daicel CHIRALPAK IC): 96.5:3.5 er, tR (major) = 4.8 min, tR (minor) = 6.9 
min; [α]D = -48.9 (c = 0.02, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.4. 
 
Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-(2-
methoxyphenyl)butanoate (8i): The title compound was 
prepared according to Method G using 6.5 equiv of 2-
methoxyphenylboronic acid and 6.5 equiv of cesium fluoride. The reaction time was 60 h. 
The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. The 
reaction was run in duplicate; the reported yields and enantioselectivities are averages of 
two runs. The crude product was purified by silica gel column chromatography using 
gradient elution from 2.5% ethyl acetate in hexanes to 5% ethyl acetate in hexanes 
affording 8i as a clear oil. Analytical data for 8i: 1H NMR (600 MHz, CDCl3): δ (dd, 
J = 7.8, 1.0 Hz, 1H), 7.40 (d, J = 8.5 Hz, 2H), 7.32–7.30 (m, 1H), 7.24 (d, J = 8.4 Hz, 2H), 
7.05– 7.03 (m, 1H), 6.92 (d, J =  8.2 Hz, 1H), 4.70 (s, 1H), 3.93 (q, J = 7.0 Hz, 1H), 3.89–
3.80 (m, 5H), 1.39 (d, J = 7.1 Hz, 3H), 0.99 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): 
δ 173.7, 157.7, 140.7, 132.5, 131.0, 129.2, 129.0, 128.0, 127.8, 120.9, 111.7, 80.2, 61.3, 55.5, 
43.4, 16.4, 13.8; IR (thin film): 2360.4, 1742.4, 1490, 1247, 1121, 1028 cm-1; HRMS 
(ESI+): Calcd. for C19H21ClO4 ([M+Na]): 371.1026, Found: 371.1027; HPLC (98:2 
hexanes:iPrOH, Daicel CHIRALPAK IC): 95.5:4.5 er, tR (major) = 8.2 min, tR (minor) = 11.7 
min; [α]D = -74.5 (c = 0.01, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.2. 
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Ethyl (2R,3S)-3-(4-chlorophenyl)-2-hydroxy-2-(1H-
indol-6-yl)butanoate (8j): The title compound was 
prepared according to Method G using 3.5 equiv of 6-
indolylboronic acid and 3.5 equiv of cesium fluoride. The 
reaction time was 60 h. The diastereoselectivity was determined by analysis of the crude 
1H NMR spectrum. Note: The reaction was run in triplicate and two of the trials were 
averaged; during the second trial it was noticed the reaction was not stirring due to the 
low solubility of 6-indoylboronic acid under the reaction conditions and in this run what 
is presumably the opposite diastereomer was observed in the crude 1H NMR spectrum 
and the enantioselectivity was lower (89:11 er). Thus a third trial was run in a 20 mL 
scintillation with a larger stir bar (instead of a 1 dram vial) to promote stirring. The results 
from the third trial closely matched those obtained in the first trial. In this case the results 
from the first and third trial were averaged. This is the only instance where the first and 
second trials yielded inconsistent selectivities. The crude product was purified by silica 
gel column chromatography using 20% ethyl acetate in hexanes as eluent providing 8j as 
a clear oil (24.4 mg, .068 mmol, 68% yield). Analytical data for 8j: 1H NMR (600 MHz, 
CDCl3) δ 8.25 (br s, 1H), 7.87 (s, 1H), 7.66 (d, J = 8.5 Hz, 1H), 7.54 (dd, J = 8.4, 1.3 Hz, 
1H), 7.42 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 7.25–7.24 (m, 1H), 6.56 (br s, 1H), 
4.00 (q, J = 7.1 Hz, 2H), 3.85 (s, 1H), 3.78 (q, J = 14.3, 7.1 Hz, 1H), 1.17 (t, J = 7.1 Hz, 3H), 
1.08 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.9, 140.7, 135.8, 134.4, 132.6, 
130.5, 128.0, 127.1, 124.9, 120.3, 118.1, 109.1, 102.3, 80.8, 62.4, 47.1, 15.3, 13.9; IR (thin 
film): 3750, 2820, 2360, 2341, 1771, 1748, 1558, 1541, 1507, 1497, 1457, 1396; HRMS 
(ESI+):  Calcd. for C20H20ClNO3 ([M+1]): 358.1210, Found: 358.1218; HPLC (97:3 
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hexanes:iPrOH, Daicel CHIRALPAK IC): 94:6 er, tR (major) = 13.6 min, tR (minor) = 15.8 min; 
[α]D: -45.7 (c = .01, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf =  0.1. 
 
Ethyl (2R,3S)-2-hydroxy-2-phenyl-3-(p-tolyl)butanoate 
(8m): The title compound was prepared according to Method G 
using 3.0 equiv of phenylboronic acid and 3.0 equiv of cesium 
fluoride. The reaction time was 60 h. The diastereoselectivity was determined by analysis 
of the crude 1H NMR spectrum. The reaction was run in duplicate; the reported yields and 
enantioselectivities are averages of two runs. The crude product was purified by silica gel 
column chromatography using 2.5% ethyl acetate in hexanes affording 8m as an 
amorphous white solid (28.3 mg, .095 mmol, 95% yield). Analytical data for 3m: 1H 
NMR (600 MHz, CDCl3): δ 7.83–7.82 (m, 2H), 7.41– 7.39 (m, 2H), 7.33–7.31 (m, 3H), 
7.12–7.11 (d, J = 7.9 Hz, 2H), 4.04–3.96 (m, 2H), 3.74 (s, 1H), 3.69 (q, J = 7.1 Hz, 1H), 
2.33 (s, 3H), 1.18 (t,  J = 7.1 Hz, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): 
δ 174.6, 140.6, 138.6, 136.5, 128.9, 128.7, 128.1, 127.5, 126.3, 80.8, 62.3, 47.2, 21.1, 15.1, 
13.9; IR (thin film): 3501, 2361, 1731, 1535, 1496, 1457, 1240, 1157, 1031 cm-1; HRMS 
(ESI+): Calcd. for C19H22O3 ([M+Na]): 321.1467, Found: 321.1465; HPLC (99:1 
hexanes:EtOAc, Daicel CHIRALPAK IA): 95:5 er, tR (major) = 8.3 min, tR (minor) = 7.6 min; 
[α]D = -50.1 (c = 0.01, CHCl3); TLC (90:10 hexanes: ethyl acetate): Rf = 0.4.  
 
Ethyl (2R,3S)-2-hydroxy-2-(naphthalen-2-yl)-3-(p-
tolyl)butanoate (8n): The title compound was prepared 
according to Method G using 3.0 equiv of 2-naphthylboronic 
acid and 3.0 equiv of cesium fluoride. The reaction time was 60 
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h. The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. 
The reaction was run in duplicate; the reported yields and enantioselectivities are 
averages of two runs. The crude product was purified by silica gel column 
chromatography using 2.5%  ethyl acetate in hexanes affording 8n as an amorphous white 
solid (28.6 mg, .082 mmol, 82%). Analytical data for 8n: 1H NMR (500 MHz, CDCl3) 
δ 8.32 (s, 1H), 7.97–7.86 (m, 4H), 7.53–7.49 (m, 2H), 7.38 (d, J = 7.9, 2H), 7.15 (d, J = 
7.8 Hz, 2H), 4.03 (q, J = 7.2 Hz, 2H), 3.87–3.83 (m, 3H), 2.35 (s, 3H), 1.20 (t, J = 7.1 Hz, 
3H), 1.13 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.6, 138.5, 137.9, 136.6, 
133.0, 132.7, 128.9, 128.7, 128.4, 127.7, 127.4, 126.1, 126.1, 125.7, 124.3, 81.0, 62.4, 47.0, 
21.1, 15.1, 13.9; IR (thin film):  3502, 3057, 2979, 2934, 2360, 1722, 1507, 1373, 1257, 
1240, 1156, 1132, 1022, 824 cm-1; HRMS (ESI+): Calcd. for C23H24O3 ([M+Na]): 371.1623, 
Found: 371.1630; HPLC (98:2 hexane:iPrOH, Daicel CHIRALPAK IC): 96:4 er, tR (major) 
= 5.7 min, tR (minor) = 7.1 min; [α]D = -67.6 (c = 0.01, CHCl3).  TLC (90:10 hexanes; ethyl 
acetate): Rf = 0.4.  
 
 
Ethyl (2R,3S)-2-hydroxy-3-(4-methoxyphenyl)-2-
phenylbutanoate (8o): The title compound was prepared 
according to Method G using 3.5 equiv of phenylboronic acid and 
3.5 equiv of cesium fluoride. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using a gradient elution of 2.5% ethyl 
acetate in hexanes then 5% ethyl acetate in hexanes affording 8o as a clear oil (25.5 mg, 
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0.081 mmol, 81% yield). Analytical data for  8o: 1H NMR (500 MHz, CDCl3) δ 7.81 
(d, J = 7.6 Hz, 2H), 7.41–7.30 (m, 5H), 6.84 (d, J = 8.7 Hz, 2H), 4.03–3.97 (m, 2H), 3.80 
(s, 3H), 3.74 (s, 1H), 3.68 (q, J = 7.1 Hz, 1H), 1.18 (t, J = 7.2 Hz,  3H), 1.07 (d, J = 7.2 Hz, 
3H); 13C NMR (600 MHz, CDCl3): δ 174.6, 158.5, 140.6, 133.8, 130.0, 128.1, 127.5, 126.2, 
113.3, 80.8, 62.4, 55.1, 46.8, 15.2, 13.9; IR (thin film): 3724, 2835, 1868, 1733, 1716, 1558, 
1541, 1509, 1457, 1246; HRMS (ESI+): Calcd. for  C19H22O4 ([M+Na]): 337.1416, Found: 
337.1416; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 94:6 er, tR (major) = 10.6 
min, tR (minor) = 12.6 min; [α]D: -74.5 (c = 0.01, CHCl3). TLC (90:10 hexanes: ethyl 
acetate): Rf = 0.3. 
 
Ethyl (2R,3S)-3-(2-fluorophenyl)-2-hydroxy-2-
phenylbutanoate (8p): The title compound was prepared 
according to Method G using 3.0 equiv of phenylboronic acid and 3.0 
equiv of cesium fluoride. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 2.5% ethyl acetate in hexanes 
affording 8p as a clear oil (20.7 mg, .069 mmol, 69% yield). Analytical data for 8p: 1H 
NMR (500 MHz, CDCl3): δ 7.83 (d, J = 7.7 Hz, 2H), 7.77–7.74 (m, 1H), 7.41 (app t, J = 
7.5 Hz, 2H), 7.34–7.31 (m, 1H), 7.22–7.18 (m, 1H), 7.11 (app t, J = 7.6 Hz, 1H), 7.03–6.99 
(m, 1H), 4.20 (q, J = 7.2 Hz, 1H), 3.98 (q, J = 7.1 Hz, 2H), 3.92 (s, 1H), 1.12 (t, J = 7.2 Hz, 
3H), 1.08 (d, J = 7.2 Hz); 13C NMR (151 MHz, CDCl3): δ 174.8, 160.0 (d, J19F-13C = 245.3 
Hz), 140.6, 130.2 (d, J19F-13C = 3.4 Hz), 129.2 (d, J19F-13C = 14.2 Hz), 128.2 (d, J19F-13C = 8.5 
Hz), 128.1, 127.7, 126.2, 124.0 (d, J19F-13C = 3.4 Hz), 114.8 (d, J19F-13C = 23.9 Hz), 80.4, 62.7, 
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38.1 (d, J19F-13C = 2.6 Hz), 15.2, 13.5; 19F NMR (376 MHz, CDCl3): δ 117.9; IR (thin film): 
3649, 2360, 1867, 1733, 1716, 1558, 1541, 1507, 1489, 1457; HRMS (ESI+): Calcd. for 
C18H19FO3 ([M+Na]): 325.1216, Found: 325.1214; HPLC (98:2 hexanes:iPrOH, Daicel 
CHIRALPAK IC): 92:8 er, tR (major) = 4.4 min, tR (minor) = 4.7 min; [α]D = -37.7 (c = 0.01, 
CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.4.  
 
Ethyl (2R,3S)-2-hydroxy-2-(naphthalen-2-yl)-3-(o-
tolyl)butanoate (8q): The title compound was prepared 
according to Method G using 3.50 equiv of 2-naphthylboronic acid 
and 3.50 equiv of cesium fluoride. The reaction was run for 48 h. 
The diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. The 
reaction was run in duplicate; the reported yields and enantioselectivities are averages of 
two runs. Note in this instance the reaction did not reach full conversion. One trial 
reached 80% conversion while the other reached 84% conversion by analysis of the crude 
1H NMR spectrum. Further optimization of the reaction parameters for this substrate was 
not pursued. The crude product was purified by silica gel column chromatography using 
2.5% ethyl acetate in hexanes affording 8q as a light yellow oil (19.0 mg, .055 mmol, 55% 
yield). Analytical data for 8q: 1H NMR (500 MHz, CDCl3): δ 8.33 (s, 1H), 7.95–7.86 
(m, 5H), 7.53– 7.49 (m, 2H), 7.21–7.11 (m, 3H), 4.13 (s, 1H), 4.07 (q, J = 7.1 Hz, 1H), 3.98–
3.87 (m, 2H), 2.53 (s, 3H),  1.10 (d, J = 7.1 Hz, 3H), 0.98 (t, J = 7.2 Hz, 3H); 13C NMR 
(151 MHz, CDCl3):  174.7, 141.4, 138.8, 135.5, 133.0, 132.7, 130.0, 128.5, 127.8, 127.6, 127.4, 
126.5, 126.2, 126.2, 126.1, 125.6, 124.0, 81.1, 62.4, 41.8, 20.1, 15.8, 13.5; IR (thin film): 
3565.7; 3545.5, 2966, 2930, 2319, 1771, 1733, 1716, 1558, 1541, 1521, 1507, 1457, 1256, 
1241, 1021 cm-1; HRMS (ESI+): Calcd. for C23H24O3: ([M+Na]): 371.1623, Found: 
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371.1624; HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 94:6 er, tR (major) = 6.2 
min, tR (minor) = 9.2 min; [α]D = -14.7 (c = 0.01, CHCl3); TLC (90:10 hexanes: ethyl 
acetate): Rf = 0.4. 
 
Ethyl (2R,3S)-2-hydroxy-2-(naphthalen-2-yl)-3-(m-
tolyl)butanoate (8r): The title compound was prepared 
according to Method G using 3.50 equiv of 2-naphthylboronic acid 
and 3.50 equiv of CsF. The reaction was run for 48 h. The 
diastereoselectivity was determined by analysis of the crude 1H NMR spectrum. The 
reaction was run in duplicate; the reported yields and enantioselectivities are averages of 
two runs. The crude product was purified by silica gel column chromatography using 2.5% 
ethyl acetate in hexanes affording 8r as an amorphous solid (29.7 mg, .085 mmol, 85% 
yield). Analytical data for 8r: 1H NMR (500 MHz, CDCl3): δ 8.32 (s, 1H), 7.96 –7.86 
(m, 4H), 7.53–7.49 (m, 2H), 7.29–7.27 (m, 2H), 7.23–7.20 (m, 1H), 7.08 (d, J = 7.4 Hz, 
1H), 4.05–3.98 (m, 2H), 3.86–3.81 (m, 2H), 2.37 (s, 3H), 1.18 (t, J = 7.1 Hz, 3H), 1.12 (d, 
J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 174.5, 141.5, 137.9, 137.40, 133.0, 132.7, 
129.9, 128.4, 127.9, 127.8, 127.7, 127.4, 126.1, 126.1, 126.0, 125.7, 124.2, 80.9, 62.4, 47.4, 
21.5, 15.1, 13.9; IR (thin film): 3587, 3566, 3502, 2978, 2933, 2359, 2330, 1748, 1732, 
1717, 1558, 1541, 1507, 1457, 1258, 1238, 1131, 1023 cm-1 HRMS (ESI+): Calcd. for 
C23H24O3: ([M+Na]): 371.1623, Found: 371.1631;  [α]D = -63.2 (c = 0.02, CHCl3); HPLC 
(99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 96.5:3.5 er, tR (major) = 6.7 min, tR (minor) = 
8.7 min; TLC (90:10 hexanes: ethyl acetate): Rf = 0.4. 
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Ethyl (2R,3S)-2-hydroxy-3-(naphthalen-2-yl)-2-
phenylbutanoate (8s): The title compound was prepared 
according to Method G using 3.50 equiv of phenylboronic acid 
and 3.50 equiv of cesium fluoride. The reaction was run for 48 h. The diastereoselectivity 
was determined by analysis of the crude 1H NMR spectrum. The reaction was run in 
duplicate; the reported yields and enantioselectivities are averages of two runs. The crude 
product was purified by silica gel column chromatography using 2.5% ethyl acetate in 
hexanes affording 8s as an amorphous solid (24.5 mg, 0.073 mmol, 73% yield). 
Recrystallization: A suspension of 8s (24.5 mg) in hexanes was heated until complete 
dissolution was observed. Allowing the resulting solution to stand at room temperature 
for 24 h provided crystalline 8s (16.1 mg, 0.048 mmol, 48% yield) enriched to 97.5:2.5 er. 
Analytical data for 3s: 1H NMR (500 MHz, CDCl3): 7.89–7.78 (m, 6H), 7.64–7.62 (m, 
1H), 7.49–7.42 (m, 4H), 7.36–7.33 (m, 1H), 3.97 (q, J = 7.2 Hz, 2H), 3.90 (q, J = 7.1 Hz, 
1H), 3.84 (s, 1H), 1.20 (d, J = 7.1 Hz, 3H), 1.14 (t, J = 7.2 Hz, 3H); 13C NMR (151 MHz, 
CDCl3): 174.5, 140.6, 139.4, 133.2, 132.6, 128.2, 127.8, 127.7, 127.6, 127.5, 127.4, 126.2, 
125.8, 125.5, 80.9, 62.4, 47.8, 15.2, 13.9; IR (thin film): 3524, 3502, 3481, 3460, 3057, 
2979, 2935, 2874, 2359, 2340, 2089, 1770, 1718, 1698, 1519, 1507, 1489, 1446, 1249, 1137, 
1023 cm-1; HRMS (ESI+): Calcd. for C22H22O3: ([M+Na]): 357.1467, Found: 357.1468; 
HPLC (99:1 hexanes:iPrOH, Daicel CHIRALPAK IC): 94:6 er, tR (major) = 9.7 min, tR (minor) 
= 12.4 [α]D = -85.2 (c = 0.01, CHCl3); mp 94 – 96 °C. TLC (90:10 hexanes: ethyl acetate): 
Rf = 0.4 
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Ethyl (2R,3S)-2-hydroxy-3-(1H-indol-3-yl)-2-(1H-indol-
6-yl)butanoate (8t):  The title compound was prepared 
according to Method G using 3.50 equiv 1H-indol-6-ylboronic 
acid and 3.50 equiv of cesium fluoride. The procedure was 
modified for this product as follows: upon completion the reaction was allowed to cool to 
room temperature and 200 μL of ethanol were added, the resulting mixture was allowed 
to stir for 10 minutes before being filtered through a plug of silica gel using ethyl acetate 
to rinse and concentrated. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 20% ethyl acetate in hexanes 
followed by 40% ethyl acetate in hexanes affording 8t as an off white solid (26.7 mg, 0.074 
mmol, 74% yield). Analytical data for 8t: 1H NMR (600 MHz, CDCl3): δ 8.30 (s, 1H), 
8.11 (s, 1H), 7.95 (s, 1H), 7.85 (d, J = 7.6 Hz, 1H), 7.71–7.66 (m, 2H), 7.36–7.34 (m, 2H), 
7.24–7.23 (m, 1H), 7.21–7.15 (m, 2H), 6.58–6.58 (m, 1H), 4.26 (q, J = 7.1 Hz, 1H), 4.07 
(s, 1H), 3.87–3.82 (m, 1H), 3.73–3.68 (m, 1H), 1.18 (d, J = 7.2 Hz, 3H), 0.94 (t, J = 7.1 Hz, 
3H); 13C NMR (151 MHz, CDCl3): 175.6, 135.8, 135.5, 134.7, 127.2, 127.0, 124.8, 122.9, 
121.7, 120.2, 119.3, 119.0, 118.4, 117.0, 111.0, 109.2, 102.2, 81.2, 62.2, 38.5, 16.3, 13.5; IR 
(thin film): 3459, 3413, 2978, 2934, 2359, 2340, 1733, 1716, 1699, 1521, 1507, 1497, 1456, 
1339, 1259, 1016 cm-1; HRMS (ESI+): Calcd. for C22H22N2O3: ([2M+Na]): 747.3159, 
Found:  747.3187; HPLC (80:20 hexanes:iPrOH, Daicel CHIRALPAK IA): 96:4 er, tR 
(major) = 10.9 min, tR (minor)  = 20.4 min; [α]D = -21.0 (c = 0.01). TLC (70:30 hexanes:ethyl 
acetate): Rf = 0.1.  
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Ethyl (2R,3S)-2-hydroxy-2,3-diphenylpentanoate (8u): The 
title compound was prepared according to Method G Procedure C 
using 3.5 equiv of phenylboronic acid and 3.5 equiv of cesium fluoride. 
The reaction time was 60 h. The diastereoselectivity was determined by analysis of the 
crude 1H NMR spectrum. The reaction was run in duplicate; the reported yields and 
enantioselectivities are averages of two runs. The crude product was purified by silica gel 
column chromatography using 2.5% ethyl acetate in hexanes affording 8u as a clear oil 
(22.4 mg, .075 mmol, 75% yield). Analytical data for 3u: 1H NMR (500 MHz, CDCl3): 
δ 7.83–7.82 (m, 2H), 7.44– 7.39 (m, 4H), 7.34–7.29 (m, 3H), 7.25–7.23 (m, 1H), 3.99–
3.89 (m, 2H), 3.86 (s, 3H), 3.38 (dd, J = 11.8, 3.0 Hz, 1H), 1.81–1.71 (m, 1H), 1.45–1.37 
(m, 1H), 1.13 (t, J = 7.2 Hz, 3H), 0.60 (t, J = 7.4 Hz); 13C NMR (151 MHz, CDCl3): δ 174.5, 
140.8, 139.6, 129.8, 128.1, 127.9, 127.5, 127.0, 126.3, 80.9, 62.4, 55.6, 21.8, 13.8, 12.3; IR 
(thin film): 3649, 2963, 1717, 1558, 1541, 1507, 1246, 1133 cm-1; HRMS (ESI+): Calcd. for 
C19H22O3 ([M+Na]): 321.1467, Found: 321.1467; HPLC (99:1 hexanes:iPrOH, Daicel 
CHIRALCEL OJ-H): 93:7 er, tR (major) = 7.5 min, tR (minor) = 6.2 min; [α]D = -60.3 (c = 0.01, 
CHCl3); mp 80 – 82 °C. TLC (90:10 hexanes: ethyl acetate): 0.4.  
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Ethyl (2R,3S)-3-(3-bromophenyl)-2-hydroxy-2-
(naphthalen-2-yl)hex-5-enoate (8v): The title compound 
was prepared according to Method G using 3.0 equiv of 2-
naphthylboronic acid and 3.0 equiv of cesium fluoride. The 
reaction time was 60 h. The reaction was run in duplicate; the reported yields and 
enantioselectivities are averages of two runs. The crude product was purified by 
preparatory thin layer chromatography on silica gel using 5% ethyl acetate  in hexanes as 
aluent affording 8v as a clear oil (19.9 mg, .045 mmol, 45% yield). Note: This yield is 
based off of starting material that contained ~6% toluene as an impurity. Analytical 
data for 8v: 1H NMR (600 MHz, CDCl3) δ 8.30 (s, 1H), 7.92–7.85 (m, 4H), 7.62 (s, 1H), 
7.54–7.50 (m, 2H), 7.44 (d, J = 7.7 Hz, 1H), 7.40–7.39 (m, 1H), 7.20 (app t, J = 7.8 Hz, 
1H), 5.42–5.35 (m, 1H), 4.77–4.74 (m, 2H), 4.07–3.98 (m, 2H), 3.68 (dd, J = 11.9, 3.2 Hz, 
1H), 2.56–2.50 (m, 1H), 2.14– 2.10 (m, 1H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, 
CDCl3): δ 174.0, 141.5, 137.4, 136.0, 133.2, 133.0, 132.8, 130.2, 129.6, 128.5, 128.4, 128.0, 
127.4, 126.4, 126.3, 125.7, 123.8, 122.0, 116.4, 80.8, 62.9, 53.0, 33.3, 13.9; IR (thin film): 
3649, 3628, 3502, 2979, 2360, 1733, 1717, 1698, 1558, 1540, 1507, 1237 cm-1; HRMS 
(ESI+): Calcd. forC24H23BrO3: ([M+Na]): 461.0728, Found: 461.0743; HPLC (99:1 
hexanes:iPrOH, Daicel CHIRALPAK IC): 97:3 er, tR (major) = 5.5 min, tR (minor) = 7.9 min; 
[α]D = -55.3 (c = 0.01, CHCl3). TLC (90:10 hexanes: ethyl acetate): Rf = 0.3.  
 
4-Ethyl 1,1-dimethyl (3S,4R)-4-hydroxy-3,4-
diphenylbutane-1,1,4-tricarboxylate (8w): The title compound 
was prepared according to Method G using 3.50 equiv of 
phenylboronic acid and 3.50 equiv of cesium fluoride. The reaction 
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was run for 48 h. The diastereoselectivity was determined by 1H NMR analysis of the 
crude reaction mixture. The reaction was run in duplicate, the reported yields and 
enantioselectivities are averages of two runs. The crude product was purified by silica gel 
column chromatography using a gradient of 5% to 10% to 20% ethyl acetate in hexanes 
affording 8w as an amorphous white solid (34.1 mg, 0.0823 mmol, 82% yield, based off 
of ~86% pure starting material). Recrystallization: A suspension of 8w (34.2 mg) in 
hexanes was gradually heated while titrating with ethyl acetate until complete dissolution 
was observed. The resulting solution was allowed to stand at room temperature for 36 h 
affording crystalline 8w (17.8 mg, 0.043 mmol, 43%) enriched to >99.5:0.5 er. 
Analytical data for 3w: 1H NMR (500 MHz, CDCl3): δ 7.81– 7.79 (m, 2H), 7.43–7.40 
(m, 4H), 7.34–7.25 (m, 4H), 3.96–2.86 (m, 3H), 3.67–3.64 (m, 4H), 3.53 (s, 3H), 2.95 
(dd, J = 11.5, 3.8 Hz, 1H), 2.36–2.30 (m, 1H), 2.05–1.99 (m, 1H), 1.09 (t, J = 7.2Hz, 3H), 
13C NMR: δ 174, 169.7, 169.4, 139.8, 137.7, 129.8, 128.3, 128.2, 127.9, 127.7, 126.3, 80.6, 
62.6, 52.4, 52.2, 50.5, 49.4, 28.3, 13.8; IR (thin film): 3524, 3502, 3481, 3059, 3030, 
2980, 2953, 2845, 2357, 2328, 2089, 1770, 1749, 1717, 1569, 1558, 1507, 1456, 1241, 1025 
cm-1; HRMS (ESI+): Calcd. for C23H26O7: ([M+Na]): 437.2576, Found: 437.1593; HPLC 
(85:15 hexanes:iPrOH, Daicel CHIRALPAK IC): 90:10 er, tR (major) = 7.8 min, tR (minor) = 
22.5 min;  [α]D = -55.1 (c = 0.02); Mp: 108 – 110 °C. TLC (90:10 hexanes: ethyl acetate): 
Rf = 0.1.  
 
Tert-butyl (2R,3S)-2-hydroxy-2-(naphthalen-2-yl)-4-
phenyl-3-(pyridin-3-yl)butanoate (8x): The title compound 
was prepared according to Method G using 4.0 equiv of 2-
naphthylboronic acid and 4.0 equiv of CsF. The procedure was 
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modified for this product as follows: upon completion the reaction was allowed to cool to 
room temperature and 200 μL of ethanol were added, the resulting mixture was allowed 
to stir for 10 minutes before being filtered through a plug of silica gel using ethyl acetate 
to rinse and concentrated. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 20% ethyl acetate in hexanes 
affording 8x as an off white amorphous solid (30.4 mg, 0.069 mmol, 69% yield). 
Recrystallization: A suspension of 8x in hexanes was gradually heated while titrating 
with ethyl aetate until complete dissolution was observed. The resulting solution was 
allowed to stand at room temperature for 36 h affording crystalline 8x (10.1 mg, 0.023 
mmol, 23%) enriched to >99.5: 0.5 er. Analytical data for 8x: 1H NMR (500 MHz, 
CDCl3): 8.45–8.39 (m, 3H), 8.02–7.90 (m, 5H), 7.55–7.54 (m, 2H), 7.25–7.22 (m, 1H), 
7.04–6.99 (m, 2H), 4.29 (s, 1H), 3.80 (d, J = 11.6 Hz, 1H), 2.96–2.78 (m, 2H), 1.21 (s, 9H); 
13C NMR (151 MHz, CDCl3):  172.9, 151.8, 148.4, 139.5, 138.1, 136.9, 135.2, 133.1, 132.9, 
128.8, 128.5, 128.1, 128.0, 127.5, 126.4, 126.3, 125.9, 125.8, 123.6, 123.0, 84.2, 81.0, 53.2, 
36.1, 27.5; IR (thin film): 3566, 3545, 3027, 2977, 2930, 2353, 2321, 1733, 1716, 1698, 
1558, 1521, 1507, 1457, 1372, 1269, 1151, 1028 cm-1; HRMS (ESI+): C29H29NO3: ([M+1]): 
440.2226, Found: 440.2214; HPLC (87.5:12.5 hexanes:iPrOH, Daicel CHIRALPAK IA): 
98.5:1.5 er, tR (major) = 6.8 min, tR (minor) = 10.9 min; [α]D = -27.9 (c = 0.02); Mp 159 – 161 
°C. TLC (70:30 hexanes: ethyl acetate): Rf = 0.2.  
 
Ethyl (2R,3S)-3-(4-bromophenyl)-2-hydroxy-2-(naphthalen-2-yl)butanoate 
(8y): The title compound was prepared according to Method G. Analytical data for 
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8y: 1H NMR (600 MHz, CDCl3): δ 8.28 (s, 1H), 7.91–7.85 (m, 4H), 7.53–7.49 (m, 2H), 
7.44 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 4.03 (q, J = 7.1 Hz, 2H), 3.88 (s, 1H), 
3.81 (q, J = 7.1 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H), 1.09 (d, J = 7.1 Hz, 3H); 13C NMR (151 
MHz, CDCl3): δ 174.3, 140.8, 137.7, 133.0, 132.7, 131.1, 130.9, 130.8, 128.4, 127.8, 127.4, 
126.2, 126.2, 125.6, 123.9, 120.9, 80.7, 62.6, 46.9, 15.2, 13.9; IR (thin film): 3750, 3734, 
2360, 1868, 1845, 1733, 1716, 1698, 1558, 1541, 1507, 1497, 1457, 1240; HRMS (ESI+): 
Calcd. for C22H21BrO3 ([M+Na]): 435.0572, Found: 435.0582; HPLC (99:1 
hexanes:iPrOH, Daicel CHIRALPAK IC), 97:3 er, tR (major) = 6.8 min, tR (minor) = 10.9 min; 
[α]D = -46.0 (c = 0.01, CHCl3); Mp 118 – 120 °C. TLC (90:10 hexanes: ethyl acetate): Rf 
= 0.4.  
 
 
Ethyl (2R,3S)-2-hydroxy-3-(1H-indol-3-yl)-2-
(naphthalen-2-yl)butanoate (19): 
The title compound was prepared according to Method G using 
3.50 equiv 2-naphthylboronic acid and 3.50 equiv of cesium fluoride. The procedure was 
modified for this product as follows: upon completion the reaction was allowed to cool to 
room temperature and 200 μL of ethanol were added, the resulting mixture was allowed 
to stir for 10 minutes before being filtered through a plug of silica gel using ethyl acetate 
to rinse and concentrated. The reaction time was 60 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using 10:90 followed by 20% ethyl 
acetate= in hexanes affording 19 as an amorphous solid (27.3 mg, 0.073 mmol, 73%). 
 76 
 
Analytical data for 19: 1H NMR (500 MHz, CDCl3): δ 8.37 (s, 1H), 8.12 (s, 1H), 8.04–
8.02 (m, 1H), 7.95–7.83 (m, 4H), 7.54–7.49 (m, 2H), 7.37–7.35 (m, 2H), 7.22–7.16 (m, 
2H), 4.30 (q, J = 7.1 Hz, 1H), 4.08 (s, 1H), 3.91–3.84 (m, 1H),  3.76–3.70 (m, 1H), 1.18 (d, 
J = 7.2 Hz, 3H), 0.97 (t, J = 7.1 Hz, 3H); 13C NMR (500 MHz, CDCl3): δ 175.0, 138.1, 
135.6, 133.1, 132.7, 128.4, 127.7, 127.4, 127.1, 126.1, 126.1, 125.6, 124.3, 122.9, 121.8, 119.3, 
119.1, 116.7, 111.0, 81.1, 62.3, 38.4, 16.2, 13.5; IR (thin film): 3566, 3545, 3420, 2977, 2932, 
2358, 2323, 1733, 1716, 1698, 1558, 1541, 1507, 1457, 1259, 1242, 1017 cm-1; HRMS 
(ESI+): Calcd. for C24H23NO3: ([M+1]): 374.1756, Found: 374.1758; HPLC (87.5:12.5 
hexanes:iPrOH, Daicel CHIRALPAK IA): 96:4 er, tR (major) = 9.3 min, tR (minor) = 26.4  [α]D 
= -36.9 (c = 0.01). TLC (90:10 hexanes: ethyl acetate): Rf = 0.1. 
 
Ethyl (2R,3S)-2-hydroxy-3-(1H-indol-3-yl)-2-(m-
tolyl)butanoate (20): 
The title compound was prepared according to Method G using 
3.50 equiv m-tolylboronic acid and 3.50 equiv of cesium fluoride. The procedure was 
modified for this product as follows: upon completion the reaction was allowed to cool to 
room temperature and 200 μL of ethanol were added, the resulting mixture was allowed 
to stir for 10 minutes before being filtered through a plug of silica gel using ethyl acetate 
to rinse and concentrated. The reaction time was 48 h. The diastereoselectivity was 
determined by analysis of the crude 1H NMR spectrum. The reaction was run in duplicate; 
the reported yields and enantioselectivities are averages of two runs. The crude product 
was purified by silica gel column chromatography using a gradient of 5% to 10% to 20% 
ethyl acetate in hexanes affording 20 as a light yellow oil (21.5 mg, 0.064 mmol, 64% 
yield). Analytical data for 20: 1H NMR (500 MHz, CDCl3): 8.08 (s, 1H), 7.80 (d, J = 
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7.7 Hz, 1H), 7.69–7.67 (m, 2H), 7.35–7.30 (m, 3H), 7.19–7.13 (m, 3H), 4.14 (q, J = 7.2 Hz, 
1H), 3.94 (s, 1H), 3.88–3.81 (m, 1H), 3.71–3.65 (m, 1H), 2.43 (s, 3H), 1.15 (d, J = 7.2 Hz, 
3H), 0.94 (t, J = 7.2 Hz, 3H); 13C NMR (500 MHz, CDCl3): δ 175.2, 140.6, 137.7, 135.5, 
128.2, 128.0, 127.2, 126.9, 123.4, 122.8, 121.7, 119.3, 119.0, 116.8, 111.0, 80.9, 62.2, 38.5, 
21.7, 16.3, 13.5; IR (thin film): 3502, 3414, 2977, 2931, 2360, 2341, 1716, 1683, 1539, 1506, 
1487, 1456, 1256, 1233, 1153, 1017 cm-1; HRMS (ESI+): Calcd. for C21H23NO3: ([M+1]): 
338.1756, Found: 338.1760; HPLC (97:3 hexanes:iPrOH, Daicel CHIRALPAK IC): 
94.8:5.2 er, tR (major) = 16.2 min, tR (minor) = 14.8 min;  [α]D = -17.5 (c = 0.01, CDCl3); TLC 
(90:10 hexanes: ethyl acetate): Rf = 0.1. 
 
Iodoetherification to form 15v: 
Ethyl (2R,3S)-3-(3-bromophenyl)-2-hydroxy-2-(naphthalen-2-yl)hex-5-enoate 83v 
(67.0 mg, 0.153 mmol) was dissolved in acetonitrile (2.40 mL, 0.064M) in a round-
bottomed flask equipped with a stir bar. Sodium carbonate (24.2 mg, 0.229 mmol, 1.5 
equiv) was added and the flask was covered with aluminum foil. Iodine (77.4 mg, 0.31 
mmol, 2.0 equiv) was added and the reaction was stirred at room temperature under an 
atmosphere of N2 for 24 h before being quenched with saturated aqueous Na2S2O3 until a 
colorless solution was observed. The mixture was diluted further with water (20.0 mL) 
and extracted three times with methylene chloride (12.0 mL per extraction). The 
combined organic layers were dried over anhydrous MgSO4. Upon concentration the 
crude residue was analyzed by 1H NMR analysis, indicating the formation of an equimolar 
mixture of diastereomers. The residue was purified by silica gel column chromatography 
(2.5% ethyl acetate/hexanes then 5% ethyl acetate/hexanes) which enabled separation of 
the diastereomeric mixture (diastereomer 1: 29.3 mg, diastereomer 2: 27.4 mg, 0.10 mmol 
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combined, 66% combined yield). Analytical data for diastereomer 1: 1H NMR (500 
MHz, CDCl3): δ 8.10 (s, 1H), 7.89–7.85 (m ,3H), 7.66–7.64 (m, 1H), 7.54 – 7.50 (m, 3H), 
7.44–7.43 (m, 1H), 7.32 –7.31 (m, 1H), 7.24–7.21, 4.43–4.37 (m, 1H), 4.00 (app t, 1H), 
3.85 (q, J = 7.1 Hz, 2H), 3.70 (dd,  J = 9.7, 4.8 Hz, 1H), 3.50 (app t, 1H), 2.71–2.66 (m, 
1H), 2.18–2.12, (m, 1H), 0.91 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 170.1, 
142.9, 137.6, 132.8, 132.8, 131.4, 130.4, 130.1, 128.4, 128.0, 127.5, 127.1, 126.4, 126.3, 
124.9, 124.4, 122.4, 91.6, 78.3, 61.4, 55.3, 40.8, 13.6, 7.2; HRMS (ESI+): Calcd. for 
C24H22BrIO3: ([M+1]): 564.9875, Found: 564.9881. TLC (90:10 hexanes: ethyl acetate): 
Rf = 0.3. Analytical data for diastereomer 2: 1H NMR (600 MHz, CDCl3): δ 8.19 (s, 
1H), 7.90–7.85 (m, 3H), 7.76–7.75 (m, 1H), 7.55–7.51 (m, 3H), 7.44–7.43 (m, 1H), 7.32–
7.31 (m, 1H), 7.24–7.22 (m, 1H); 4.91–4.86 (m, 1H), 4.13 (dd, J = 7.6, 3.7 Hz, 1H), 3.91–
3.82 (m, 2H), 3.61 (dd, J = 9.4, 4.2 Hz, 1H), 3.06 (app t, 1H), 2.53–2.49 (m, 1H), 2.11–
2.07 (m, 1H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 170.32, 142.6, 138.2, 
132.9, 132.7, 131.2, 130.4, 130.2, 128.4, 127.9, 127.5, 126.7, 126.6, 126.4, 125.2, 124.1, 
122.6, 92.0, 79.8, 61.4, 54.6, 39.6, 13.6, 9.7; HRMS (ESI+): Calcd. for C24H22BrIO3: 
([M+1]): 564.9875, Found: 564.9872. TLC (90:10 hexanes: ethyl acetate): Rf = 0.2. 
Note on structural assignment: Both compounds exhibit 13C resonances above 10.0 
ppm, this is consistent with the heavy atom effect and a primary alkyl iodide. The methine 
resonances at ca. 4.40 ppm for diastereomer 1 and 4.85 ppm for diastereomer 2 do not 
show correlation to these upfield 13C signals in an HSQC experiment but instead correlate 
with 13C signals at 78.3 ppm and 79.8 ppm, respectively. This data suggests 
tetrahydrofurans bearing primary alkyl iodides rather than tetrahydropyrans containing 
secondary alkyl iodides.  
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Chapter III Palladium-Catalyzed β-Arylation of α-Keto Esters 
3.1 Introduction 
In the previous chapter a chiral (diene)rhodium(I) complex catalyzed 
enantioconvergent arylation of α-keto esters was described.1 The reduced activity of 
highly electron deficient boronic acids prevented access to heteroaryl tertiary glycolates. 
Heteraromatic rings, especially pyridine derivatives, are encountered frequently as 
important structural units of small molecule therapeutics.2 Therefore, we sought to 
incorporate this functionality in the α-keto ester precursor. Initial attempts to access a 
pyridyl-substituted α-keto ester via the aerobic deacylation used for analogous 
carbocyclic starting compounds failed (Scheme 3-1, eq. 1).3 Similarly, oxidation of the 
corresponding α-hydroxy ester failed to deliver the targeted α-keto esters (Scheme 3-1, 
eq. 2).   
Scheme 3-1 Challenges During Synthesis of Pyridyl Substrates 
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Considering the limitations with known methods, the development of a novel route 
toward β-heteroaryl α-keto esters was necessary. Harnessing the nucleophilic nature of 
α-keto esters by reaction with a heteroaryl electrophile would constitute an underutilized 
strategy for the synthesis of these compounds.   
Scheme 3-2 Semmelhack’s Seminal Report of an Enolate Arylation Reaction 
 
Since Semmelhack’s pioneering report of a transition metal-catalyzed carbonyl 
arylation,4 which described the synthesis of cephalotaxinone 2 using a preformed enolate 
derived from iodoketone 1 (Scheme 3-2), the scope of this general transformation has 
dramatically expanded. The reaction has grown to include the use of ketones, aldehydes, 
amides, esters, amino acids, nitriles, and activated methylene compounds as substrates.5-
10 The mechanism of this transformation is shown below (Scheme 3-3). Modern variants 
employ Pd0/phosphine derived catalysts and proceed via direct enolization under the 
action of inorganic bases.  
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Scheme 3-3 Mechanism of Transition Metal-Catalyzed Enolate Coupling 
 
While the relatively high acidity of α-keto esters would be an enabling feature, we 
perceived several challenges associated with our reaction design. First, a slow reductive 
elimination from a Pd-enolate species could lead to competitive β-hydride elimination in 
the case of n-alkyl α-keto esters.11 Furthermore, we, as well as others, have observed that 
α-keto esters 3 with enolizable protons form isotetronic acid derivatives 4 via a 
homoaldol/lactonization pathway in the presence of inorganic bases such as K2CO3.12   
Scheme 3-4 Sensitivity of Linear α-Keto Esters Toward Base 
 
 Neverthless, if successful, this method would allow for a variety of electronically diverse 
β-aryl α-keto esters to be generated in short order from feedstock chemicals.  
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3.2 Optimization Studies 
With the goal of suppressing the competitive homo-aldol process in mind, the tert-
butyl α-keto ester 5a (Table 3-1) was chosen as a model substrate. We first chose to 
probe the effect of the supporting ligand, beginning with the electron rich and sterically 
hindered ligand tricyclohexylphosphine (entry 1), shown previously to be an effective 
ligand in Pd-catalyzed enolate arylation reactions.13 When no appreciable quantity of 
desired coupled product 7a was obtained, we moved on to the more sterically encumbered 
ligand cataCXium A®, which delivered keto ester 7a in reasonable yield (entry 2). 
Encouraged by this result, we switched to the Buchwald-type ligand DavePhos (entry 3), 
which is also well-precedented to work in this reaction.14 When a slight decrease in yield 
was observed, we took inspiration from Hartwig’s arylation of malonate derivatives, 
employing tri-tert-butylphosphine.15 This ligand provided product 7a in an isolated yield 
of 85% (entry 4).  
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Table 3-1 Optimization Studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further optimization led to the discovery that less basic potassium carbonate improved 
the isolated yield of the reaction to 95% (entry 6). Notably, product 7a was still formed in 
high yield when 2 mol % of palladium was employed. (1 mol % Pd2dba3, entry 7). 
Furthermore, the known dimerization product 4 was not observed, which suggests that 
the desired pathway is faster than this side reaction under the optimal catalytic 
conditions. 
entry base ligand temp 
(°C) 
NMR yield 
(isolated yield) 
1 
2 
 
3 
 
 
 
K3PO4 
K3PO4 
 
K3PO4 
 
 
 
PCy3 
PAd2nBu 
(cataCXium® A) 
 
(DavePhos) 
110 
110 
 
110 
 
 
 
< 5 
50 
 
43 
 
 
4 
5 
6 
7b 
K3PO4 
KOtBu 
K2CO3 
K2CO3 
PtBu3 
PtBu3 
PtBu3 
PtBu3 
110 
110 
110 
110 
85 (85) 
< 5 
99 (95) 
89 
 
aReaction conditions: 1.0 equiv of 5a, 2.0 equiv of 6a, 3.0 equiv of base, 
2 mol % Pd2dba3, 8 mol % ligand, 110 °C, PhMe ([5a]0 = 0.2 M), 12 h. 
bReaction conducted with 1 mol % Pd2(dba)3 and 4 mol %  PtBu3. 
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3.3 Scope of Palladium-Catalyzed Arylation Reaction 
With optimal conditions in hand, we next turned to analyzing the scope of the Pd-
catalyzed β-arylation reaction (Scheme 3-5). First, a variety of aryl bromides were 
tested. Both electron-rich and electron-poor aryl groups gave excellent results, including 
α-keto esters 7c and 7d, which would have been difficult compounds to access using 
previous routes. The reaction also tolerated various types of aryl groups, allowing the 
synthesis of products with meta-substituents (7e) and ortho-substituents (7f). Of 
particular interest to us was the use of heterocyclic aryl bromides. We were pleased to find 
that 3-bromopyridine and unprotected 5-bromoindole proved to be viable coupling 
partners (7g and 7h). The use of alkenyl halides resulted in decomposition of the starting 
materials (not shown). In addition to the parent substrate 5a, other α-keto esters were 
evaluated in the enolate arylation reaction. As seen with product 7j, this method allowed 
facile entry to α-keto esters with bulky β-alkyl substituents. Additionally, decreasing the 
size of the β-alkyl substituent did not significantly decrease yields (7k). Finally, in order 
to test the chemoselectivity of this reaction, a substrate containing both an ester and an 
α-keto ester was tested. Product 7l was generated without any noticeable formation of a 
bis-arylated product, highlighting the gentle nature of these reaction conditions. When β-
disubstituted α-keto esters were used in this reaction, decomposition of the starting 
materials and low conversion to the quaternary β-substituted product was observed (not 
shown). 
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Scheme 3-5 Scope of Pd-Catalyzed β-Arylation Reaction 
 
aReaction conditions: 1.0 equiv of 5, 2.0 equiv of 6, 3.0 equiv of K2CO3, 2 mol % Pd2dba3, 
8 mol % PtBu3, PhMe (0.2 M), 110 °C, 12 h. bReaction gave 69% yield when scale was 
increased to 2.7 mmol. cReaction conducted on 1 g scale. 
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3.4 Gram Scale arylation Reaction and Glovebox-Free Conditions 
The syntheses of products 7k (Scheme 3-5) and 7g (Scheme 3-6, eq. 1) were 
accomplished on one-gram scale with yields almost identical to those obtained in 
experiments on a smaller scale. Furthermore, the reaction could be carried out without 
the use of a glovebox when PtBu3•HBF4 was used in place of the air sensitive PtBu3 
(Scheme 3-6, eq 2.).16 The former can be synthesized in house from cheap starting 
materials.17 
Scheme 3-6 Large Scale and Glovebox Free Syntheses 
 
aPd2(dba)3, PtBu3•HBF4, K2CO3, and PhMe were mixed for 2 h prior to addition of 5a 
and 6a. See experimental details for full procedure. 
3.5 Conclusion 
In conclusion, we have developed a Pd-catalyzed β-arylation reaction of α-keto esters 
that allows for the generation of a wide array of aryl pyruvate derivatives. These reactions 
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typically proceed in excellent yield, and provide access to previously inaccessible β-
heteroaryl derivatives. Finally, the reaction can be conducted without the use of a 
glovebox.   
 
3.6 Experimental Details 
Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C 
NMR) were recorded on a Bruker model Avance 400 (19F NMR at 376 MHz), Bruker 
Avance III 500 (1H NMR at 500 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz 
and 13C NMR at 151 MHz) spectrometer with solvent resonance as the internal standard 
(1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 1H NMR data are reported 
as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, br d 
= broad doublet, t = triplet, app t = apparent triplet, q = quartet, m = multiplet), coupling 
constants (Hz), and integration. Mass spectra were obtained using a Thermo LTqFT mass 
spectrometer with electrospray introduction and external calibration. All samples were 
prepared in methanol. Analytical thin layer chromatography (TLC) was performed on 
Sorbent Technologies 0.20 mm Silica Gel TLC plates. Visualization was accomplished 
with UV light, KMnO4, and/or Seebach’s stain (2.5 g phosphomolybdic acid, 1.0 g 
Ce(SO4)2, 6.0 mL conc. H2SO4, 94 mL H2O) followed by heating. Purification of the 
reaction products was carried out by flash column chromatography using Siliaflash-P60 
silica gel (40-63μm) purchased from Silicycle. Unless otherwise noted, all reactions were 
carried out under an atmosphere of dry nitrogen in flame-dried glassware with magnetic 
stirring. Yield refers to isolated yield of pure material unless otherwise noted. Yields are 
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reported for a specific experiment and as a result may differ slightly from those found in 
figures, which are averages of at least two experiments.  
Tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (CH2Cl2), and 
toluene (PhMe) were dried by passage through a column of neutral alumina under 
nitrogen prior to use. Tri-tert-butylphosphonium tetrafluoroborate,17 5i,18 and 5l 19and 
were synthesized according to known procedures.  
General Procedure for the Synthesis a-Keto Ester Substrates: The addition of 
Grignard reagents to di-tert-butyl oxalate is a modification of a procedure published by 
Sodeoka.2 A flame-dried 2-neck round-bottomed flask equipped with a stirbar and reflux 
condenser was cooled under a stream of N2, and charged with magnesium turnings (1.9 
equiv), a crystal of iodine, and enough THF to cover the magnesium turnings. A small 
portion of the alkyl bromide (typically less than 0.1 equiv) was then added dropwise until 
the yellow color of the reaction mixture turned to clear and colorless, indicating initiation 
of the Grignard reagent. Additional THF was added to the mixture ([magnesium 
turnings]0 = 1.5 M), and the rest of the alkyl bromide (1.8 equiv in total) was added 
dropwise, while maintaining a gentle reflux. The reaction mixture was stirred for 1 h at rt. 
A separate flame-dried round-bottomed flask equipped with a stirbar was cooled under a 
stream of N2, and charged with di-tert-butyl oxalate (1.0 equiv), and a 5:3 mixture of 
methylene chloride:THF (to give a solution with [di-tert-butyl oxalate] = 0.37 M). The 
solution was cooled to -78 °C, and the solution of Grignard reagent was added to it 
dropwise. The reaction mixture was stirred for 4 h at -78 °C, then quenched with saturated 
aqueous NH4Cl (3 mL/mmol substrate) and diluted with methylene chloride (1.5 
mL/mmol substrate). The biphasic mixture was added to a separatory funnel, and the 
layers were separated. The aqueous layer was extracted with methylene chloride (2 x 3 
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mL/mmol substrate). The combined organic extracts were dried over Na2SO4, and 
concentrated in vacuo. The crude material was purified by column chromatography on 
silica gel.  
 
tert-Butyl 2-oxo-4-phenylbutanoate (5a): The general procedure 
was employed for the reaction of (2-bromoethyl)benzene (2.5 mL, 18.0 
mmol) and di-tert-butyl oxalate (2.20 g, 10.0 mmol). The crude material was purified by 
column chromatography (methylene chloride/hexane = 30/70 to 70/30) to afford 2.34 g 
(57%) of the title compound as a white solid. Spectroscopic properties were identical to 
those previously reported:2 1H NMR (400 MHz, CDCl3) d = 7.32-7.25 (m, 2 H), 7.23-7.18 
(m, 3 H), 3.12 (t, J = 8.0 Hz, 2 H), 2.94 (t, J = 7.6 Hz, 2 H), 1.53 (s, 9 H). 
 
tert-Butyl 2-oxo-4-phenylbutanoate (5k): The general procedure 
was employed for the reaction of bromoethane (4.0 mL, 54.0 mmol) and 
di-tert-butyl oxalate (6.07 g, 30.0 mmol). The crude material was purified by column 
chromatography (methylene chloride/hexane = 30/70 to 70/30) to afford 4.75 g (44%) of 
the title compound as a clear and colorless liquid. Spectroscopic properties were identical 
to those previously reported: 1H NMR (400 MHz, C6D6) d = 2.36 (q, J = 7.2 Hz, 2 H), 
1.28 (s, 9H), 0.81 (t, J = 7.3 Hz, 3H). 
 
tert-Butyl 4-methyl-2-oxopentanoate (5j): A flame-dried round-
bottomed flask equipped with a stirbar was cooled under a stream of 
N2, and charged with ethyl 4-methyl-2-oxopentanoate20 (4.51 g, 28.5 mmol, 1.0 equiv), 
methanol (91 mL, 0.31 M), and water (30 mL, 0.94 M). Powdered KOH (9.60 g, 171.0 
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mmol, 6.0 equiv) was added to the solution portion-wise in order to control the resulting 
exotherm. The solution was stirred for 30 min at rt before being concentrated in vacuo to 
remove the methanol. The reaction mixture was cooled to 0 °C, then diluted with 
concentrated HCl until pH = 1 was reached. The mixture was diluted with methylene 
chloride (40 mL), and added to a separatory funnel. The layers were separated, and the 
aqueous layer was extracted with methylene chloride (2 x 40 mL). The combined organic 
extracts were dried over Na2SO4, filtered, and concentrated in vacuo to afford the crude 
carboxylic acid intermediate.  
The crude carboxylic acid, methylene chloride (57 mL, [carboxylic acid]0 = 0.5 M), and 
DMF (44 mL, 0.6 mmol, 0.02 equiv) were added to a flame-dried round-bottom flask 
equipped with a stirbar. The solution was cooled to 0 °C, and oxalyl chloride (4.9 mL, 57.0 
mmol, 2.0 equiv) was added dropwise at a rate such that gas evolution was controlled. 
The solution was warmed to rt slowly overnight. The solution was then concentrated in 
vacuo, taking care to ensure that all residual oxalyl chloride was removed.  
The crude acid chloride was dissolved in methylene chloride (43 mL, [acid chloride]0 = 
0.67 M) and cooled to 0 °C. tert-Butyl alcohol (5.4 mL, 57.0 mmol, 2.0 equiv) was added 
dropwise to the solution. Pyridine (2.3 mL, 28.5 mmol, 1.0 equiv) was added dropwise to 
the solution. The solution was stirred at 0 °C for 6 h, after which time it was quenched by 
water (30 mL). The biphasic mixture was added to a separatory funnel, and the layers 
were separated. The aqueous layer was extracted with methylene chloride (2 x 30 mL). 
The combined organic extracts were dried over Na2SO4, and concentrated in vacuo. 
Purification by column chromatography on silica gel (EtOAc/hexane = 2.5/97.5) afforded 
1.98 g (37% over 3 steps) of the title compound as a clear and colorless liquid.21 Analytical 
data for 5j: 1H NMR (400 MHz, CDCl3) d = 2.64 (d, J = 6.8 Hz, 2 H), 2.21-2.12 (m, 1 H), 
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1.54 (s, 9 H), 0.96 (d, J = 6.7 Hz, 6 H); 13C NMR (151 MHz, CDCl3) d 195.5, 160.9, 83.8, 
47.7, 27.8, 24.2, 22.5; IR (thin film): 2962, 2936, 2874, 1722.1, 1395, 1272, 1138, 1052 cm–
1; HRMS: (ESI+): Calcd. for C10H18O3: ([M+Na]): 209.1154, Found: 209.1145. TLC 
(EtOAc/hexane = 10/90): Rf = 0.5.  
General Procedure for the Pd-Catalyzed Arylation of a-Keto Ester Enolates: 
A flame-dried 1-dram vial was cooled under a stream of N2, and charged with the 
appropriate a-keto ester (0.2 mmol, 1.0 equiv) and aryl halide (0.4 mmol, 2.0 equiv). This 
vial and a separate flame-dried 1-dram vial equipped with a stirbar were transferred to a 
N2-filled glovebox. The vial equipped with only a stirbar was charged with Pd2(dba)3 
(0.004 mmol, 0.02 equiv), a 1.0 M solution of PtBu3 in toluene (0.016 mmol, 0.08 equiv), 
and K2CO3 (0.6 mmol, 3.0 equiv). To the 1-dram vial containing the a-keto ester and aryl 
halide was added toluene (1 mL, [a-keto ester ]0 = 0.2 M). This solution was transferred 
to the 1-dram vial containing the base and catalyst. The vial was capped with a red 
PTFE/silicone cap, removed from the N2 filled glovebox, and heated at 110 °C (external 
oil bath temperature) for 12 h. The reaction mixture was transferred to a separatory funnel 
filled with methylene chloride (50 mL/mmol substrate) and saturated aqueous NH4Cl (50 
mL/mmol substrate). The 1-dram vial was washed with methylene chloride (2 x 5 
mL/mmol substrate), saturated aqueous NH4Cl (1 x 5 mL/mmol substrate), and 
methylene chloride (2 x 5 mL/mmol substrate). The layers were separated, and the 
aqueous layer was extracted with methylene chloride (2 x 50 mL/mmol substrate). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude material was purified by column chromatography on silica gel.  
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tert-Butyl 2-oxo-3,4-diphenylbutanoate (7a): The general 
procedure was employed for the coupling of 5a (46.9 mg, 0.2 mmol) 
and bromobenzene (62.8 mg, 42 mL, 0.4 mmol). The crude material 
was purified by column chromatography (EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 
62.0 mg (99%) of the title compound as an off-white amorphous solid. Analytical data for 
7a: 1H NMR (400 MHz, CDCl3) d 7.32–7.14 (m, 8 H), 7.07–7.02 (m, 2 H), 4.55 (app t, J 
= 7.4 Hz, 1 H), 3.44 (dd, J = 13.9, 6.9 Hz, 1 H), 2.96 (dd, J = 13.9, 7.9 Hz, 1 H), 1.31 (s, 9 
H); 13C NMR (151 MHz, CDCl3) d 193.9, 160.4, 138.8, 135.9, 129.1, 128.8, 128.2, 127.6, 
126.2, 84.0, 56.2, 37.6, 27.5; IR (thin film): 2981, 2932, 1742, 1722, 1455, 1160 cm–1; 
HRMS: (ESI+): Calcd. for C20H22O3: ([M+Na]): 333.1467, Found: 333.1453. TLC 
(EtOAc/hexane = 10/90): Rf = 0.45. 
tert-Butyl 3-(4-methoxyphenyl)-2-oxo-4-phenylbutanoate 
(7b): The general procedure was employed for the coupling of 5a (46.9 
mg, 0.2 mmol) and 1-bromo-4-methoxybenzene (74.8 mg, 50 mL, 0.4 
mmol). The crude material was purified by column chromatography 
(EtOAc/hexanes = 2.5/97.5 to 5/95) to afford 65.3 mg (96%) of the title compound as a 
light-yellow amorphous solid. Analytical data for 7b: 1H NMR (400 MHz, CDCl3) d 7.23–
7.10 (m, 3 H), 7.07–7.01 (m, 4 H), 6.84–6.79 (m, 2 H), 4.51 (app t, J = 7.4 Hz, 1 H), 3.78 
(s, 3 H), 3.40 (dd, J = 13.9, 6.8 Hz, 1 H), 2.94 (dd, J = 13.9, 8.1 Hz, 1 H), 1.34 (s, 9 H); 13C 
NMR (151 MHz, CDCl3) d 193.8, 160.6, 159.0, 138.9, 130.2, 129.1, 128.2, 127.6, 126.2, 
114.2, 83.9, 55.2, 55.2, 37.6, 27.6; IR (thin film): 2980, 2934, 2837, 1721, 1609, 1511, 1253 
cm–1; HRMS: (ESI+): Calcd. for C21H24O4: ([M+Na]): 363.1573, Found: 363.1558. TLC 
(EtOAc/hexane = 10/90): Rf = 0.35. 
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Methyl 4-(4-(tert-butoxy)-3,4-dioxo-1-phenylbutan-2-
yl)benzoate (7c): The general procedure was employed for the 
coupling of 5a (46.9 mg, 0.2 mmol) and methyl 4-bromobenzoate 
(86.0 mg, 0.4 mmol). The crude material was purified by column 
chromatography (EtOAc/hexanes = 2.5/97.5 to 5/95) to afford 70.5 mg (96%) of the title 
compound as an off-white amorphous solid. Analytical data for 7c: 1H NMR (400 MHz, 
CDCl3) d 7.98–7.93 (m, 2 H), 7.22–7.11 (m, 5 H), 7.03–6.99 (m, 2 H), 4.63 (dd, J = 8.4, 
6.6 Hz, 1 H), 3.90 (s, 3 H), 3.43 (dd, J = 13.9, 6.6 Hz, 1 H), 2.97 (dd, J = 13.9, 8.4 Hz, 1H), 
1.33 (s, 9 H); 13C NMR (151 MHz, CDCl3) d 193.3, 166.6, 159.9, 141.2, 138.1, 130.0, 129.4, 
129.1, 129.0, 128.3, 126.4, 84.4, 56.1, 52.2, 37.7, 27.5; IR (thin film): 2981, 2953, 1723, 
1608, 1282, 1112 cm–1; HRMS: (ESI+): Calcd. for C22H24O5: ([M+Na]): 391.1522, Found: 
391.1510. TLC (EtOAc/hexane = 10/90): Rf = 0.3. 
 
tert-Butyl 2-oxo-4-phenyl-3-(4-
(trifluoromethyl)phenyl)butanoate (7d): The general procedure 
was employed for the coupling of 5a (46.9 mg, 0.2 mmol) and 1-bromo-
4-(trifluoromethyl)benzene (90.0 mg, 55 mL, 0.4 mmol). The crude 
material was purified by column chromatography (column 1: EtOAc/hexanes = 1/99 to 
2.5/97.5, column 2: methylene chloride) to afford 74.5 mg (98%) of the title compound as 
an off-white amorphous solid. Analytical data for 7d: 1H NMR (600 MHz, CDCl3) d 7.55 
(d, J = 8.1 Hz, 2 H), 7.27 (d, J = 8.0 Hz, 2 H), 7.24-7.19 (m, 2 H), 7.19-7.15 (m, 1 H), 7.05-
7.01 (m, 2 H), 4.67 (dd, J = 8.2, 6.8 Hz, 1 H), 3.44 (dd, J = 13.9, 6.8 Hz, 1 H), 2.97 (dd, J 
= 13.9, 8.2 Hz, 1 H), 1.35 (s, 9H); 13C NMR (151 MHz, CDCl3) d 193.3, 159.9, 140.2 (d, 
J13C-19F = 1.7 Hz), 138.0, 129.9 (q, J13C-19F  = 32.4 Hz), 129.3, 129.0, 128.4, 126.5, 125.7 (q, 
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J13C-19F  = 3.9 Hz), 123.9 (q, J13C-19F  = 270.3 Hz), 84.5, 55.8, 37.8, 27.5; IR (thin film): 
2982, 2935, 1723, 1327, 1165, 1126, 1068 cm–1; HRMS: (ESI+): Calcd. for C21H21F3O3: 
([M+Na]): 401.1341, Found: 401.1325. TLC (EtOAc/hexane = 10/90): Rf = 0.45. 
 
tert-Butyl 3-(3,5-dimethylphenyl)-2-oxo-4-phenylbutanoate 
(7e): The general procedure was employed for the coupling of 5a (46.9 
mg, 0.2 mmol) and 1-bromo-3,5-dimethylbenzene (74.0 mg, 54 mL, 
0.4 mmol). The crude material was purified by column chromatography (EtOAc/hexanes 
= 2.5/97.5) to afford 66.8 mg (99%) of the title compound as an off-white amorphous 
solid. Analytical data for 7e: 1H NMR (400 MHz, CDCl3) d 7.24-7.13 (m, 3 H), 7.19-7.15 
(m, 1 H), 7.12-7.06 (m, 2 H), 6.88 (s, 1 H), 6.76 s, 2 H) 4.50 (app t, J = 7.3 Hz, 1 H), 3.43 
(dd, J = 14.0, 7.6 Hz, 1 H), 2.94 (dd, J = 13.9, 7.1 Hz), 2.26 (s, 6 H), 1.32 (s, 9 H); 13C NMR 
(151 MHz, CDCl3) d 193.9, 160.5, 139.1, 138.3, 135.7, 129.3, 129.1, 128.2, 126.8, 126.2, 83.8, 
56.0, 37.5, 27.5, 21.2; IR (thin film): 2980, 2921, 1743, 1722, 1160, 700 cm–1; HMRS: 
(ESI+): Calcd. for C22H26O3: ([M+Na]): 361.1780, Found: 361.1765. TLC (EtOAc/hexane 
= 10/90): Rf = 0.45. 
 
tert-Butyl 3-(naphthalen-1-yl)-2-oxo-4-phenylbutanoate 
(7f): The general procedure was employed for the coupling of 5a (46.9 
mg, 0.2 mmol) and 1-bromonaphthalene (82.8 mg, 56 mL, 0.4 mmol). 
The crude material was purified by column chromatography (EtOAc/hexanes = 2.5/97.5) 
to afford 65.2 mg (89%) of the title compound as a light-yellow liquid. Analytical data for 
7f: 1H NMR (400 MHz, CDCl3) d 8.01-7.95 (m, 1 H), 7.88-7.82 (m, 1 H), 7.78 (d, J = 8.2 
Hz, 1 H), 7.52-7.45 (m, 2 H), 7.44-7.38 (m, 1 H), 7.20-7.10 (m, 6 H), 5.33-5.23 (m, 1 H), 
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3.60 (dd, J = 13.9, 7.6 Hz, 1 H), 3.04 (dd, J = 13.9, 6.4 Hz, 1 H), 1.04 (s, 9 H); 13C NMR 
(151 MHz, CDCl3) d 194.0, 160.3, 139.2, 134.1, 133.0, 131.5, 129.1, 128.9, 128.4, 128.3, 
126.5, 126.3, 125.9, 125.4, 123.2, 83.8, 51.9, 37.7, 27.2; IR (thin film): 3061, 3029, 2980, 
2932, 1742, 1724, 1153 cm–1; HRMS: (ESI+): Calcd. for C24H24O3: ([M+Na]): 383.1623, 
Found: 383.1608. TLC (EtOAc/hexane = 10/90): Rf = 0.5. 
 
tert-Butyl 2-oxo-4-phenyl-3-(pyridin-3-yl)butanoate (7g): The 
general procedure was employed for the coupling of 5a (46.9 mg, 0.2 
mmol) and 3-bromopyridine (63.2 mg, 39 mL, 0.4 mmol). The crude 
material was purified by column chromatography (EtOAc/hexanes = 20/80 to 30/70) to 
afford 58.6 mg (94%) of the title compound as a light-yellow amorphous solid, existing as 
a 93:7 mixture of ketone:enol tautomers. Analytical data for 7g: 1H NMR (400 MHz, 
CDCl3) d 8.52 (d, J = 4.8 Hz, 1 H), 8.41 (s, 1 H), 7.53-7.48 (m, 1 H), 7.30-7.14 (m, 4 H), 
7.07-7.02 (m, 2 H), 4.65 (dd, J = 8.4, 6.7 Hz, 1 H), 3.46 (dd, J = 13.9, 6.7 Hz, 1 H), 2.99 
(dd, J = 13.9, 8.4 Hz, 1 H) 1.38 (s, 9 H); 13C NMR (151 MHz, CDCl3) d 193.3, 159.8, 150.5, 
148.9, 137.8, 136.0, 132.0, 129.0, 128.5, 126.6, 123.6, 84.6, 53.4, 37.7, 27.6; IR (thin film): 
3061, 3030, 2980, 2933, 1723 cm–1; HRMS: (ESI+): Calcd. for C19H21NO3: ([M+H+]): 
312.1600, Found: 312.1597. TLC (EtOAc/hexane = 30/70): Rf = 0.3. 
 
tert-Butyl 3-(1H-indol-5-yl)-2-oxo-4-phenylbutanoate (7h): 
The general procedure was employed for the coupling of 5a (46.9 mg, 
0.2 mmol) and 5-bromo-1H-indole (78.4 mg, 0.4 mmol). The crude 
material was purified by column chromatography (EtOAc/hexanes = 
10/90 to 15/85) to afford 52.5 mg (75%) of the title compound as an off-white amorphous 
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solid. Analytical data for 7h: 1H NMR (400 MHz, CDCl3) d 8.16 (br s, 1 H), 7.43 (s, 1 H), 
7.30 (d, J = 8.4 Hz, 1 H), 7.22-7.06 (m, 6 H), 6.98-6.94 (m, 1 H), 6.51-6.47 (m, 1 H), 4.66 
(app t, J = 7.4 Hz, 1 H), 3.50 (d, J = 13.9, 7.1 Hz, 1 H), 3.04 (d, J = 13.9, 7.6 Hz, 1 H), 1.28 
(s, 9 H); 13C NMR (151 MHz, CDCl3) d 194.1, 160.8, 139.4, 135.2, 129.1, 128.2, 128.2, 
126.8, 126.1, 124.8, 123.2, 121.4, 111.4, 102.6, 83.7, 56.1, 37.9, 27.5; IR (thin film): 3420 
(br), 2980, 2931, 1723, 1156, 1091 cm–1; HRMS: (ESI+): Calcd. for C22H23NO3: ([M+Na]): 
372.1576, Found: 372.1561. TLC (EtOAc/hexane = 20/80): Rf = 0.35. 
 
tert-butyl 4-(4-methoxyphenyl)-2-oxo-3-
phenylbutanoate (7i): The general procedure was employed 
for the coupling of 5i (52.9 mg, 0.2 mmol) and bromobenzene 
(62.8 mg, 42 mL, 0.4 mmol). The crude material was purified by column chromatography 
(EtOAc/hexanes = 2.5/97.5 to 5/95) to afford 57.9 mg (85%) of the title compound as a 
light-yellow liquid. Analytical data for 7i: 1H NMR (400 MHz, CDCl3) d 7.31-7.22 (m, 3 
H), 7.15-7.11 (m, 2 H), 6.96 (d, J = 8.6 Hz, 2 H), 6.74 (d, J = 8.6 Hz, 2 H), 4.51 (app t, J = 
7.4 Hz, 1 H), 3.75 (s, 3 H), 3.37 (dd, J = 14.0, 6.9 Hz, 1 H), 2.91 (dd, J = 14.0, 7.9 Hz, 1 H), 
1.32 (s, 9 H); 13C NMR (151 MHz, CDCl3) d 194.0, 160.4, 158.0, 136.0, 130.8, 130.0, 129.1, 
128.8, 127.6, 113.6, 83.9, 56.5, 55.1, 36.8, 27.5; IR (film) 2980, 2934, 2836, 1722, 1513, 
1248.7 cm–1; HRMS: (ESI+): Calcd. for C21H24O4: ([M+Na]): 363.1573, Found: 363.1818. 
TLC (EtOAc/hexane = 10/90): Rf = 0.35. 
 
tert-Butyl 4-methyl-2-oxo-3-phenylpentanoate (7j): The 
general procedure was employed for the coupling of 5j (37.3 mg, 0.2 
mmol) and bromobenzene (62.8 mg, 42 mL, 0.4 mmol). The crude 
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material was purified by column chromatography (EtOAc/hexanes = 1/99 to 2.5/97.5) to 
afford 47.3 mg (90%) of the title compound as a clear, colorless liquid. Analytical data for 
7j: 1H NMR (400 MHz, CDCl3) d 7.36-7.24 (m, 3 H), 7.23-7.18 (m, 2 H), 4.03 (d, J = 9.8 
Hz, 1 H), 2.52-2.39 (m, 1 H), 1.39 (s, 9 H), 1.04 (d, J = 6.5 Hz, 3 H), 0.74 (d, J = 6.7 Hz, 3 
H); 13C NMR (151 MHz, CDCl3) d 194.6, 160.8, 135.5, 129.6, 128.7, 127.5, 83.8, 61.6, 29.8, 
27.6, 21.5, 20.1; IR (thin film): 2977, 2935, 2873, 1742, 1724, 1370, 1256 cm–1; HRMS: 
(ESI+): Calcd. for C16H22O3: ([M+Na]): 285.1467, Found: 285.1454. TLC (EtOAc/hexane 
= 10/90): Rf = 0.55.  
 
tert-butyl 2-oxo-3-(pyridin-3-yl)butanoate (7k): The general 
procedure was employed for the coupling of 7k (31.6 mg, 0.2 mmol) and 
3-bromopyridine (63.2 mg, 39 mL, 0.4 mmol). The crude material was 
purified by column chromatography (EtOAc/hexanes = 30/70 to 40/60) to afford 37.9 
mg (81%) of the title compound as a light-yellow amorphous solid. Analytical data for 7k: 
1H NMR (400 MHz, CDCl3) d 8.55-8.51 (m, 2 H), 7.55-7.50 (m, 1 H), 7.30-7.25 (m, 1 H), 
4.42 (q, J = 7.0 Hz, 1 H), 1.48 (d, J = 7.1 Hz, 3 H), 1.39 (s, 9 H); 13C NMR (151 MHz, 
CDCl3) d 194.3, 160.3, 150.1, 148.8, 135.5, 134.0, 123.7, 84.5, 46.0, 27.6, 16.7; IR (thin 
film): 2981, 2936, 1723, 1576, 1479, 1455 cm–1; HRMS: (ESI+): Calcd. for C13H17NO3: 
([M+H+]): 236.1287, Found: 236.1282. TLC (EtOAc/hexane = 30/70): Rf = 0.2. 
 
Di-tert-butyl 2-oxo-3-phenylpentanedioate (7l): The general 
procedure was employed for the coupling of 5l (51.7 mg, 0.2 mmol) 
and bromobenzene (62.8 mg, 42 mL, 0.4 mmol). The crude material 
was purified by column chromatography (column 1: EtOAc/hexanes = 1/99 to 2.5/97.5, 
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column 2: EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 56.9 mg (85%) of the title 
compound as a clear and colorless liquid. Analytical data for 7l: 1H NMR (500 MHz, 
CDCl3) d 7.36-7.26 (m, 3 H), 7.24-7.17 (m, 2 H), 4.79 (dd, J = 9.5, 5.6 Hz, 1 H), 3.12 (dd, 
J = 16.8, 9.5 Hz, 1 H), 2.61 (dd, J = 16.8, 5.7 Hz, 1 H), 1.41 (s, 9 H), 1.38 (s, 9 H); 13C NMR 
(151 MHz, CDCl3) d 193.1, 170.5, 159.8, 135.2, 129.0, 128.9, 127.9, 84.0, 81.1, 50.2, 37.7, 
27.9, 27.6; IR (thin film): 2980, 2933, 1727, 1369, 1255, 1157 cm–1; HRMS: (ESI+): Calcd. 
for C19H26O5: ([M+Na]): 357.1678, Found: 357.1662. TLC (EtOAc/hexane = 10/90): Rf = 
0.45. 
Procedure for the Gram Scale Pd-Catalyzed Arylation: A flame-dried 150 mL 
pressure vessel equipped with a stirbar was cooled under a stream of N2, and charged with 
5a (1.00 g, 4.27 mmol, 1.0 equiv) and 3-bromopyridine (1.35 g, 820 mL, 8.54 mmol, 2.0 
equiv). The vessel was transferred to a N2 filled glovebox. The vessel was then charged 
with Pd2(dba)3 (78 mg, 0.09 mmol, 0.02 equiv), a 1.0 M solution of PtBu3 in toluene (340 
mL, 0.34 mmol, 0.08 equiv), K2CO3 (1.77 g, 12.8 mmol, 3.0 equiv), and toluene (21 mL, 
[5a]0 = 0.2 M). The vessel was capped, removed from the N2 filled glovebox, and heated 
at 110 °C (external oil bath temperature) for 12 h. The reaction mixture was transferred 
to a separatory funnel filled with diethyl ether (30 mL) and saturated aqueous NH4Cl (30 
mL). The pressure vessel was washed with diethyl ether (2 x 5 mL), saturated aqueous 
NH4Cl (1 x 5 mL), and diethyl ether (2 x 5 mL). The layers were separated, and the aqueous 
layer was extracted with diethyl ether (2 x 40 mL). The organic extracts were combined, 
washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
material was purified by column chromatography on silica gel (EtOAc/hexanes = 20/80 
to 30/70) to afford 1.33 g (90%) of 7g as a white amorphous solid.  
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Procedure for the Air-Tolerant Pd-Catalyzed Arylation: A flame-dried 1-dram 
vial was cooled under a stream of N2, and charged with Pd2(dba)3 (3.7 mg, 0.004 mmol, 
0.02 equiv), tri-tert-butylphosphonium tetrafluoroborate (4.6 mg, 0.016 mmol, 0.08 
equiv), K2CO3 (83 mg, 0.6 mmol, 3.0 equiv), and toluene (1 mL, [K2CO3]0 = 0.6 M). The 
reaction mixture was purged under a stream of N2, capped with a red PTFE/silicone cap, 
and stirred at rt for 2 h. The cap was removed, and the vial was charged with 5a (47 mg, 
0.2 mmol, 1.0 equiv) and bromobenzene (62.8 mg, 42 mL, 0.4 mmol, 2.0 equiv). The 
reaction mixture was purged under a stream of N2, capped, and stirred at 110 °C (external 
oil bath temperature) for 12 h. The reaction mixture was transferred to a separatory funnel 
filled with methylene chloride (20 mL) and saturated aqueous NH4Cl (20 mL). The 1-
dram vial was washed with methylene chloride (2 x 1 mL), saturated aqueous NH4Cl (1 x 
1 mL), and methylene chloride (2 x 1 mL). The layers were separated, and the aqueous 
layer was extracted with methylene chloride (2 x 20 mL). The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated in vacuo. The crude material was 
purified by column chromatography (EtOAc/hexanes = 1/99 to 2.5/97.5) to afford 62.0 
mg (99%) of 7a compound as an off-white amorphous solid. 
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Chapter IV Catalytic Enantioselective [3+2] Cycloaddition of α-Keto Ester 
Enolates and Nitrile Oxides 
4.1 Introduction to Soft Enolization 
 
The stereoselective functionalization of enolate derivatives is a venerable, time-honored 
strategy for the assembly of complex molecular frameworks.1 Historically, the preparation 
of enolates has involved the use of group I metal-amides as thermodynamically strong 
bases. In these reactions, stereoselectivity has often relied on pre-installed chiral 
auxiliaries.2 More recently, it has been shown that complexation of a Lewis acid to the 
non-bonding electrons of a carbonyl pro-nucleophile can lower the energy of its π system, 
leading to enhanced acidity, which thereby enables enolization under milder conditions.3 
This process has been referred to as soft enolization In an early report, Mukaiyama and 
co-workers developed an aldol reaction between ketone nucleophiles and aldehyde 
electrophiles promoted by Sn(OTf)2 and a trialkylamine base (Scheme 4-1, eq 1).4 Prior 
to this work the same lab had developed direct cross-aldol reactions employing boron 
enolates formed under the action of a trialkylamine and nBu2OTf.5 An early catalytic 
version of this process was disclosed by Evans and co-workers.6 They showed that a 
magnesium halide salt in conjunction with a trialkylamine base, could catalyze the 
diastereoselective aldol reaction of chiral acyloxazolidinone nucleophiles (Scheme 4-1, 
eq 2). This finding set the stage for the development of asymmetric reactions proceeding 
by direct enolization catalyzed by chiral metal complexes. In 1992, Shibasaki and 
coworkers reported a direct asymmetric Henry reaction catalyzed by a rare earth metal-
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binolate complex.7 Several years later they reported the first direct asymmetric aldol 
reaction catalyzed by a related chiral lanthanum-binolate complex (Scheme 4-1, eq. 3).8  
 
Scheme 4-1. Exemplary Soft Enolization Reactions  
 
A number of research groups have since reported that chiral late transition metal 
complexes act as catalysts for reactions that proceed via soft enolization of carbonyl 
compounds.9 Transformations developed under this paradigm include Michael,9a 
halogenation,9b,c Mannich,9d and aldol9e reactions of β-keto esters, as well as Michael9f 
additions and halogenations9g-i using α-keto esters as pro-nucleophiles. Substrates, that 
are capable of forming strong chelates with the chiral metal catalyst perform particularly 
well in these reactions. Consequently, α-keto esters have emerged as a privileged 
substrate class. The chiral Ni(II)-diamine catalyzed 1,4-addition of α-keto ester pro-
nucleophiles and nitroolefins, disclosed by the Sodeoka laboratory, is an important 
example of a direct asymmetric addition via a soft enolization reaction manifold.9f  This 
reaction proceeds via the intermediacy of a chiral (Z)-Ni(II)-enolate 4 which evades 
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destabilizing A1,3 interactions between the β-substituent and tBu group of the α-keto ester 
present in the opposite geometrical isomer (Scheme 4-2).  
Scheme 4-2. Sodeoka’s Ni(II)-Diamine Catalyzed Michael Addition of α-Keto Esters 
and Nitroolefins. 
 
4.2 Reaction Design 
The integration of unconventional electrophiles under the mechanistic construct 
discussed above carries with it the possibility to create heretofore unknown compounds: 
1,3-dipolar synthons emerged as attractive targets. Sustmann classified 1,3-dipolar 
cycloadditions based on the relevant FMO interactions:10 Type I cycloadditions are 
controlled by the homo of the dipole and LUMO of the dipolarophile. In type II 
cycloadditions the orbital energy levels of the dipole and dipolarophile are effectively 
matched. Finally, type III cycloadditions are controlled by the HOMO of the dipolarophile 
and the LUMO of the dipole (Scheme 4-3) The cycloaddition of an electron rich vinyl 
ether 6 and a nitrile oxide 7 constitutes a type III cycloaddition.11 
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Scheme 4-3. Sustmann’s Frontier Orbital Control Classification Scheme for Dipolar 
Cycloadditions 
 
Drawing a parallel with electron-rich dipolarophiles12 we postulated that transition 
metal enolates could similarly engage dipoles in [3+2] cycloadditions. Precedent for 
achieving catalytic asymmetric dipolar cycloadditions by way of HOMO raising activation 
exists. Yanagisawa and coworkers reported the cycloaddition of nitrones and alkenyl 
acetates and proposed the intermediacy of catalytically formed tin(IV) enolates.13 
Additionally, enamine catalysis has been used to facilitate asymmetric [3+2] 
cycloadditions of aldehydes and azomethine imines.14,15 Building on this concept, the 
Sodeoka laboratory recently developed a catalytic asymmetric [3+2] cycloaddition of 
nitrones 9 and enolates derived from α-keto esters 10 that was inspired by the structural 
characterization of a Ni(II)–diamine catalyst that merges Ni(II)–enolate and hydrogen-
bonding activation modes (Scheme 4-4).16 However, the scope of the process was 
limited to isolable (E)-nitrones, specifically dihydroquinoline derivatives.  
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Scheme 4-4. Sodeoka’s [3+2] Cycloaddition of Nitrones and α-Keto Ester Enolates. 
 
The generation of heretofore unknown isoxazolines via the reaction of an ephemeral 
metalloenolate with a transient nitrile oxide emerged as an attractive, yet challenging next 
step (Scheme 4-5).17 
 
Scheme 4-5 Proposed [3+2] Cycloaddition and Competitive Reactions. 
 
At the outset, we perceived several unique challenges to our reaction plan. Foremost 
among these is the inherent instability of nitrile oxides toward dimerization (Scheme 4-
5, path A)11b,18 and the need to generate them in situ via base mediated 
 112 
 
dehydrohalogenation of the corresponding hydroximoyl chloride, or by the dehydration 
of nitroalkanes.19 Additionally, our labs have observed that α-keto esters 10 react via 
homo-aldol (path B) in the absence of other viable pathways. The known hetero [3+2] 
cycloaddition of nitrile oxides with α-keto esters defines a third relative rate concern (path 
C),20 especially since the latter will be present in great excess relative to the derived 
metalloenolate. Finally, the inherent competition of O- versus C-trapping of 
metalloenolates (path D vs. E) must be effectively managed for a successful outcome.  
4.3 Reaction Optimization 
We hypothesized that the Ni(II)-catalyst developed for the cycloaddition of nitrones 
with α-keto ester 10a16  would display similar efficiency with nitrile oxides and running 
the reaction at –40 °C would preclude the undesired dioxazole coproduct 14 (Table 4-
1). Catalytic amounts of tertiary amine bases have been shown to accelerate reactions 
involving Ni(II)–enolates of α-keto esters,9f thus nitrile oxides were generated in situ from 
hydroximoyl chlorides using triethylamine. Hydroximoyl chloride 12a was chosen as a 
model substrate. As shown in entries 1 and 2, utilizing Ni(OAc)2 complexes of ligands 16 
and 17, these conditions did not favor formation of the desired 5-hydroxy-2-isoxazoline 
13a. In addition to the anticipated dioxazole coproduct 14a, the intervention of the O-
imidoylation pathway was concurrently observed (15a);21 however, we were encouraged 
by the promising levels of stereoselectivity observed for 13a (Table 4-1, entry 1: –82% 
ee, 11:1 dr and entry 2: –53% ee, 11:1 dr) without interference by the forecasted homo-
dimerization (path A) and homo-aldol adducts (path B). A solvent screen (entries 3-5) 
revealed that the chemoselectivity could be dramatically improved (Table 4-1, entry 5: 
10:1 13a:15a) if N,N-dimethylformamide was employed as solvent. In contrast, the use of 
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iPrOH as solvent induced a preference for 15a (Table 4-1, entry 6, 1:2 13a:15a). Further 
screening of conditions with Ni(II) failed to yield satisfactory results.  
Table 4-1 Reaction Optimization Studies 
 
entry lig-
and 
M(OAc)2 solvent yield 
13a 
[%]c 
ratiod 
13:14:15 
dr 
(13a)d 
ee 
major 
[%]e 
1f 16 Ni(OAc)2 THF 34  1:0.3:1 11:1
 g –82 
2f 17 Ni(OAc)2 THF 20  1:1:1 11:1
 g –53 
3f 16 Ni(OAc)2 DCM 22  1:0.3:1 18:1 n.d. 
4f 16 Ni(OAc)2 PhMe 25  1:0.6:1 13:1 n.d. 
5f 16 Ni(OAc)2 DMF 65  10:1:1 11:1 –58 
6f 16 Ni(OAc)2 
iPrOH 24 1:_:2 13:1 –78  
7h 17 Cu(OAc)2 THF <17  1:5:_ 11:1
 g 54 
8h 3 Cu(OAc)2 THF 15  1:4:_ 12:1 74 
9h 3 Cu(OAc)2 DCM 16  1:5:_ 12:1 74 
10h 3 Cu(OAc)2 PhMe 38  1.6:1:_ 10:1 70 
11h 3 Cu(OAc)2 
iPrOH 77  >20:1:_ 11:1 70 
12h 18 Cu(OAc)2 
iPrOH 86  8:1:_. 9:1 66 
13h 19 Cu(OAc)2 
iPrOH 72  >20:1:_ 10:1 64 
14h 20 Cu(OAc)2 
iPrOH 79  >20:1:_ 10:1 83 
15h 21 Cu(OAc)2 
iPrOH 82  >20:1:_ 10:1 91 
16i 21 Cu(OAc)2 
iPrOH 75  >20:1:_ 13:1 90 
17i,j 21 Cu(OAc)2 
iPrOH 83  >20:1:_ 13:1 91 
18i,j 22 Cu(OAc)2 
iPrOH 86  >20:1:_ 11:1 92 
19,j,k 23 Cu(OAc)2 
iPrOH 9 1:3:0.2 12:1 8 
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a) Reactions were run on 0.1 mmol scale; M(OAc)2 refers to hydrate. b) 20 mol % ligand 
and metal acetate were used unless otherwise noted. c) Isolated yield. d) Determined by 
1H NMR analysis of crude reaction mixture, unless noted otherwise; _ = not observed e) 
HPLC analysis using chiral stationary phase, n.d. = not determined. f) Isolated complex 
used. g) Isolated dr. h) Catalyst complexed in situ. i) 5 mol % of isolated complex used. j) 
1.5 equiv 2, 2.5 equiv Et3N. k) 0.2 mmol scale. Catalyst complexed in situ; 5 mol % loading. 
 
Switching to Cu(OAc)2·H2O as the metal source in THF completely eliminated the O-
addition byproduct while favoring the opposite enantiomer of 13a (Table 4-1, entry 7: 
54% ee, 11:1 dr),22 although the concurrence of the undesired hetero-[3+2] pathway was 
still observed. Diamine complexes of Ni(II) and Cu(II) exhibit distinct coordination 
geometries,23 thereby leading to different coordination modes for the derived enolates. 
We postulate that these differences manifest in opposite enantiofacial selectivity in the 
present system. The differences in coordination geometry may also result in preferential 
chiral recognition of geometrically distinct nitrones (trigonal) and nitrile oxides (linear) 
by the Ni(II) and Cu(II) complexes, respectively, via hydrogen bonding with the H-bond 
donating diamine ligand. These considerations could account for the unique ability of the 
Cu(II) complexes to provide high enantioselectivity with nitrile oxides while the 
previously developed Ni(II) complexes perform poorly (Scheme 4-6). Along these lines, 
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the inclination of Ni(II) enolates to undergo O-trapping may, in part, result from a kinetic 
preference for this pathway induced by the distinct geometry of Ni(II)-enolates.  
 
 
 
 
 
Scheme 4-6 Rationale for Stereodivergence Observed with Ni(II) and Cu(II) 
 
While exchanging the cyclohexyl substituted ligand 17 with the benzyl-type ligand 3 did 
not lead to an improvement in chemoselectivity, a noticeable enhancement in 
enantioselectivity was observed (Table 4-1, entry 8: 74% ee). Further solvent screening 
was performed; while no improvement in chemoselectivity occurred in DCM (Table 4-1, 
entry 9: 1:5 13a:14a), 13a was favored slightly in PhMe (Table 4-1, entry 10: 1.6:1 
13a:14a). We and others have noted that reactions involving transition metal enolates 
display enhanced rates in alcoholic solvent.9f,24 In fact, the use of iPrOH gave >20:1 
preference for the desired product 13a, (Table 4-1, entry 11: 77% yield, 70% ee, 11:1 dr). 
The protic solvent may promote fragmentation of less active catalyst oligomers, or catalyst 
turnover from the Cu(II)-alkoxide intermediate proceeding [3+2]-cycloaddition via 
protonolysis.25 
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Having overcome the issue of low chemical yield, we shifted our focus toward the 
influence of ligand structure on enantioselectivity. The electronic features of the of the 
benzyl-type ligands 18 and 19 have little influence on enantioselection (Table 4-1, entry 
12: 66% ee and Table 1, entry 13: 64% ee); however, the results with ligand 20 suggest 
that non-bonding interactions are important (Table 4-1, entry 14: 83% ee).  Ligand 21 
provided satisfactory levels of enantioselectivity (entry 15, 91% ee) and we were pleased 
to find that the catalyst loading could be reduced to 5 mol % without adversely influencing 
reactivity or selectivity (entry 16). Additionally, the amount of hydroximoyl chloride 12a 
and Et3N could be reduced to 1.5 equiv and 2.5 equiv, respectively (entry 17). The 2-CF3 
substituted benzyl-type ligand 22 also provided high selectivity for this substrate and was 
later found to be uniquely suited for achieving high enantioselectivity with 2-substituted 
benzenenitrile oxides (entry 18, 92% ee). Finally, the reduced yield and stereocontrol 
obtained with N-Me ligand 23 suggests the secondary diamine as a key design feature of 
the present catalyst system (entry 19, 9% yield, 8% ee).  
4.4 Scope of Enantioselective [3+2] Cycloaddition 
With suitable reaction conditions in hand, we sought to investigate how the steric and 
electronic parameters of the reaction partners might affect the process (Scheme 4-7). 
Nitrile oxides bearing electron withdrawing groups in the 4-position were tolerated under 
the optimized conditions, for instance 4-CF3C6H4 substituted 13b and 4-FC6H4 
substituted 13c were obtained in good chemical yield with high levels of diastereo- and 
enantioselectivity (Scheme 4-7, 13b: 91% yield, 90% ee, 10:1 dr and 13c: 88% yield, 91% 
ee, 10:1 dr). Electron-rich aromatic nitrile oxides also participated and 4- PhC6H4 
substituted 13d and 4-MeC6H4 substituted 13e were obtained with similarly high levels 
of diastereo- and enantioselectivity (Scheme 4-7, 13d: 58% yield, 88% ee, 11:1 dr and 
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13e: 75% yield, 90% ee, 13:1  dr). Mesityl ligand 21 displayed lower levels of 
enantioselection when 2-substituted aryl nitrile oxides were used, however, the 2-CF3 
analogue 22 promoted high selectivity with these substrates. This effect was not as 
marked with smaller substituents as 2-FC6H4 13f was obtained in high levels of 
enantioselectivity using both catalysts (Scheme 4-7, lig. 21: 90% ee and lig. 22: 92% ee). 
The difference in selectivity increased upon moving from 2-OMe to larger 2-Me 
substitution (Scheme 4-7, 13g: 80% ee vs. 92% ee and 13h: 76% ee vs. 90% ee). The 
enantioselectivity difference was accentuated in the case of 2-BrC6H4 substituted 13i, 
which was obtained in 62% ee using the mesityl substituted ligand 21, while the 2-
CF3C6H4 substituted ligand 22 provided 91 % ee. Heteroaromatic nitrile oxides were 
compatible with the optimized reaction conditions; the 2-keto glutaric acid derived 3-
pyridyl substituted 3j could be formed, albeit with lower enantioselectivity (Table 2, 3j: 
90% yield, 74% ee). Cycloadduct 13k was obtained in good yield, excellent 
diastereoselectivity, with high levels of enantioselectivity (Scheme 4-7, 13k: 85% yield, 
93% ee). The absolute stereochemistry of 13k was determined via X-ray crystallography 
and the configurations of the remaining products are assigned by analogy. Other 
electronically diverse nitrile oxides reacted well with this α-keto ester (13l-o). The 
homobenzyl substituted α-keto ester furnished the corresponding cycloadduct 13p in 
88% ee with high diastereoselection when the 2-FC6H4 substituted hydroxyimidoyl 
chloride was employed. In contrast, the n-propyl substituted product 13q was formed 
with lower levels of diastereoselectivity. A γ-branched α-keto ester could be employed 
when the catalyst loading was increased to 20 mol % (Scheme 4-7, 13r: 45% yield, 14:1 
dr, 83% ee). A β-aryl substituted α-keto ester (R2 = 3-tolyl) provided low diastereo- and 
enantiocontrol during the formation of the derived cycloadduct (59% yield, 1.3:1 dr, 62% 
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ee and 68% ee. Similarly, lower levels of enantiocontrol were observed for a product, 
derived from a Me substituted α-keto ester (R2 = Me) and 2-fluorobenzonitrile oxide, 
although satisfactory levels of diastereocontrol were maintained (79% yield, 54% ee, 7:1 
dr. The isoxazoline, derived from tert-butyl pyruvate (R2 = H), was furnished in racemic 
form (58% yield, 2% ee). The identity of the ester influenced enantiocontrol as lower levels 
of enantioselectivity were obtained for product 13s using the i-propyl substituted 
analogue of our model α-keto ester 10a (Scheme 4-7, 88% ee). Finally, alkenyl nitrile 
oxides are viable partners under the reaction conditions and the styryl isoxazoline 13t 
was obtained in good yield, as a single diastereomer, with high levels of enantioselectivity 
(Scheme 4-7, 65% yield, 20:1 dr, 90% ee). Unfortunately, aliphatic nitrile oxides are not 
compatible at this stage of optimization (i.e. 13u). Aliphatic nitrile oxides are less stable 
than their sp2-carbon-substituted counterparts15 and we believe that competitive 
decomposition is to blame.  
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Scheme 4-7 Scope of Reaction 
 
a) The reactions were run on 0.2 mmol scale, see SI for reaction times. Yields are for 
isolated products. Diastereomeric ratio (dr) values were determined by 1H NMR 
analysis of crude reaction mixture, isolated dr values were written in parentheses. 
The enantiomeric excess (ee) values were determined by HPLC using chiral 
stationary phase. b) Ligand 21 employed. c) Ligand 22 employed. d) 20 mol % of 
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Cu(OAc)2–diamine employed. e) 3.0 equiv of hydroximoyl chloride, 3.6 equiv of 
Et3N.   
4.5 Gram Scale Reaction and Isoxazoline Reduction 
 
Having established the scope of this transformation, we sought to study the reactivity 
of the C=N bond installed during the cycloaddition reaction (Scheme 4-8). We found 
that the 2-ketoglutaric acid derived cycloadduct 13k could be prepared on gram scale (2.5 
mol % catalyst). Under the action of NaBH4/NiCl2,26 13k (90% ee) was converted to γ-
lactam 24k containing three vicinal stereocenters (2.5 mmol scale). Lactam 24k was 
moderately enriched upon recrystallization and the structure of this product was obtained 
via X-ray crystallography.  
Scheme 4-8 Gram Scale Reaction and Isoxazoline Reduction 
 
4.6 Unusual Configurational Stability of Products 
The isoxazoline products delivered by the title reaction are hemiacetals that could in 
principle coexist with their ring-opened acyclic γ-oximo-β-keto ester isomers (25, 
Scheme 4-9). Such structures would appear to be quite vulnerable toward racemization 
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via facile keto-enol tautomerization due to high C-H acidity for the methine proton (25  
26). The obtention of isoxazoline adducts 3 and a downstream adduct like 24k with high 
enantiomeric enrichment allows us to draw conclusions regarding the intervention of the 
equilibria depicted in Scheme 4-9. We postulate that the lack of racemization stems 
from the high stability of the isoxazoline hemiacetal that disfavors ring-opening. 
Circumstantial evidence against formation of the acyclic oxime 25 is the constant product 
diastereomeric ratio as a function of time: ring opening/ring closure would presumably 
change the diastereomeric composition. The kinetic reluctance to form the oxime 25 may 
stem from the system’s preference to avoid creation of a highly electrophilic α-keto ester 
in the presence of multiple electronegative atoms/functional groups. The isoxazoline 
hemiacetal thus insulates a potentially labile stereocenter from undesired racemization.  
Scheme 4-9 Izoxazoline Hemiacetals do not Racemize via Tautomerization 
 
4.7 Conclusion 
In summary, we have developed an enantioselective [3+2] cycloaddition reaction 
between nitrile oxides and transiently generated enolates of α-keto esters catalyzed by a 
chiral copper(II)–diamine complex. The catalyst system was found to be compatible with 
in situ nitrile oxide generation. This constitutes the first catalytic enantioselective 
preparation of this unique class of heterocycles, which can be transformed into interesting 
lactams. With this data in hand we are currently assessing the reactivity of the 5-hydroxy-
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2-isoxazolines in other downstream transformations in addition to studying the 
mechanism of this transformation in detail. These results will be reported in due course. 
4.8 Experimental Details 
All air and or moisture sensitive transformations were performed in a flame dried 
flask or sealed Schlenk tube under a positive pressure of argon or nitrogen. 
Dichloromethane, toluene, and tetrahydrofuran were purified by passage through a 
column of activated alumina, anhydrous isopropyl alcohol was purchased and used 
without further purification. All commercial reagents were purchased and used without 
further purification. Non-commercial starting compounds and title products were 
purified using silica gel column chromatography with Siliaflash-P60 (40-63 μm) or silica 
gel N 60 (40-100 μm) silica gel. Racemic standards were purified using semi-preparative 
thin layer chromatography (silica gel 60 F254). TLC analysis (0.25 mm silica gel 60 F254 
precoated glass plates) employing UV light and phosphomolybdic acid or ceric 
ammonium molybdate stains.  
Infrared spectra were recorded using a Thermo Nicolet iS5. ESI-MS spectra were 
obtained using a Bruker microTOF-QII-RSL. 1H and 13C NMR spectra were recorded at 
room temperature using a JEOL JNM-ECS-400 (1H at 400 MHz and 13C at 100 MHz), a 
Bruker DRX 600 (1H at 600 MHz and 13C at 151 MHz), and a Bruker 500 (1H at 500 MHz 
and 13C at 125 MHz).  Proton and carbon chemical shifts are reported relative to CHCl3 as 
an internal reference (1H at 7.26 ppm and 13C at 77.0 ppm).1H NMR data are listed by 
chemical shift, multiplicity (s = singlet, br s = broad singlet, d = doublet, dd = doublet of 
doublets, ddd = doublet of doublet of doublets, t = triplet, app t = apparent triplet, dt = 
doublet of triplets, m = multiplet), coupling constants, and normalized integration. 
Enantiomeric ratios of enantioenriched products were determined by chiral HPLC 
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analysis using a chiral stationary phase (Daicel CHIRALPAK IA) on a JASCO HPLC 
system or a Perkin Elmer flexar photodiode array (PDA) system.  
α-Keto Esters 10 and hydroximoyl chlorides 12 and were prepared according to 
literature procedures. Triethylamine was purified by distillation and stored over 4Å 
molecular sieves. Ligands 3, and 16-23 were prepared via known literature methods. In 
all transformations M(OAc)2 refers to the hydrate: Ni(OAc)2·4H2O or Cu(OAc)2·H2O were 
purchased and used without further purification.  
Density functional theory (DFT) calculations were performed for singlet 
configurations using the Gaussian 09 program package.27 All geometry optimizations 
and vibrational analyses were carried out using the M06-2X functional with the 6-
311+G(d) basis set.28 
We recently reported that the (E)-cyclic nitrone and (E)-aliphatic nitrone serve as 
the 1,3-dipole in the [3+2] cycloaddition of a-keto ester enolate using Ni(II)–diamine 
catalyst.16 To broaden the available 1,3-dipolalopihle in our catalytic strategy using 
metal–diamine–acetate complex, we performed DFT calculations. Initial theoretical 
calculations suggest that the both HOMO (highest occupied molecular orbital) and LUMO 
(lowest unoccupied molecular orbital) of DFT-nitrile oxide (HOMO: –8.12 eV and 
LUMO: –0.816 eV) is between those of DFT-(E)-cyclic nitrone (HOMO: –7.09 eV and 
LUMO: –0.831 eV) and DFT-(E)-aliphatic nitrone (HOMO: –8.19 and LUMO: –1.06 
eV). On the basis of these preliminary results, we planned to apply the nitrile oxide, which 
can be prepared from N-hydroxyimidoyl chloride 12, in the catalytic asymmetric [3+2] 
cycloaddition of α-keto ester enolate. 
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Cartesian coordinates (in Å) and energy of DFT-(E)-cyclic nitrone 
SCF Done: E(RM062X) = –478.203232680 A.U. 
----------------------------------------------------------------------------------- 
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 Center        Atomic      Atomic             Coordinates (Angstroms) 
 number     number       type               X                     Y                    Z 
----------------------------------------------------------------------------------- 
      1              6               0           2.922814    0.383181    0.094680 
      2              6               0           2.705703   -0.991316    0.101682 
      3              6               0           1.413192   -1.492112    0.011215 
      4              6               0           0.326763   -0.619201   -0.086461 
      5              6               0           0.547528    0.766311   -0.107669 
      6              6               0           1.842464    1.256079   -0.013401 
      7              6               0          -1.032338   -1.132314   -0.178781 
      8              7               0          -2.074896   -0.376467    0.026379 
      9              6               0          -1.872710    1.050441    0.397731 
     10             6               0          -0.662088    1.641377   -0.302281 
     11             8               0          -3.271945   -0.777295    0.004779 
     12             1               0           3.930291    0.775847    0.169878 
     13             1               0           3.543611   -1.674352    0.181284 
     14             1               0           1.239796   -2.563308    0.023139 
     15             1               0           2.010599    2.328551   -0.030586 
     16             1               0          -1.247255   -2.174674   -0.377007 
     17             1               0          -1.763601    1.066419    1.485770 
     18             1               0          -2.803222    1.543955    0.128730 
     19             1               0          -0.484147    2.652169    0.070643 
     20             1               0          -0.874212    1.724353   -1.375023 
----------------------------------------------------------------------------------- 
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Cartesian coordinates (in Å) and energy of DFT-(E)-aliphatic nitrone 
SCF Done: E(RM062X) = –554.849139711 A.U. 
----------------------------------------------------------------------------------- 
 Center        Atomic      Atomic             Coordinates (Angstroms) 
 number     number       type               X                     Y                    Z 
----------------------------------------------------------------------------------- 
      1               8              0           0.285081   -1.302380   -0.004865 
      2               6              0           0.289075   -0.092934   -0.003426 
      3               8              0          -0.802577    0.680119   -0.002377 
      4               6              0           1.472069    0.773757   -0.002792 
      5               7              0           2.705508    0.327118    0.000607 
      6               8              0           3.692146    1.092210   -0.000254 
      7               6              0          -2.141861    0.095245    0.000863 
      8               6              0          -3.042865    1.322246   -0.000627 
      9               6              0          -2.358343   -0.730046   -1.262967 
     10              6              0          -2.353233   -0.723541    1.269731 
     11              6              0           3.025052   -1.124120    0.004035 
     12              1              0           1.365207    1.847844   -0.005266 
     13              1              0          -4.091050    1.017194    0.003657 
     14              1              0          -2.854230    1.935413    0.882483 
     15              1              0          -2.859830    1.929177   -0.889231 
     16              1              0          -3.409795   -1.020349   -1.325589 
     17              1              0          -1.749344   -1.632138   -1.265035 
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     18              1              0          -2.118445   -0.135862   -2.147865 
     19              1              0          -2.113688   -0.123577    2.150822 
     20              1              0          -3.403439   -1.017440    1.336120 
     21              1              0          -1.741109   -1.623575    1.275455 
     22              1              0           2.578085   -1.592779    0.876529 
     23              1              0           4.108196   -1.171127    0.024799 
     24              1              0           2.614319   -1.585837   -0.890069 
 ----------------------------------------------------------------------------------- 
 
Cartesian coordinates (in Å) and energy of DFT-(E)-nitrile oxide 
SCF Done: E(RM062X) = –399.567943760 A.U. 
----------------------------------------------------------------------------------- 
 Center        Atomic      Atomic             Coordinates (Angstroms) 
 number     number       type               X                     Y                    Z 
----------------------------------------------------------------------------------- 
      1               8              0           3.832095    0.000201    0.000115 
      2               7              0           2.626621   -0.000092   -0.000012 
      3               6              0           1.472116   -0.000321   -0.000146 
      4               6              0           0.040804   -0.000403   -0.000119 
      5               6              0          -0.658599   -1.212208    0.000009 
      6               6              0          -2.046497   -1.205384    0.000017 
      7               6              0          -2.741692    0.000356    0.000048 
      8               1              0          -2.586617   -2.144876    0.000053 
      9               1              0          -3.825500    0.000597    0.000109 
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     10              6              0          -2.045927    1.205822    0.000016 
     11              6              0          -0.658071    1.211874    0.000007 
     12              1              0          -2.585635    2.145556    0.000062 
     13              1              0          -0.108557    2.145558   -0.000030 
     14              1              0          -0.109605   -2.146217   -0.000029 
 ----------------------------------------------------------------------------------- 
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Table 4-2 Additional Screening Experiments with Ni(II)a 
 
  
entry ligand solvent yield 3a 
[%]c 
Ratiod 3:4:5 dr (3a)d ee major 
[%]e 
1f 16 THF 34  1:0.3:1 11:1g –82 
2f 17 THF 20  1:1:1 11:1 g –53 
3f 16 DCM 22  1:0.3:1 18:1 n.d. 
4f 16 PhMe 25  1:0.6:1 13:1 n.d. 
5f 16 DMF 65  10:1:1 11:1 –58 
6f 16 iPrOH 24j 1:_:2 13:1 –78 
7f,i, 16 DMF/THFk 51j 4:1:0.3 12:1 –66 
8f,i, 16 MeCN 51j 2:_:1 11:1 –76 
9f,i 16 MeOH 40j 2:1:0.5 11:1 –66 
10f,i 16 DMF/NMPk 67j 11:_:1 14:1 –64 
11f,i 16 DMF/iPrOHk 71j 11:_:1 9:1 –60 
12f,i 16 DMF/H2Ok < 13j 1:6:0.5 >10:1 –60 
13f,i 16 DMF/TBMEk < 57j 2:1:0.5 10:1 –64 
14f,i,l 16 DMF/THFk n.d. n.d. n.d. –60 
15f,i,m 16 DMF/THFk 61j 12:1:1 11:1 –66 
16f,i,n 16 DMF/THFk 20j 10:_:1 n.d. –60 
17f,i,o 16 DMF/THFk <25j 1:1:_ n.d. 0 
18f,i,p 16 DMF/THFk trace n.d. n.d. n.d. 
19i,q 27 DMF 22j 1:2:1 14:1 –12 
20i,q 28 DMF 47j 5:1:1 11:1 –44 
21i,q 29 DMF 63j 11:_:1 11:1 –58 
22i,q 30 DMF 54j 10:_:1 17:1 –62 
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a) Reactions were run on 0.1 mmol scale; Ni(OAc)2 refers to hydrate. b) 20 mol % ligand 
and Ni(OAc)2 were used unless otherwise noted. c) Isolated yield unless otherwise noted. 
d) Determined by 1H NMR analysis of crude reaction mixture, unless noted otherwise, 
n.d. = not determined. e) HPLC analysis using chiral stationary phase, n.d. = not 
determined. f) Isolated complex used. g)  Isolated dr. h) _ = not observed i) 24 h reaction 
time. j) NMR yield using mesitylene as internal standard. k) DMF/solv = 1:1 l) 3.6 equiv 
Hünig’s base used in place of Et3N. m) 3.6 equiv iPr2NH used in place of Et3N. n) 3.6 equiv 
of DBU used in place of Et3N o) 3.6 equiv TMEDA used in place of Et3N. p) 3.6 equiv equiv 
2,6-lutidine used in place of Et3N. q) Catalyst complexed in situ. 
 
 
Discussion: DMF afforded a large enhancement in chemoselectivity for the desired [3+2] 
over the O-imidoylation pathway. Mixed solvent systems employing DMF with less polar 
solvents afforded high chemoselectivity and the enantioselectivity was higher than when 
DMF was used alone as solvent. Unfortunately, further screening of parameters including 
23f,i 3 DMF/MeCNk < 80j 4:_:1 12:1 –30 
24i,q 21 THF 24 1:0.2:1 13:1g –60 
25i,q 31 THF 25 2:1:1 10:1g –40 
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the identity of the amine base and chiral ligand failed to provide satisfactory 
enhancements in enantioselectivity.  
 
 
IV. Preparation of a-Keto Esters  
General procedure A :9fStep 1: To a solution of oxalyl chloride (distilled, 1.02 equiv) 
in THF (0.63 M relative to alcohol) was added alcohol (1.0 equiv) at 0 °C under an N2 
atmosphere. The mixture was stirred for 1 h at 0 °C, then N,O-dimethylhydroxylamine 
hydrochloride (1.02 equiv) and triethylamine (3.0 equiv) were added, and the solution 
was further stirred for 2 h. The reaction was quenched with saturated NH4Claq, and THF 
in the resulting mixture was evaporated under reduced pressure. The aqueous layer was 
extracted with ethyl acetate (100 mL x 3). The combined organic layers were washed with 
water (100 mL) and brine (100 mL), dried over Na2SO4, and concentrated under reduced 
pressure. The residue was purified by column chromatography (SiO2) to give N-methoxy-
N-methylamide. Step 2: To a solution of magnesium turnings (972 mg, 40.0 mmol) in 
diethyl ether were added pieces of iodine. A solution of alkyl bromide (1.5 equiv.) in 
diethyl ether was added dropwise over 30 min at 0 °C. The reaction mixture was stirred 
for 1 h to give the Grignard solution. The Grignard solution was added dropwise to a 
solution of N-methoxy-N-methylamide (1.0 equiv), which prepared in step 1, in 
dichloromethane over 30 min at –78 °C. The mixture was stirred at –78 °C for 1.5 h and 
then the reaction was quenched with saturated aqueous NH4Claq. The aqueous layer was 
extracted with dichloromethane (50 mL x 3). The combined organic layer was washed 
with brine (100 mL), dried over Na2SO4, and concentrated under reduced pressure. The 
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residue was purified by column chromatography, and distilled or recrystallized to give the 
a-keto ester. 
 
Procedure B: Synthesis of tert-butyl 2-oxo-5-
phenylpentanoate (10p): Step 1:29 Ethyl 2-oxo-5-
phenylpentanoate 1p’ (1.00 g, 4.54 mmol) was dissolved in methanol (4.0 mL). Next, 3 M 
sodium hydroxide (4.0 mL) was added at room temperature resulting in an exotherm and 
solidification of the reaction mixture, which was left to stand for 12 h. The mixture was 
quenched with 3M HCl (5.0 mL), extracted with methylene chloride, and dried over 
anhydrous magnesium sulfate. Step 2: The crude α-keto acid from step 1 was dissolved 
in tetrahydrofuran (9.1 mL) and a small drop of N,N-dimethylformamide was added. The 
resulting solution was cooled to 0 °C using an ice bath and oxalyl chloride (0.58 mL, 864 
mg, 6.81 mmol) was slowly added. The reaction was stirred for 12 h at room temperature 
and concentrated. Step 3: The crude α-keto acid chloride from step 2 was slowly added 
to a solution of tBuOH (1.01 g, 13.6 mmol) and pyridine (0.73 mL, 718 mg, 9.08 mmol) in 
methylene chloride (9.1 mL) cooled to 0 °C using an ice bath. The reaction was stirred for 
24 h and diluted with water. The aqueous phase was extracted several times with ethyl 
acetate and the combined organic layers were dried over anhydrous magnesium sulfate. 
Silica gel column chromatography (2.5% ethyl acetate/hexanes as eluent) afforded the 
desired product as colorless oil (437 mg, 1.76 mmol, 39% yield over 3 steps). 1H NMR 
(500 MHz, CDCl3): δ 7.31–7.28 (m, 2H), 7.21–7.17 (m, 3H), 2.79 (t, J = 7.2 Hz, 2H), 2.66 
(t, J = 7.5 Hz, 2H), 1.98–1.92 (m, 2H), 1.53 (s, 9H). 
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Preparation of tert-butyl 2-oxo-3-(m-tolyl)propanoate: tert-Butyl 3-chloro-2-
oxo-3-(m-tolyl)propanoate 32 (640 mg, 2.38 mmol) was dissolved in chloroform (6.0 
mL) in a 20 mL scintillation vial equipped with a stir bar. Benzothiazoline 33 was added 
(610 mg, 2.86 mmol, 1.2 equiv). The homogenous solution was stirred at room 
temperature for 1 h and concentrated. Silica gel column using DCM as eluent afforded the 
title compound 34 as a light yellow oil (482 mg, 2.06 mmol, 86% yield, approximately 
90% purity). The product is depicted as the keto form, but exists as a tautomeric mixture 
of enol and keto isomers. Analytical data for 34: 1H NMR: (2.5:1 keto:enol, benzyl 
methylene of keto normalized to 2H, 500 MHz, CDCl3): δ 7.58 – 7.56 (m, 2H, enol), 7.28–
7.2 (m, 2H, enol), 7.10–7.01 (m, 4H, keto), 6.55 (s, 1H, enol), 6.40 (s, 1H, enol), 4.0 (s, 
2H, keto), 2.36 (s, 3H, enol), 2.33 (s, 3H, keto), 1.58 (s, 9H, enol), 1.47 (s, 9H, keto); 13C 
NMR (2.5:1 keto: enol): CDCl3, 150 MHz): 192.7, 165.4, 160.5, 140.0, 138.4, 137.9, 135.3, 
134.2, 131.8, 130.5, 130.4, 128.6, 128.5, 128.3, 128.1, 126.9, 126.8,  109.7, 84.2, 83.3, 45.8, 
28.0, 27.7,21.5, 21.3; HRMS (ESI): Calcd. for C14H18O3 ([M+Na]): 257.1154, Found: 
257.1147. 
 
References describing preparation of known substrates and their corresponding 
analytical data are found below. α-Keto esters are numbered in accord with which product 
described in the main text they first appear in: 
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Prepared via general procedure A  
Reference 9f 
 
Prepared via modified literature 
procedure from 2-ketoglutaric acid: 
Reference 30 
 
Prepared via Procedure B starting 
from the corresponding known ethyl 
ester.  
Procedure B adapted from: 
Reference 29   
 
Prepared via general procedure A  
Reference 31 
 
Prepared via general procedure A  
9f 
 
Prepared via known literature 
procedure: 
Reference 32 
 
Prepared via general procedure A  
Reference 33 
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Reference 9i 
 
Reference 34 
 
Prepared as described above.  
 
Reference 9f 
 
Reference 35 
 
General procedure C: preparation of hydroximoyl chlorides: All hydroximoyl 
chlorides are known compounds that were synthesized from commercially available 
aldehydes according to the procedure that follows. Step 1: aldehyde (1.0 equiv) was 
added to a solution of sodium acetate (3.0 equivalents) and hydroxylamine hydrochloride 
in 1:1 ethanol:water (0.5 M relative to aldehyde) at room temperature. The solution was 
stirred at this temperature until completion was indicated by TLC. The reaction was then 
diluted with water and extracted three times with methylene chloride. The combined 
organic extracts were dried over MgSO4 and concentrated. Note: In the case of 
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hydroximoyl chlorides 12d, 12j and 12l the oxime precipitated from the reaction mixture 
in step 1 and was collected via filtration in lieu of an aqueous work-up. Step 2: Without 
further purification, the resulting material was dissolved in DMF (1.2 M relative to 
aldehyde) and cooled in an ice bath. Next, N-chlorosuccinimide was added in a single 
portion and the reaction was stirred for 12-14 h. Upon completion, as indicated by TLC, 
the reaction mixture was diluted with ether or ethyl acetate. The organic layer was then 
washed three times with water, and three times with brine to remove succinimide and 
DMF. The organic layer was dried over MgSO4 and concentrated to afford the 
corresponding N-hydroxyimidoyl chloride as an off white solid that could be used in the 
title reaction without further purification.  
 
References describing preparation of known substrates and their corresponding 
analytical data are found below. N-Hydroxyimidoyl chlorides are numbered in accord 
with which product described in the main text they first appear in: 
 
 
 
Prepared via general procedure C  
Reference 36 
 
Prepared via general procedure C  
Reference 37 
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Prepared via general procedure C  
Reference 38 
 
Prepared via general procedure C  
Reference 39 
 
Prepared via general procedure C  
Reference 37 
 
Prepared via general procedure C  
Reference 40 
 
Prepared via general procedure C  
Reference 36 
 
Prepared via general procedure C 
Reference 37 
 
Prepared via general procedure C  
Reference 36 
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Prepared via general procedure C 
Reference 41 
 
Prepared via general procedure C 
Reference 42 
 
Prepared via general procedure C 
Reference 37 
 
Prepared via general procedure C  
Reference 36 
 
Prepared via general procedure C 
 
 
 
Ligand 21:  (1R,2R)-diaminocyclohexane (512 mg, 4.48 mmol) was dissolved in MeOH, 
mesitaldehyde (1.395 g, 9.42 mmol, 1.39 mL) was then added and the 
solution was heated to reflux for 17.5 h. Once the solution had reached 
room temperature, sodium borohydride was added in portions. Once 
cessation of gas evolution occurred, the solution was heated to reflux 
for an additional 6 h and diluted with water. Finally, the resulting solid was collected by 
filtration, while rinsing with H2O, and purified by recrystallization from methanol 
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affording (1R,2R)-N1,N2-bis(2,4,6-trimethylbenzyl)cyclohexane-1,2-diamine 21 as a 
white solid (995 mg, 2.63 mmol, 59% yield). The spectral data for this compound were in 
agreement with reported literature values. 
 
Ligand 22: Diamine ligand 22 is a known compound that can be 
prepared using the procedure that follows: (1R,2R)-Diaminocyclohexane 
(300 mg, 2.63 mmol) was dissolved in MeOH (20.0 mL). Next, 2-
trifluoromethylbenzaldehyde (938 mg, 711 μL, 5.39 mmol) was added and 
the solution was heated at reflux for 3 h. The solution was then cooled to room 
temperature and sodium borohydride (298 mg, 7.88 mmol) was added in portions. Once 
all the sodium borohydride had been added and the evolution of gas had ceased the 
reaction was heated at 40 °C for 12 h, cooled to room temperature and diluted with water 
(100 mL). The aqueous layer was extracted three times with DCM (20 mL each extraction) 
and the combined organic layers dried over Na2SO4. Concentration of the organic layers 
and purification of the residue by silica gel column chromatography (50% hexane:ethyl 
acetate) afforded (1R,2R)-N1,N2-bis(2-(trifluoromethyl)benzyl)cyclohexane-1,2-diamine 
22 as a colorless oil (501 mg, 1.16 mmol, 44% yield). The spectral data for this compound 
was in agreement with reported literature values.  
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Ligand 23: Ligand 22 (343 mg, 0.80 mmol) was dissolved in MeOH (8.0 mL, 0.1 M), in 
a 25 mL round-bottomed flask under an N2 atmosphere, paraformaldehyde (239 mg, 8.0 
mmol, 10 equiv) was added followed by NaCNBH3 (501 mg, 0.80 mmol, 10 equiv). The 
mixture was stirred for 48 h at room temperature. Upon complete consumption of ligand 
22, as indicated by TLC analysis, 10.0 mL of saturated aqueous NaHCO3 was added and 
the resulting solution was extracted several times with ethyl acetate. The combined 
organic phase was washed with brine and dried over sodium sulfate. The crude material 
was purified by silica gel column chromatography (2.5% MeOH/DCM) affording Ligand 
23 as a clear oil (165 mg, 0.36 mmol, 45% yield). Analytical data for ligand 23: 1H NMR 
(CDCl3, 500 MHz): δ 8.01 (d, J = 7.9 Hz, 2H), 7.62 (d, J = 7.9 Hz, 2H), 7.47–7.44 (m, 2H), 
7.32–7.29 (m, 2H), 3.97 (d, J = 15.4 Hz, 2H), 3.87 (d, J = 15.3 Hz, 2H), 2.73–2.67 (m, 2H), 
2.23 (s, 6H), 2.05–2.02 (m, 2H), 1.82–1.80 (m, 2H), 1.37– 1.33 (m, 2H), 1.26–1.20 (m, 
2H); 13C NMR (CDCl3, 125 MHz): δ 140.0, 131.6, 130.3, 128.1 (q, J19F-13C = 29.9 Hz), 126.2, 
125.2 (q, J19F-13C = 5.7 Hz), 124.7 (q, J19F-13C = 272.3 Hz), 64.9, 54.3, 35.7, 26.1, 25.8; HRMS 
(ESI): Calcd. for C24H28F6N2 ([M+H]): 459.2235, Found: 459.2200. 
 
 
Reference 43 
Note: We advise using the procedure 
described in reference 23 for 1,2-
diphenylethylene diamine derived 
benzyl-type ligands; racemization is 
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observed when the reductive 
amination procedure is employed. 
 
Reference 16 
 
Reference 44, Reference 9f 
 
 
 
 
Reference 45 
 
Reference 45 
 
Reference 9h  
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Reference 45 
 
Reference 46 
 
Reference 47 
 
 
 
 
 
Ligand 21 or 22 (1.0 equiv) was dissolved in iPrOH (0.05 M). Copper(II) acetate 
monohydrate (1.0 equiv) was then added and the resulting suspension was stirred for 4 
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to 6 h at room temperature, eventually producing a homogenous blue solution which was 
filtered through celite with DCM and concentrated to yield blue powder. Isolated 1:1 
complexes of ligands 21 and 22 were air and moisture tolerant and both could be stored 
on the bench for months without noticeable decline in appearance or catalytic 
performance.  
  
General Procedure E: Asymmetric [3+2] cycloaddition (solid α-keto esters): 
To a flame dried Schlenk tube under N2 was added iPrOH (2.0 mL) followed by the N-
hydroxyimidoyl chloride (1.5 equiv, 0. 30 mmol). The resulting solution was cooled to 0 
°C using an ice bath. Triethylamine (2.5 equiv, 0.5 mmol, 70 μL) slowly added (usually 
resulting in immediate precipitation of triethylammonium chloride) and the solution was 
stirred for 10 min at 0 °C. The resulting nitrile oxide was cooled to –78 °C using a dry 
ice/acetone bath and the solid α-keto ester (0.2 mmol) and copper complex (0.01 mmol)* 
were added successively. The reaction was warmed to –40 °C and stirred under an 
atmosphere of nitrogen or argon while monitoring periodically for completion by TLC 
analysis using phosphomolybdic acid to stain. Upon completion the reaction mixture was 
passed through a thin plug of silica gel, concentrated, and purified by silica gel column 
chromatography. Individual reaction times are indicated along with the analytical data 
below.  
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General Procedure F: Asymmetric [3+2] cycloaddition (liquid/oil α-keto 
esters): To a flame dried Schlenk tube under N2 was added iPrOH (1.0 mL) followed by 
the N-hydroxyimidoyl chloride (1.5 equiv, 0. 30 mmol). The resulting solution was cooled 
to 0 °C using an ice bath. Triethylamine (2.5 equiv, 0.5 mmol, 70 μL) slowly added 
(usually resulting in immediate precipitation of triethylammonium chloride) and the 
solution was stirred for 10 min at 0 °C. Next, the resulting nitrile oxide was cooled to –78 
°C using a dry ice/acetone bath and the α-keto ester (0.2 mmol, 0.2 M solution in iPrOH) 
and copper complex (0.01 mmol)* were added successively. The reaction was warmed to 
–40 °C and stirred under an atmosphere of nitrogen or argon while monitoring 
periodically for completion by TLC analysis using phosphomolybdic acid to stain. Upon 
completion the reaction mixture was passed through a thin plug of silica gel, 
concentrated, and purified by silica gel column chromatography. Individual reaction 
times are indicated along with the analytical data below.  
 
*Calculated assuming complexation of Cu(OAc)2·H2O (1 equiv) with ligand 21 and 22 (1 
equiv) results in complexes with formulae C30H44CuN2O4 and C26H30CuF6N2O4, 
respectively. Inclusion of a molecule of water into the formula for ligand 21 and ligand 22 
changes the mass by 3.11% and 2.86%, respectively. Calculating catalyst loading on the 
basis of either formula should not significantly influence reaction performance.  
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tert-butyl (4S,5S)-4-benzyl-5-hydroxy-3-phenyl-4,5-
dihydroisoxazole-5-carboxylate (13a): The title compound was 
prepared according to General Procedure E on 0.1 mmol scale. Reaction 
times = 48 h (Table 1, entries 16 and 17). The diastereoselectivity was determined by 
analysis of the crude 1H NMR spectrum by the relative integration of the methine 
resonances at δ 4.45 (major diastereomer) and δ 4.32 (minor diastereomer): 11:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
yielded a colorless oil, isolated dr = 11:1. The diastereomers of 13a were inseparable. 
Analytical data for 13a (major): 1H NMR (400 MHz, CDCl3, major diastereomer): δ 7.61–
7.68 (m, 2H), 7.45–7.49 (m, 3H), 7.17– 7.28, 4.79 (br s, 1H), 4.10–4.49 (m, 1H), 3.03–
3.11 (m, 2H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 167.4, 
159.9, 138.8, 130.2, 128.8, 128.6, 128.8, 128.4, 127.7, 126.5, 103.0, 84.8, 54.6, 30.7, 27.4; 
IR (thin film): 3468, 2980, 1729, 1497, 1476, 1140, 1066, 895 cm-1; TLC (70:30 
hexanes:EtOAc): Rf = 0.50; HRMS (ESI): Calcd. for C21H23NO4: ([M+Na]): 376.1525, 
Found: 376.1525; HPLC: IA, 90:10 hexanes/EtOH, flow rate = 1.0 mL/min, λ = 254 nm, 
tR (major) = 34.0 min, tR (minor) = 11.0 min, ligand 22: 96:4 er, ligand 21 95.5:4.5 er; [α]D = 
85.4 (c = 1.33, CHCl3, 92% ee, 11:1 diastereomeric mixture). 
tert-butyl (4S,5S)-4-benzyl-5-hydroxy-3-(4-
(trifluoromethyl)phenyl)-4,5-dihydroisoxazole-5-
carboxylate (13b): The title compound was prepared according to 
General Procedure C. Reaction time = 48 h. The diasteroselectivity 
was determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.45 (major diastereomer) and δ 4.28 (minor diastereomer): 10:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
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afforded a white solid, isolated dr = 9:1. The diastereomers of 13b were inseparable. 
Analytical data for 13b (major): mp = 110 °C; 1H NMR (400 MHz, CDCl3, major 
diastereomer): δ 7.75 (d, J = 8.4 Hz, 2H), 7.71 (d, J = 8.3 Hz, 2H), 7.17–7.29 (m, 5H), 4.89 
(br s, 1H), 4.45 (dd, J = 11.2, 4.2 Hz, 1H), 3.10 (dd, J = 14.2, 11.3 Hz, 1H), 3.02 (dd, J = 
14.2, 4.1 Hz, 1H), 1.32 (s, 9H); 13C NMR (150 MHz, CDCl3, major diastereomer): δ  167.1, 
159.0, 138.3, 132.2, 131.9 (q, J19F-13C = 32.6 Hz), 128.7, 128.5, 128.0, 126.7, 125.7 (q, J19F-
13C = 4.5 Hz), 123.7 (q, J19F-13C = 270.7 Hz), 103.4, 85.1, 54.2, 30.6, 27.4; IR (thin film): 
3469, 2982, 1732, 1165, 1073, 842 cm-1; TLC (70:30 hexanes/EtOAc): Rf = 0.53; HRMS 
(ESI): Calcd. for C22H22F3NO4: ([M+Na]): 444.1399, Found: 444.1369; HPLC: IA, 95:5 
hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 33.2 min, tR (minor) = 22.7 
min, Ligand 22: 95:5 er; [α]D = 99.7 (c = 1.14, CHCl3, 90% ee, 9:1 diastereomeric 
mixture). 
tert-butyl (4S,5S)-4-benzyl-3-(4-fluorophenyl)-5-hydroxy-4,5-
dihydroisoxazole-5-carboxylate (13c): The title compound was 
prepared according to General Procedure E. Reaction time = 48 h. The 
diastereoselectivity was determined by analysis of the crude 1H NMR by 
the relative integration of the methine resonances at δ 4.42 (major diastereomer) and δ 
4.25 (minor diastereomer): 10:1 dr. Purification by silica gel column chromatography 
using 90:10 hexanes/ethyl acetate afforded a colorless oil, isolated dr = 9:1. The 
diastereomers of 13c were inseparable. Analytical data for 13c (major): 1H NMR (400 
MHz, CDCl3, major diastereomer): δ 7.60–7.66 (m, 2H), 7.13–7.27 (m, 7H), 4.42 (dd, J = 
10.9, 4.5 Hz, 1H), 3.00–3.13 (m, 2H), 1.31 (s, 9H); 13C NMR (100 MHz, CDCl3, major 
diastereomer): δ 167.3, 163.8 (d, J19F-13C = 248.7 Hz), 159.0, 138.58, 129.68 (d, J19F-13C = 
8.0 Hz), 128.7, 128.5, 126.6, 124.8 (d, J19F-13C = 3.5 Hz), 116.0 (d, J19F-13C = 21.8 Hz), 103.1, 
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84.9, 54.5, 30.7, 27.4; IR (thin film): 1731, 1603, 1157, 837 cm-1; TLC (70:30 
hexanes/EtOAc): Rf = 0.50;  HRMS (ESI): Calcd. for C21H22FNO4: ([M+Na]): 394.1431, 
Found: 394.1406; HPLC: IA, ligand 22: 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ 
= 254 nm, tR (major) = 34.5 min, tR (minor) = 25.4 min, 95.5:4.5 er; [α]D = 84.7 (c = 1.48, 
CHCl3, 91% ee, 9:1 diastereomeric mixture).   
     
tert-butyl (4S,5S)-3-([1,1'-biphenyl]-4-yl)-4-benzyl-5-
hydroxy-4,5-dihydroisoxazole-5-carboxylate (13d): The title 
compound was prepared according to General Procedure E. Reaction 
time = 72 h. The diastereoselectivity was determined by analysis of the 
crude 1H NMR by the relative integration of the methine resonances at δ 4.50 (major 
diastereomer) and δ 4.36 (minor diastereomer): 11:1 dr. Purification by silica gel column 
chromatography using 90:10 hexanes/ethyl acetate afforded a colorless oil, isolated dr = 
10:1. The diastereomers of 13d were inseparable. Analytical data for 13d (major): 1H 
NMR (400 MHz, CDCl3, major diastereomer): δ 7.69–7.76 (m, 4H), 7.60–7.69 (m, 2H), 
7.37– 7.51 (m, 3H), 7.19–7.31 (m, 5H), 4.50 (m, 1H), 3.09–3.19 (m, 1H), 1.33 (s, 9H); 13C 
NMR (100 MHz, CDCl3, major diastereomer): δ 167.4, 159.6, 143.0, 140.1, 138.8, 138.0, 
128.9, 128.8, 128.4, 128.1, 127.9, 127.4, 127.1, 126.5, 103.1, 84.8, 54.6, 30.8, 27.4; IR (thin 
film): 3854, 3735, 3473, 2981, 2342, 1729, 1071, 840 cm-1; TLC (70:30 hexanes/EtOAc): 
Rf = 0.53; HRMS (ESI): Calcd. for C27H27NO4: ([M+Na]): 452.1838, Found: 452.1881; ; 
HPLC: IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 50.1 min, 
tR (minor) = 37.5 min, ligand 21: 94:6 er; ; [α]D = 85.6 (c = 1.64, CHCl3, 88% ee, 10:1 
diastereomeric mixture).   
 148 
 
tert-butyl (4S,5S)-4-benzyl-5-hydroxy-3-(p-tolyl)-4,5-
dihydroisoxazole-5-carboxylate (13e): The title compound was 
prepared according to General Procedure E. Reaction times = 72 h 
(Table 2, entry 5) and 48h (Table 2, entry 6). The diastereoselectivity 
was determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.43 (major diastereomer) and δ 4.31 (minor diastereomer): 13:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded a colorless oil, isolated dr = 11:1. The diastereomers of 13e were inseparable. 
Analytical data for 13e (major): 1H NMR (400 MHz, CDCl3, major diastereomer): δ 
7.50–7.58 (m, 2H), 7.22–7.40 (m, 7H), 4.78 (br s, 1H), 4.39–4.49  (m, 1H), 3.00–3.13 (m, 
2H), 2.41 (s, 3H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 167.5, 
159.8, 140.42, 138.9, 129.5, 128.8, 128.4, 127.6, 126.5, 125.7, 102.9, 84.7, 54.7, 30.8, 27.4, 
21.4; IR (thin film):  1734, 1663, 1313, 1159, 822 cm-1; TLC (70:30 hexanes/EtOAc): Rf = 
0.47; HRMS (ESI): Calcd. for C22H25NO4: ([M+Na]): 390.1681, Found: 390.1692; 
HPLC: IA, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 22.4 
min, tR (minor) = 15.0 min, ligand 21: 95:5 er; ; [α]D = 83.8 (c = 1.33, CHCl3, 90% ee, 11:1 
diastereomeric mixture). 
tert-butyl (4S,5S)-4-benzyl-3-(2-fluorophenyl)-5-hydroxy-
4,5-dihydroisoxazole-5-carboxylate (13f): The title compound 
was prepared according to General Procedure E. Reaction times = 44 h 
(ligand 21) and 48 h (ligand 22). The diastereoselectivity was determined by analysis of 
the crude 1H NMR by the relative integration of the methine resonances at δ 4.54 (major 
diastereomer) and δ 4.48 (minor diastereomer): >20:1 dr. Purification by silica gel 
column chromatography using 90:10 hexanes/ethyl acetate afforded a colorless oil, 
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isolated dr >20:1. Analytical data for 13f: 1H NMR (400 MHz, CDCl3, major): δ 7.68–
7.74 (m, 1H), 7.45–7.52 (m, 1H), 7.15–7.30 (m, 7H), 4.85 (br s, 1H), 4.54 (ddd, J = 11.9, 
2.9, 2.9 Hz, 1H), 3.00 (dd, J = 13.6, 12.0 Hz, 1H), 2.90 (ddd, J = 13.6, 3.3, 2.0 Hz, 1H), 
1.27 (s, 9H); 13C NMR (100 MHz, CDCl3, major): δ 167.3, 159.9 (d, J19F-13C = 247.7 Hz), 
157.7, 138.8, 132.3 (d, J19F-13C = 8.5 Hz), 130.6 (d, J19F-13C = 3.5 Hz), 128.8, 128.3, 126.4, 
124.9 (d, J19F-13C = 3.5 Hz), 116.8 (d, J19F-13C = 13.1 Hz), 116.1 (d, J19F-13C = 21.2 Hz), 103.0, 
84.7, 56.2 (d, J19F-13C = 3.6 Hz), 30.3 (d, J19F-13C = 2.4 Hz), 27.3; IR (thin film): 3467, 2980, 
1731, 1240, 1141, 859 cm-1; TLC (70:30 hexanes/EtOAc): Rf = 0.67; HRMS (ESI): Calcd. 
for C21H22FNO4: ([M+Na]): 394.1431, Found: 394.1402; HPLC: IA, 95:5 hexanes/iPrOH, 
flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 28.7 min, tR (minor) = 20.6 min, ligand 22: 
96:4 er; [α]D = 108.8 (c = 1.06, CHCl3, 92% ee, >20:1 dr).   
tert-butyl (4S,5S)-4-benzyl-5-hydroxy-3-(2-methoxyphenyl)-
4,5-dihydroisoxazole-5-carboxylate (13g): The title compound 
was prepared according to General Procedure E. Reaction times = 48 h 
(ligands 21 and 22). The diastereoselectivity was determined by analysis 
of the crude 1H NMR by the relative integration of the methine resonances at δ 4.65 
(major diastereomer) and δ 4.37 (minor diastereomer): >20:1 dr. Purification by silica gel 
column chromatography using 90:10 hexanes/ethyl acetate afforded a colorless oil, 
isolated dr = 20:1 dr. Analytical data for 13g: 1H NMR (400 MHz, CDCl3, major 
diastereomer): δ 7.59 (dd, J = 7.5, 1.6 Hz, 1H), 7.42–7.47 (m, 1H), 7.12–7.27 (m, 5H), 
7.01–7.07 (m, 1H), 6.97 (d, J = 8.3 Hz, 1H), 4.68 (br s, 1H), 4.65 (dd, J = 11.8, 3.5 Hz, 1H), 
3.94 (s, 1H), 2.92 (dd, J = 13.5, 11.8 Hz, 1H), 2.79 (dd, 13.5, 3.5 Hz, 1H), 1.28 (s, 9H); 13C 
NMR (100 MHz, CDCl3, major diastereomer): δ 167.5, 160.5, 157.0, 139.4, 131.7, 130.8, 
128.7, 128.3, 126.2, 121.1, 117.7, 110.9, 102.7, 84.4, 56.5, 55.5, 30.3, 27.3; IR (thin film): 
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3467, 2979, 1728, 1601, 1142, 1063, 982 cm-1; TLC (90:10 hexanes/EtOAc): Rf = 0.15; 
HRMS (ESI): Calcd. for C22H25NO5: ([M+Na]): 406.1630, Found: 406.1648; HPLC: IA, 
90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 17.3 min, tR (minor) = 
23.0min, ligand 22: 96:4 er; [α]D = 74.8 (c =1.33, CHCl3, 92% ee, 20:1 dr).  
tert-butyl (4S,5S)-4-benzyl-5-hydroxy-3-(o-tolyl)-4,5-
dihydroisoxazole-5-carboxylate (13h): The title compound was 
prepared according to General Procedure E. Reaction times = 48 h 
(ligand 21) and 60 h (ligand 22). The diastereoselectivity was 
determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.42 (major diastereomer) and δ 4.32 (minor diastereomer): >20:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded a colorless oil, isolated dr >20:1. Analytical data for 13h (major): 1H NMR (400 
MHz, CDCl3, major diastereomer): δ 7.11– 7.38 (m, 9H), 4.74 (br s, 1H), 4.42 (dd, J = 12.1, 
3.6 Hz, 1H), 2.99 (dd, J = 13.9, 12.1 Hz, 1H), 2.70 (dd, J = 13.9, 3.6 Hz, 1H), 2.47 (s, 3H), 
1.30 (s, 9H) ; 13C NMR (100 MHz, CDCl3, major diastereomer): δ 167.4, 160.7, 138.62, 
137.2, 130.9, 129.6, 128.9, 128.7, 128.4, 128.0, 126.4, 125.9, 102.3, 84.6, 57.0, 30.3, 27.4, 
20.3; IR (thin film): 3467, 2979, 2361, 1730, 1142, 1065, 893 cm-1; TLC 
(70:30hexanes/EtOAc): Rf = 0.56; HRMS (ESI): Calcd. for C22H25NO4: ([M+Na]): 
390.1681, Found: 390.1661; HPLC: IA, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ 
= 254 nm, tR (major) = 28.3 min, tR (minor) = 15.0 min, ligand 22: 95:5 er; [α]D = 83.1 (c = 
1.45, CHCl3, 90% ee, >20:1 dr).  
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tert-butyl (4S,5S)-4-benzyl-3-(2-bromophenyl)-5-hydroxy-
4,5-dihydroisoxazole-5-carboxylate (13i): The title compound 
was prepared according to General Procedure E. Reaction times = 48 h 
(ligands 21 and 22). The diastereoselectivity was determined by 
analysis of the crude 1H NMR by the relative integration of the methine resonances at δ 
4.85 (major diastereomer) and δ 4.68 (minor diastereomer): >20:1 dr. Purification by 
silica gel column chromatography using 90:10 hexanes/ethyl acetate afforded a colorless 
oil, isolated dr >20:1. Analytical data for 13i: 1H NMR (400 MHz, CDCl3, major): 7.64–
7.69 (m, 1H), 7.48–7.53 (m, 1H), 7.38–7.43 (m, 1H), 7.31–7.37 (m, 1H), 7.21–7.23  (m, 
4H), 7.13–7.18 (m, 1H), 4.86 (dd, J = 12.2, 3.5 Hz, 1H), 4.80 (br s, 1H), 2.88–2.94 (m, 
1H), 2.72 (dd, J = 13.7, 3.5 Hz), 1.28 (s, 9H); 13C NMR (100 MHz, CDCl3, major): δ 167.3, 
161.4, 138.6, 133.4, 132.1, 131.6, 130.3, 128.9, 128.5, 127.9, 126.6, 122.0, 103.0, 84.9, 56.2, 
30.2, 27.5; IR (thin film): 3469, 2980, 1731, 1143, 1062, 835 cm-1; TLC (70:30 
hexanes/EtOAc): Rf = 0.50; HRMS (ESI): Calcd. for C21H22BrNO4: ([M+Na]): 454.0630, 
Found: 454.0623; HPLC: IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, 
tR (major) = 25.4 min, tR (minor) = 30.1 min, ligand 22: 95.5:4.5 er; [α]D = 54.5 (c = 1.15, 
CHCl3, 91% ee, >20:1 dr).  
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-5-
hydroxy-3-(pyridin-3-yl)-4,5-dihydroisoxazole-5-
carboxylate (13j): The title compound was prepared according to 
General Procedure F. Reaction time = 168 h. The diastereoselectivity was determined by 
analysis of the crude 1H NMR by the relative integration of the methine resonances at δ 
4.51 (major diastereomer) and δ 4.14 (minor diastereomer): >20:1. Purification by silica 
gel column chromatography using 80:20 hexanes/ethyl acetate followed by 70:30 
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hexanes: EtOAc afforded a white solid, isolated dr >20:1. Analytical data for 13j: mp = 
135-137 °C ; 1H NMR (600 MHz, CDCl3, major diastereomer): δ 8.78 (d, J = 1.5 Hz, 1H), 
8.66 (dd, J = 4.8, 1.5 Hz, 1H), 7.93–7.96(m, 1H), 7.37 (dd, J = 7.6, 4.8 Hz, 1H), 5.60 (br s, 
1H), 4.51 (dd, J = 11.6, 4.1 Hz, 1H), 2.68 (dd, J = 17.2, 11.6 Hz, 1H), 2.61 (dd, 17.2, 4.1 Hz, 
1H), 1.55 (s, 9H), 1.38 (s, 9H); 13C NMR (151 MHz, CDCl3, major diastereomer): δ 170.3, 
167.5, 156.1, 151.0, 147.9, 134.8, 124.8, 123.7, 103.8, 84.8, 81.4, 48.5, 31.6, 27.8, 27.7; IR 
(thin film): 1733, 1679, 1489, 1395, 1153, 2359 cm-1; HRMS (ESI): Calcd. for C19H26N2O6: 
([M+H]): 379.1869, Found: 379.1866; TLC (70:30hexanes/EtOAc): Rf = 0.17; HPLC: IA, 
90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) = 11.6 min, tR (minor) = 
14.7 min, ligand 21: 87:13 er; [α]D = 158.2 (c = 3.42, CHCl3, 74% ee, >20:1 dr). 
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-5-
hydroxy-3-phenyl-4,5-dihydroisoxazole-5-carboxylate 
(13k):  The title compound was prepared according to General 
Procedure F on 0.2 on 0.2 mmol scale. Reaction time = 24 h. No 
resonances corresponding to the minor diastereomer were detected in the crude 1HNMR 
for 13k: >20:1 dr. Purification by silica gel column chromatography using 90:10 hexanes: 
EtOAc afforded a white solid, isolated dr > 20:1. Crystals suitable for x-ray analysis were 
produced by titrating a suspension of 13k in hot hexanes with ethyl acetate and allowing 
the resulting homogenous solution to stand at room temperature for 24 h. Analytical data 
for 13k: mp = 147-149 °C; 1H NMR (400 MHz, CDCl3, major diastereomer): δ 7.55 – 
7.60 (m, 2H), 7.40 – 7.44 (m, 3H), 5.06 (br s, 1H), 4.46–4.56 (m, 1H), 2.62–2.72 (m, 2H), 
1.57 (s, 9H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 170.8, 
168.0, 158.5, 130.2, 128.8, 128.4, 127.3, 103.3, 84.7, 81.2, 48.9, 31.9, 27.9, 27.7; IR (thin 
film): 3424, 2985, 2360, 2342, 1730, 1705, 1252, 1232, 1110, 842 cm-1; TLC (70:30 
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hexanes/EtOAc): Rf = 0.6; HRMS (ESI): Calcd. for C20H27NO6: ([M+Na]): 400.1736, 
Found: 400.1727; HPLC: IA, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 210 nm, 
tR (major) = 9.2, tR (minor) = 13.0 min, ligand 22: 96.5:3.5 er; [α]D = 79.5 (c = 1.43, CHCl3, 
90% ee, >20:1 dr). Note: the difference in enantiomeric ratio between the material used 
for optical rotation and the reported value (entry 14, Table 2) is due to the fact that this 
material was generated with ligand 21. 
 
 
tert-butyl (4S,5S)-3-(4-bromophenyl)-4-(2-(tert-butoxy)-
2-oxoethyl)-5-hydroxy-4,5-dihydroisoxazole-5-
carboxylate (13l): The title compound was prepared according to 
General Procedure F. Reaction time = 72 h. The diastereoselectivity 
was determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.46 (major diastereomer) and δ 4.29 (minor diastereomer): >20:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded a white solid, isolated dr >20:1. Analytical data for 13l: mp = 129-131 °C; 1H 
NMR (400 MHz, CDCl3, >20:1 dr): δ 7.54–7.58 (m, 2H), 7.43–7.47 
(m, 2H), 5.06 (br s, 1H), 4.46 (dd, J = 11.2, 4.4 Hz Hz, 1H), 2.66 
(dd, J = 17.2, 11.2 Hz, 1H), 2.58 (dd, J = 17.2, 4.4 Hz, 1H), 1.56 (s, 
9H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCl3, >20:1 dr): δ 170.6, 
167.8, 157.7, 132.2, 128.8, 127.4, 124.7,103.6, 84.9, 81.4, 48.6, 31.8, 27.9, 27.7; IR (thin 
film): 3459, 2984, 1736, 1719, 1368, 1143, 1010, 844 cm-1; TLC (90:10 hexanes/EtOAc): 
0.2; HRMS (ESI): Calcd. for C20H26BrNO6: ([M+Na]): 478.0841, Found: 478.0814; 
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HPLC: IA, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 15.3, tR 
(minor) = 11.1 min, ligand 21: 98:2 er; [α]D = 62.7 (c = 1.64, CHCl3, 96% ee, >20:1 dr). 
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-5-hydroxy-3-(p-tolyl)-4,5-
dihydroisoxazole-5-carboxylate (13m): The title compound was prepared 
according to General Procedure F. Reaction time = 60 h. No resonances corresponding to 
the minor diastereomer of 13m were detected by analysis of the crude 1H NMR spectrum: 
>20:1 dr. Purification by silica gel column chromatography using 90:10 hexanes/ethyl 
acetate afforded a white solid, isolated dr >20:1. Analytical data for 13m (major): mp = 
143-155 °C; 1H NMR (400 MHz, CDCl3, major diastereomer): δ 7.47 (d, J = 8.0 Hz, 2H), 
7.23 (d, J = 8.0 Hz, 2H), 5.02 (br s, 1H), 4.44–4.54 (m, 1H), 2.61–2.70 (m, 2H), 2.38 (s, 
3H), 1.57 (s, 9H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 170.8, 
168.1, 158.5, 140.5, 129.5, 127.3, 125.5, 103.2, 84.7, 81.1, 48.9, 32.0, 27.9, 27.7, 21.4; IR 
(thin film): 3460, 2980, 2360, 1729, 1394, 1302, 913 cm-1; TLC (70:30 hexanes/EtOAc): 
0.50; HRMS (ESI): Calcd. for C21H29NO6: ([M+Na]): 414.1893, Found: 414.1948; HPLC: 
IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 24.3, tR (minor) = 
20.3 min, ligand 22: 95.5:4.5 er; [α]D = 80.3 (c = 1.57, CHCl3, 91% ee, >20:1 dr). 
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-3-(3-
fluorophenyl)-5-hydroxy-4,5-dihydroisoxazole-5-
carboxylate (13n): The title compound was prepared according 
to General Procedure F. Reaction time = 35 h. The 
diastereoselectivity was determined by analysis of the crude 1H NMR by the relative 
integration of the methine resonances at δ 4.46 (major diastereomer) and δ 4.21 (minor 
diastereomer): >20:1 dr. Purification by silica gel column chromatography using 90:10 
hexanes/ethyl acetate afforded a white solid, isolated dr >20:1. Analytical data for 13n 
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(major): mp = 125-127 °C; 1H NMR (400 MHz, CDCl3, major diastereomer): δ 7.29–7.43 
(m, 3H), 7.11–7.16 (m, 1H), 5.08 (br s, 1H), 4.46 (dd, J = 10.7, 4.9 Hz, 1H), 2.59–2.72 (m, 
2H), 1.57 (s, 9H), 1.40 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 170.6, 
167.8, 162.7 (d, J19F-13C = 245.2 Hz), 157.6, 130.6 (d, J19F-13C = 8.3 Hz), 130.5 (d, 8.2 Hz), 
123.1 (d, J19F-13C = 3.3 Hz), 117.3 (d, J19F-13C = 21.1 Hz), 114.3 (d, 22.9 Hz), 103.6, 84.9, 81.4, 
48.6, 31.7, 27.9, 27.7; IR (thin film): 1731, 1700, 1541, 1369, 1147; TLC (70:30 
hexanes/EtOAc): 0.52; HRMS (ESI): Calcd. for C20H26FNO5: ([M+Na]): 418.1642, 
Found: 418.1636; HPLC: IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, 
tR (major) = 10.1, tR (minor) = 19.6 min, ligand 21: 97:3 er; [α]D = 73.2 (c = 0.81, CHCl3, 94% 
ee, >20:1 dr). 
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-3-(2-
fluorophenyl)-5-hydroxy-4,5-dihydroisoxazole-5-
carboxylate (13o): The title compound was prepared according to 
General Procedure F. Reaction time = 37 h. The diastereoselectivity 
was determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.57 (major diastereomer) and δ 4.22 (minor diastereomer): >20:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded a white solid, isolated dr >20:1. Analytical data for 13o (major): mp = 113-115 
°C; 1H NMR (400 MHz, CDCl3, major diastereomer): δ 7.67 (td, J = 7.5, 1.8 Hz, 1H), 7.41–
7.46 (m, 1H), 7.20 (td, J = 7.5, 1.0 Hz, 1H), 7.13 (dd, J = 10.8, 0.9 Hz, 1H), 5.07 (br s, 1H), 
4.57 (ddd, J = 11.6, 4.0 Hz, 2.5 Hz, 1H), 2.62 (dd, J = 17.0, 11.6 Hz, 1H), 2.52 (17.0, 4.0 
Hz, 1H), 1.58 (s, 9H), 1.38 (s, 9H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 
170.6, 167.9, 159.9 (d, J19F-13C = 248.4 Hz), 155.9 (d, J19F-13C = 1.6 Hz), 132.2 (d, J19F-13C = 
8.5 Hz), 130.4 (d, J19F-13C = 3.5 Hz), 124.8 (d, J19F-13C = 3.5 Hz), 116.6 (d, J19F-13C = 12.9 Hz), 
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116.2 (d, J19F-13C = 21.3 Hz), 103.5, 84.8, 81.1, 50.2, 31.4, 27.9, 27.7; IR (thin film): 2980, 
1729, 1599, 1394, 1233, 867, 844 cm-1; TLC (70:30 hexanes/EtOAc): 0.47; HRMS (ESI): 
Calcd. for C20H26FNO5: ([M+Na]): 418.1642, Found: 418.1648; HPLC: IA, 90:10 
hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, tR (major) = 8.0 min, tR (minor) = 13.1 
min, ligand 22: 97:3 er; [α]D = 81.0 (c = 1.21, CHCl3, 94% ee, >20:1 dr). 
tert-butyl (4S,5S)-3-(2-fluorophenyl)-5-hydroxy-4-
phenethyl-4,5-dihydroisoxazole-5-carboxylate (13p): The title 
compound was prepared according to general procedure F. Reaction 
time = 48 h. The diastereoselectivity was determined by analysis of the 
crude 1H NMR by integration of the methane resonance at δ 4.25 and the absence of an 
analogous resonance corresponding to the minor diastereomer >20:1 dr. Purification by 
silica gel column chromatography afforded an amorphous off white solid, isolated dr = 
20:1. Analytical data for 13p: 1H NMR (600 MHz, CDCl3): δ 7.68 – 7.65 (m, 1H), 7.48–
7.44 (m, 1H), 7.30–7.27 (m, 2H), 7.24–7.19 (m, 2H); 7.17–7.13 (m, 3H), 4.88 (br s, 1H), 
4.25 (dt, J = 11.4, 2.58 Hz, 1H), 2.74–2.59 (m, 2H), 2.13–2.06 (m, 1H), 1.89–1.84 (m, 1H), 
1.58 (s, 9H); 13C NMR (151 MHz, CDCl3): δ 168.4, 159.9 (d, J19F-13C = 250.8 Hz), 157.7, 
141.1, 132.1 (d, J19F-13C = 8.3 Hz), 132.1 (d, J19F-13C = 3.2 Hz), 128.3 (d, J19F-13C = 13.3 Hz), 
126.1, 124.7 (d, J19F-13C = 3.2 Hz), 116.8 (d, J19F-13C = 13.2 Hz), 116.1 (d, J19F-13C = 21.7), 103.5, 
85.1, 53.0 (d, J19F-13C = 3.4 Hz), 33.9, 27.7, 27.0; IR (thin film): 3468, 2985, 1732, 1243, 
1141, 1080, 859 cm-1; TLC (70:30 hexanes/EtOAc): Rf = 0.7; HRMS (ESI): Calcd. for 
C22H24FNO4: ([M+1]): 386.1768, Found: 386.1767; HPLC: IA, 95:5 hexanes/iPrOH, flow 
rate = 1.0 mL/min, λ = 210 nm, tR (major) = 27.1 min, tR (minor) = 22.8 min, ligand 21: 94:6 
er; [α]D = 52.0 (c = 0.40, CHCl3, 88% ee, 20:1 dr). 
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tert-butyl (4S,5S)-5-hydroxy-3-phenyl-4-propyl-4,5-
dihydroisoxazole-5-carboxylate (13q): The title compound was 
prepared according to General Procedure F. Reaction time = 36 h. The 
diastereoselectivity was determined by analysis of the crude 1H NMR by the relative 
integration of the methine resonances at δ 4.07(major diastereomer) and δ 3.74 (minor 
diastereomer): 7:1 dr. Purification by silica gel column chromatography using 90:10 
hexanes/ethyl acetate afforded a colorless oil, isolated dr = 6:1. The major and minor 
diastereomer of 13q were inseparable. Analytical data for 13q (major): 1H NMR (400 
MHz, CDCl3): δ 7.56–7.59 (m, 2H), 7.42–7.45 (m, 3H), 4.69 (br s, 1H), 4.07 (dd, J = 11.4, 
3.1 Hz), 1.61–1.85 (m, 3H), 1.55 (s, 9H), 1.23–1.45 (m, 2H), 0.91 (dd, J = 9.2, 9.2 Hz, 3H); 
13C NMR (100 MHz, CDCl3): δ 168.6, 160.6, 130.2,129.0, 128.8, 127.6, 103.6, 85.0, 52.2, 
27.8, 27.4, 21.2, 14.1; IR (thin film): 3468, 2962, 2874, 2360, 1728, 1245, 1031, 837; TLC 
(70:30 hexanes/EtOAc): 0.56; HRMS (ESI): Calcd. for C17H23NO4: ([M+Na]): 328.1525, 
Found: 328.1563; HPLC: IA, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, 
tR (major) = 31.5 min, tR (minor) = 10.6 min, ligand 22: 94.5:5.5 er; [α]D = 68.4 (c = 1.96, 
CHCl3, 94% ee, 6:1 mixture of diastereomers). 
 
 tert-butyl (4S,5S)-3-(2-fluorophenyl)-5-hydroxy-4-isopropyl-
4,5-dihydroisoxazole-5-carboxylate (13r): The title compound was prepared 
according to General Procedure F. Reaction time = 48 h. The diastereoselectivity was 
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determined by analysis of the crude 1H NMR by the relative integration of the methine 
resonances at δ 4.02 (major diastereomer) and δ 3.80 (minor diastereomer): 14:1 dr. 
Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded a colorless oil, isolated dr = 13:1. Analytical data for 13r (major): 1H NMR (500 
MHz, CDCl3, major diastereomer): δ 7.65-7.62 (m, 1H), 7.45–7.41 (m, 1H), 7.23–7.20 (m, 
1H), 7.13–7.10 (m, 1H), 4.80 (s, 1H), 4.03–4.02 (m, 1H), 2.25–2.18 (m, 1H), 1.54 (s, 9H), 
0.98 (d, J = 6.9 Hz, 3H), 0.88 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3): δ 169.0, 
160.4 (d, J19F-13C = 250.1 Hz), 157.8, 131.9 (d, J19F-13C = 8.5 Hz), 130.2 (d, J19F-13C = 3.4 Hz), 
124.8 (d, J19F-13C = 3.4 Hz), 118.5 (d, J19F-13C = 13.3 Hz), 116.0 (d, J19F-13C = 21.5 Hz), 105.2, 
84.9, 57.5 (d, J19F-13C = 3.2  Hz), 27.7, 26.4, 19.9, 19.3; IR (thin film): 3464, 3071, 2969, 
2936, 2342, 1731, 1617, 1342, 1302, 1261, 842 cm-1; TLC (70:30 hexanes/EtOAc): 0.60; 
HRMS (ESI): Calcd. for C17H22FNO4: ([M+Na]): 346.1431, Found: 346.1433; HPLC: IC, 
90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 210 nm, tR(major) = 8.7 min, tR(minor) = 
11.1 min, ligand G: 91.5:8.5 er [α]D = 45.3 (c = 0.95, CHCl3, 83% ee, 13:1 mixture of 
diastereomers) 
isopropyl (4S,5S)-4-benzyl-3-(2-fluorophenyl)-5-hydroxy-
4,5-dihydroisoxazole-5-carboxylate (13s): The title compound 
was prepared according to General Procedure F. Reaction time = 24 h. 
The diastereoselectivity was determined by analysis of the crude 1H 
NMR by the relative integration of the methine resonances at δ 4.57 (major diastereomer) 
and δ 4.46 (minor diastereomer): >20:1 dr. Purification by silica gel column 
chromatography using 90:10 hexanes/ethyl acetate afforded a colorless oil, isolated dr = 
17:1. Analytical data for 13r (major): 1H NMR (400 MHz, CDCl3, major diastereomer): δ 
7.72 (m, 1H), 7.49 (m, 1H), 7.15–7.27 (m, 7H), 4.85 (sept, J = 6.3 Hz, 1H), 4.79 (br s, 1H), 
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4.57 (dt, J = 11.8, 3.0 Hz, 1H), 2.90–3.05 (m, 2H), 1.18 (d, J = 6.3 Hz, 3H), 0.98 (d, 6.3 
Hz, 3H); 13C NMR (100 MHz, CDCl3, major diastereomer): δ 167.9, 159.9 (d, J19F-13C = 
247.8 Hz), 157.7 (d, J19F-13C = 1.5 Hz), 138.6, 132.3 (d, J19F-13C = 8.5 Hz), 130.6 (d, J19F-13C = 
3.5 Hz), 128.8, 128.3, 126.5, 124.9 (d, J19F-13C = 3.5 Hz), 116.7 (d, J19F-13C = 13.2 Hz), 116.1 
(d, J19F-13C = 21.2 Hz), 102.8, 71.9, 56.3 (d, J19F-13C = 3.46 Hz), 30.2 (d, J19F-13C = 2.5 Hz), 
21.3, 21.1; IR (thin film): 3463, 2984, 2360, 1740, 1238, 1063, 858 cm-1; TLC (70:30 
hexanes/EtOAc): 0.41; HRMS (ESI): Calcd. for C20H21FNO4: ([M+Na]): 380.1274, 
Found: 380.1256; HPLC: IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 254 nm, 
tR (major) = 20.8 min, tR (minor) = 18.6 min, ligand 22: 94:6 er; [α]D = 97.7 (c = 1.02, CHCl3, 
88% ee, 17:1 dr) 
tert-butyl (4S,5S)-4-(2-(tert-butoxy)-2-oxoethyl)-5-
hydroxy-3-((E)-styryl)-4,5-dihydroisoxazole-5-
carboxylate (13t): The title compound was prepared according to 
General Procedure F. Reaction time = 48 h. The diastereoselectivity was determined by 
analysis of the crude 1H NMR by the relative integration of the methine resonances at δ 
4.27 (major diastereomer) and δ 3.94 (minor diastereomer): 20:1 dr. Purification by silica 
gel column chromatography using 95:5 followed by 90:10 hexanes/ethyl acetate afforded 
a white solid, >20:1 dr. Analytical data for 13s (major): mp = 122 to 124 °C; 1H NMR 
(500 MHz, CDCl3): δ7.47 (m, 2H), 7.31–7.39 (m, 3H), 6.95 (d, J = 16.8 Hz, 1H), 6.86 (d, 
J = 16.8, 1H), 5.02 (br s, 1H), 4.23–4.31 (m, 1H), 2.74–2.82 (m, 2H), 1.56 (s, 9H), 1.44 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ 170.9, 167.9, 158.2, 136.4, 135.4, 129.2, 128.9, 127.0, 
116.3, 103.8, 84.8, 81.4, 47.9, 32.1, 27.9, 27.7; IR (thin film): 1732, 1473, 1396, 1151 cm-1; 
TLC (70:30 hexanes/EtOAc): Rf = 0.45; HRMS (ESI): Calcd. for C22H29NO6: ([M+H]): 
404.2073, Found: 404.2071;  HPLC: IA, 95:5 hexanes/iPrOH, flow rate = 1.0 mL/min, λ 
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= 210 nm, tR (major) = 18.9 min, tR (minor) = 17.6 min, ligand 21: 95:5 er; [α]D = 141.3 (c = 
1.43, CHCl3, 90% ee, >20:1 dr). 
tert-butyl (4S,5S)-3-(2-fluorophenyl)-5-hydroxy-4-(m-
tolyl)-4,5-dihydroisoxazole-5-carboxylate (35): The title 
compound was prepared according to General Procedure F. 
Reaction time = 36 h. The diastereoselectivity was determined by analysis of the crude 1H 
NMR by the relative integration of the methine resonances at δ = 5.40 (major 
diastereomer) and 5.03 (minor diastereomer): 1.3:1 dr. Purification by silica gel column 
chromatography using 90:10 hexanes/ethyl acetate afforded 35 as a clear oil (43.6 mg, 
0.12 mmol, 59% yield). Product 35 epimerized during chromatography to afford a 1.7:1 
mixture favoring the opposite diastereomer. The fact that this product was still isolated 
via chromatography with significant levels of enantioenrichment for both diastereomers 
suggests the ring open form is not involved in this process. The increased acidity of this 
species due to conjugation with the aryl ring may promote epimerization via an 
alkoxyenamine intermediate. The absolute stereochemical assignment for 35 is tentative.  
Analytical data for 35: 1H NMR (CDCl3, 500 MHz): Distinguishing aryl protons of 
diastereomers was not possible, the assignment that follows includes only non aromatic 
resonances:  δ 5.40 (s, 1H, minor), 5.03 (s, 1H, major), 4.77 (s, 1H, major), 4.45 (s, 1H, 
minor), 2.26 (s, 3H, major), 2.26 (s, 3H, minor), 1.59 (s, 9H, minor), 1.06 (s, 9H, major); 
13C NMR: (CDCl3, 150 MHz): δ 167.5, 166.8, 160.0 (d, J19F-13C = 252.9 Hz), 159.9 (d, J19F-
13C = 251.7 Hz), 157, 155, 138.1, 137.9, 132.7, 132.1 (d, J19F-13C = 8.4), 132.0 (d, J19F-13C = 8.5 
Hz), 131.2, 130.4, 130.0 (d, J19F-13C = 3.0 Hz), 129.7 (d, J19F-13C = 3.6 Hz), 129.6824, 128.5, 
128.1, 126.8, 126.2, 124.5, 124.5, 117.0 (d, J19F-13C  = 12.2 Hz), 116.6 (d, J19F-13C = 21.9 Hz), 
116.5 (d, J19F-13C = 8.9 Hz), 116.2 (d, J19F-13C = 21.3 Hz), 106.2, 104.2, 85.2, 84.3, 65.6 (d, 
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J19F-13C = 5.0 Hz), 59.8 (d, J19F-13C = 4.3 Hz), 27.8, 27.0, 21.3, 21.3; IR (thin film): HRMS 
(ESI): Calcd. for C21H22FNO4 HRMS (ESI): Calcd. for: ([M+H]): 372.1611, Found: 
372.1608; HPLC: IC, 85:15 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 210 nm, major 
diastereomer: tR (major) =14.3 min, tR (minor) = 23.8 min, minor diastereomer: tR (major) = 10.0 
min, tR (minor) = 21.0 min, Ligand 21: 81:19 er (major diastereomer), 84:16 er (minor 
diastereomer).  
tert-butyl (4S,5S)-3-(2-fluorophenyl)-5-hydroxy-4-
methyl-4,5-dihydroisoxazole-5-carboxylate (37): The title 
compound was prepared according to General Procedure F. 
Reaction time = 36 h. The diastereoselectivity was determined by the relative integration 
of the methane resonances at δ 4.23 and δ 3.96: 7:1 dr. Purification by silica gel column 
chromatography using 90:10 hexanes/ethyl acetate afforded 37 as an amorphous white 
solid (46.9 mg, 0.16 mmol, 79% yield), 8:1 dr. Analytical data for 37 (major): 1H NMR 
(CDCl3, 500 MHz): δ 7.82–7.79 (m, 1H), 7.46–7.42 (m 1H), 7.22–7.19 (m, 1H), 7.15–7.12 
(m, 1H), 4.69 (s, 1H), 4.23 (q, J = 7.4 Hz, 1H), 1.55 (s, 9H), 1.17 (d, J = 7.5 Hz, 3H); 13C 
NMR (CDCl3, 150 MHz): δ 168.0, 160.0 (d, J19F-13C = 249.4 Hz), 158.7, 132.1 (d, J19F-13C = 
8.6 Hz), 130.4 (d, J19F-13C  = 3.3 Hz), 124.7 (d, J19F-13C  = 3.2 Hz), 116.7 (d, J19F-13C = 12.7 Hz), 
116.1 (d, J19F-13C = 21.6), 104.2, 85.0, 48.2 (d, J19F-13C = 3.7 Hz), 27.7, 9.7 (d, J19F-13C = 1.7 
Hz); HRMS (ESI): Calcd. for C15H18FNO4: ([M+H]): 296.1298, Found: 296.1289; HPLC: 
IC, 90:10 hexanes/iPrOH, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) = 10.3 min, tR (minor) 
= 17.0 min, Ligand 21: 77:23 er. 
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tert-butyl (±)-3-(2-fluorophenyl)-5-hydroxy-4,5-
dihydroisoxazole-5-carboxylate (39): The title compound 
was prepared according to General Procedure F. Reaction time = 36 
h. Purification by silica gel column chromatography using 90:10 hexanes/ethyl acetate 
afforded 39 as a colorless oil (32.8 mg, 0.12 mmol, 58% yield) Analytical data for 39: 1H 
NMR (CDCl3, 500 MHz): δ 7.93–7.90 (m, 1H), 7.43–7.40 (m, 1H), 7.21–7.18 (m, 1H), 
7.14–7.10 (m, 1H), 4.70 (s, 1H), 3.98 (d, J = 18.1, 1H), 3.48 (dd, J = 18.1 Hz, J19F-1H = 2.6 
Hz, 1H), 1.54 (s, 9H); 13C NMR (CDCl3, 150 MHz): δ = 167.2, 160.4 (d, J19F-13C = 250.7 
Hz), 153.0 (d, J19F-13C = 2.5 Hz), 132.2 (d, J19F-13C = 8.3 Hz), 129.0 (d, J19F-13C = 2.3 Hz), 
124.6 (d, J19F-13C = 3.2 Hz), 116.8 (d, J19F-13C = 11.4 Hz), 116.4 (d, J19F-13C = 21.9 Hz), 103.4 
(d, J19F-13C = 2.4 Hz), 85.0, 45.2 (d, J19F-13C = 7.7 Hz), 27.7; HRMS (ESI): Calcd. for 
C14H16FNO4: ([M+H]): 282.1142, Found: 282.1135; HPLC: OJ-H, 91:9 hexanes/iPrOH, 
flow rate 1.0 mL/min, λ = 210 nm, tR (major) = 8.2 min, tR (minor) = 9.1 min, Ligand 21: 51:49 
er. 
 
Isoxazoline 13k (954 mg, 2.53 mmol, 90% ee) was dissolved in MeOH (12.7 mL) 
and THF (4.21 mL) in a 300 mL RBF. NiCl2·6H2O (1.80 g, 7.58 mmol) was added and the 
resulting solution was cooled to –78 °C using a dry ice/acetone bath. Sodium borohydride 
(956 mg, 25.3 mmol) was added in several portions (each addition immediately produced 
a black soot-like material, presumed to be nickel boride). After complete addition of 
NaBH4 a septum was placed on the flask, which was then sealed with electrical tape. The 
 163 
 
suspension was allowed to stir at –78 °C for 7.5 h and then warmed to room temperature 
slowly, and stirred for an additional 22 h before being quenched with ammonium 
hydroxide (50 mL). The resulting biphasic mixture was filtered through a thin pad of silica 
gel using ethyl acetate to rinse.  The aqueous layer was further extracted with ethyl acetate 
and the combined organic layers were dried over sodium sulfate and concentrated. The 
resulting material was then purified by recrystallization from ethyl acetate/hexanes 
affording 24k (white solid, 314 mg, 1.08 mmol, 94% ee, >20:1 dr, 42% yield). The higher 
level of enantioenrichment for 24k relative to 13k is most likely due to enrichment upon 
crystallization. The crude er of 24k was not measured due to the presence of co-products 
and impurities. Analytical data for 24k: 1H NMR (600 MHz, CDCl3): δ 7.33–7.41 (m, 
5H), 6.13 (br s, 1H), 4.32 (d, J = 9.3 Hz, 1H), 4.26 (d, J = 8.6 Hz, 1H), 4.00 (br s, 1H), 
2.43–2.6 (m, 3H), 1.38 (s, 9H); 13C NMR (150 MHz, CDCl3): δ 175.3, 171.5, 138.9, 129.1, 
128.8, 126.9, 81.9, 74.0, 59.2, 50.4, 35.5, 27.9; IR (thin film): 3278, 2979, 2360, 1708, 
1392, 1152 cm-1; HRMS (ESI): Calcd. for C16H22NO4: ([M+H]): 292.1549, Found: 
292.1544; HPLC: IC, 80:20 hexanes/EtOH, flow rate = 1.0 mL/min, λ = 210 nm, tR (major) 
= 13.7 min, tR (minor) = 17.2 min; [α]D = -12.8 (c = 3.42, CHCl3, 94% ee). 
 
Single crystal X-ray diffraction data were collected with a Rigaku RAXIS-RAPID 
imaging-plate diffractometer (13k) and a Bruker APEX-II CCD diffractometer (24k).  
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ORTEP drawing of 13k (CCDC 1476444). H atoms except for those on chiral 
carbon and on alcohol are omitted for the sake of clarity. 
Crystallographic data of 13k (CCDC 1476444). 
 
Molecular formula 
Formula weight 
T (K) 
Wavelength (Å) 
Color 
Crystal system 
Space group 
a (Å) 
b (Å) 
 
C20H27NO6 
377.42 
90  
1.54184  
Colourless 
Orthorhombic 
P212121 
10.67160(19) 
11.1383(2)  
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c (Å) 
V (Å3) 
Z 
Density (Mg/m3) 
Absorption coefficient (mm-1) 
F (000) 
Crystal size (mm3) 
Theta range for data collection 
(°) 
Reflections collected 
Independent reflections 
Software for refinements 
Goodness of fit on F2 
R1, wR2 [I>2 (I)] 
R1, wR2 (all data) 
Flack parameter 
 
34.5954(6)  
4112.13 (13)  
8 
1.219  
0.742  
1616 
0.495 x 0.492 x 0.224  
4.170 to 68.251  
84980 
7535 
SHELXL-2014/7 
1.087 
0.0338, 0.0725 
0.0351, 0.0730 
-0.02(4) 
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ORTEP drawing of 24k (CCDC 1476445). H atoms except for those on chiral 
carbons, amine and alcohol are omitted for the sake of clarity. 
 
Crystallographic data of 24k (CCDC 1476445). 
 
Molecular formula 
Formula weight 
T (K) 
Wavelength (Å) 
Color 
Crystal system 
Space group 
a (Å) 
b (Å) 
c (Å) 
 
C16H21NO4 
291.34 
100  
1.54178  
Colourless 
Orthorhombic 
P212121 
6.0729(3) 
8.3117(5)  
30.5846(17)  
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V (Å3) 
Z 
Density (Mg/m3) 
Absorption coefficient (mm-1) 
F (000) 
Crystal size (mm3) 
Theta range for data collection 
(°) 
Reflections collected 
Independent reflections 
Software for refinements 
Goodness of fit on F2 
R1, wR2 [I>2 (I)] 
R1, wR2 (all data) 
Flack parameter 
 
1543.79(15)  
4 
1.253  
0.736  
624 
0.341 x 0.206 x 0.038  
2.890 to 74.348  
23787 
3121 
Olex2 1.2 
1.085 
0.0320, 0.0725 
0.0323, 0.0835 
-0.02(4) 
 
 
As we described in Table 1, in the main text, we found the unique metal-dependent 
enantioswitching using (R,R)-diamine as a chiral ligand in the [3+2] cycloaddition of a-
keto ester enolate with nitrile oxide. The Ni(II)–(R,R)-diamine complex gave (R,R)-13a 
as the major product (Table 1, entries 1, 2 and 5), while Cu(II)–(R,R)-diamine complex 
mainly afforded (S,S)-13a (Table 1, entries 6–17). The enantioselectivity trend [Ni(II): 
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(R,R)-selective vs. Cu(II): (S,S)-selective] is general regardless the substituents (R and R’) 
on the (R,R)-diamine and solvents we used.  
 
 
 
On the basis of a series of structural analyses in both the solid and solution states, 
supported by DFT calculations, we proposed a model that enables the merger of enolate 
formation and H-bonding activation with amine ligand (Sohtome, Y.; Nakamura, G.; 
Muranaka, A.; Hashizume, D.; Lectard, S.; Tsuchimoto, T.; Uchiyama, M.; Sodeoka, M. 
Nature Commun., 2017, 8, 14875.). In this model, the carbonyl group in the ester in 1 
coordinates to Ni(II) at the pseudoapical position. The H-bonding activation of the (E)-
nitrone would be a key driving force for the major pathway in the [3+2] cycloadditions of 
a-keto ester enolates with (E)-nitrones. Analogically, the (R,R)-selectivity of the [3+2] 
cycloaddition of a-keto ester enolates with nitrile oxides using the Ni(II) complex can be 
well explained. 
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In contrast to the distorted octahedral Ni(II)–diamine–acetate complex, the Cu(II)–
diamine–acetate complex exhibits the distorted square-pyramidal geometry (ex. CCDC 
299401: Bandini, M.; Piccinelli, F.; Tommasi, S.; Umani-Ronchi, A.; Ventrici, C. Chem. 
Commun. 2006, 616–618. CCDC 665454: Zhang, G.; Yashima, E. Woggon, W.-D. Adv. 
Synth. Catal. 2009, 351, 1255–1262. CCDC 894524: Tanaka, K.; Asakura, A.; Muraoka, 
T.; Kalicki, P.; Urbanczyk-Lipkowska, New J. Chem. 2013, 37, 2851–2855.). As shown in 
the stick illustration below, the diamine ligand occupies the equatorial plane in the Cu(II) 
complex. One of the acetates coordinates to the Cu(II)-center in the apical-equatorial 
mode. In contrast, the other acetate coordinates to the Cu(II)-center in a monodentate 
fashion. A feature in the distorted square-pyramidal Cu(II) complex is the distance 
between Cu(II) and pseudoapical O(2) [2.78(1) Å], which is significantly longer than other 
Cu(II)–O and Cu(II)–N distances [1.907(8)–2.054(8) Å], suggesting weak coordination. 
We can find the similar structural features with other related Cu(II)–diamine–acetate 
CCDC 1482739
N
O–
N
O
H
H
CO2
tBu
OHCO2
tBu
O
N N
H H
Ph
(R,R)-diamine
Ni(OAc)2·4H2O
1a
Ph
R R
Ni–O1: 2.140(1) Å
Ni–O2: 2.101(1) Å
Ni–O3: 2.045(1) Å
Ni–O4: 2.302(1) Å
Ni–N1: 2.091(1) Å
Ni–N2: 2.109(1) Å
Ni
N1
N2
O1
O2
O3
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complexes (CCDC 665454 and CCDC 894524). Based on these structural features in the 
Cu(II)–diamine–acetate complexes as well as our structural investigation of Ni(II)–
diamine–acetate complex (Sohtome, Y.; Nakamura, G.; Muranaka, A.; Hashizume, D.; 
Lectard, S.; Tsuchimoto, T.; Uchiyama, M.; Sodeoka, M. Nature Commun., 2017, 8, 
14875.), we speculate that a Cu(II)–enolate, in which the carbonyl group in the ester 
coordinates to Cu(II) at the pseudoapical position, is generated. Considering that the N–
H functionality on the Cu(II)–diamine complex can act as Brønsted acid (CCDC 1038527: 
Tanaka, K.; Iwashita, T.; Yoshida, E.; Ishikawa, T.; Otuka, S.; Urbanczyk-Lipkowska, Z.; 
Takahashi, H. Chem. Commun. 2015, 51, 7907.), we assume that the H-bonding 
activation of the nitrile oxide with amine ligand is a reasonable mechanistic scenario to 
explain the obtained absolute stereochemistry of 13a. Further mechanistic studies are 
ongoing.  
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